Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.846127085158298,2.524954623631687,0.0,0.0,0.0,19/29,9.43%,GRIA2;GABRB3;GABRA5;GABRB1;GRIA4;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GABRB2;GRIN2D;GLRA3;GRIK2;GRIK5;GABRG2;GLRA2
prerank,glutamate receptor activity (GO:0008066),0.8784443744564708,2.389610342799117,0.0,0.0,0.0,13/19,4.69%,GRIA2;GRM5;GRIA4;GRM7;GRM1;GRID1;GRID2;GRM8;GRIA1;GRIK1;GRIN2D;GRIK2;GRIK5
prerank,ligand-gated ion channel activity (GO:0015276),0.7672833878728025,2.355583392408898,0.0,0.0,0.0,14/30,7.39%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3
prerank,ligand-gated cation channel activity (GO:0099094),0.6420017938318655,2.354082834711169,0.0,0.0,0.0,23/75,8.42%,GRIA2;GRIN1;GRIA4;KCNJ3;ASIC2;KCNJ6;KCNN2;GRIN2A;ASIC4;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;KCNJ11;KCNN1;ASIC1;KCNJ10;TRPM2;GRIA3;KCNN3;KCNK1
prerank,ligand-gated channel activity (GO:0022834),0.7692825073635022,2.3406960691835783,0.0,0.0,0.0,14/29,7.39%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.7587441034144597,2.2750358927078613,0.0,0.0,0.0,11/28,8.57%,GABRA5;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GRIK2;GRIK5;GABRG2
prerank,GABA-A receptor activity (GO:0004890),0.8413085822294664,2.273870574893399,0.0,0.0,0.0,10/18,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRD;GABRG2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.8402257483601354,2.238498273576659,0.0,0.0,0.0,12/17,10.09%,GRIA2;GRIN1;GRIA4;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3;GRIN3A
prerank,ligand-gated anion channel activity (GO:0099095),0.8349337895539204,2.228242757218956,0.0,0.0,0.0,12/17,9.43%,GABRB3;GABRA5;GABRB1;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;GLRA3;GABRG2;GLRA2
prerank,GABA receptor activity (GO:0016917),0.7900315550994753,2.2278139089486357,0.0,0.0,0.0,10/21,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRD;GABRG2
prerank,voltage-gated cation channel activity (GO:0022843),0.5792585894853038,2.22314722892096,0.0,0.0,0.0,33/97,11.73%,KCND2;HCN1;GRIN1;CACNA1A;KCNH7;CACNA1B;KCNQ3;KCNC2;GRIN2A;KCNH5;KCNH8;GRIN2B;CACNA2D1;GRIN2D;CACNG2;KCNJ11;CACNA1E;HCN2;KCND3;KCNC3;KCNH1;KCNQ5;CACNB2;LRRC55;KCNC1;KCNK1;CACNG3;OPRM1;GRIN3A;CACNG8;CACNB4;KCNQ2;KCNA2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.8139259213234685,2.1957802256875865,0.0,7.18401707974765e-05,0.001,11/19,8.57%,GABRA5;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GRIK2;GRIK5;GABRG2
prerank,potassium channel activity (GO:0005267),0.575517193639357,2.142421545861219,0.0,0.00013262800762611044,0.002,27/89,8.42%,KCND2;HCN1;KCNH7;KCNQ3;KCNC2;KCNN2;KCNH5;GRIK1;KCNH8;KCNMB2;KCNMB3;GRIK2;GRIK5;KCNJ11;KCNN1;KCNK13;KCNK10;KCNMB4;HCN2;KCND3;KCNC3;KCNH1;KCNQ5;KCNK9;LRRC55;KCNC1;KCNK1
prerank,platelet-derived growth factor binding (GO:0048407),-0.8737684179330525,-2.131272626109392,0.0,0.0,0.0,7/11,3.45%,COL1A2;COL3A1;COL5A1;COL1A1;PDGFRA;PDGFRB;COL6A1
prerank,chloride channel activity (GO:0005254),0.6046806927452679,2.122808901139984,0.0,0.00018473186776493957,0.003,18/59,11.00%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;GLRA3;TTYH2;ANO5;GABRD;GABRG2;ANO4;GLRA2;CLCN1
prerank,cell adhesion mediator activity (GO:0098631),0.7400057012882042,2.110141760526415,0.0,0.00017241640991394358,0.003,17/24,14.58%,DSCAM;BSG;LRRC4C;PLXNB3;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ESAM;NINJ1;NTNG1;ROBO3;CNTN4;CNTN2;JAM3;BCAM
prerank,retinoid binding (GO:0005501),-0.7338722266314905,-2.0732308434210216,0.0,0.0016884930786995422,0.003,7/22,5.81%,NR2F2;ALDH1A2;PTGDS;RBP1;CYP26B1;RBP4;ABCA4
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8657658792334464,2.0712412040134773,0.0,0.0003771608966867515,0.007,9/12,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRG2
prerank,amyloid-beta binding (GO:0001540),0.5610275358217951,2.0612786213220637,0.0,0.0004563963791839683,0.009,29/79,13.89%,GRIA2;ITM2A;GRIN1;CACNA1A;GRIA4;CACNA1B;NLGN1;MAPK8IP2;GRIN2A;GRIA1;APBB1;GRIN2B;APBA2;PFDN5;APBB3;TGFB2;FZD6;CLU;PFDN6;ATP1A3;GRIA3;ITM2C;TLR2;APBB2;FZD4;ITGAM;SORL1;INSR;CD36
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.8324672136020079,2.052500924958909,0.0,0.000574721366379812,0.011,9/13,9.43%,GABRA5;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GLRA3;GABRG2;GLRA2
prerank,anion channel activity (GO:0005253),0.5827630464217889,2.043338756020771,0.0,0.0005898456128634912,0.012,18/61,10.28%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;LRRC8B;GABRB2;GLRA3;ANO5;GABRD;GABRG2;ANO4;GLRA2;VDAC2
prerank,voltage-gated potassium channel activity (GO:0005249),0.5609538638706876,2.022803907119061,0.0,0.001163810766919119,0.024,22/80,8.42%,KCND2;HCN1;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNJ11;KCNN1;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;KCNN3;LRRC55;KCNC1;KCNK1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.7032556367748886,1.9835098703641325,0.0,0.002586246148709154,0.053,3/21,3.12%,GRM5;GRM1;GRIA1
prerank,histone acetyltransferase activity (GO:0004402),-0.6413245077662144,-1.9221949613113305,0.0,0.04052383388878901,0.092,15/30,16.89%,KAT2B;EP300;KAT6B;BAZ1A;CREBBP;HAT1;ATF2;TADA3;KAT14;MCM3AP;EPC2;KAT8;BRCA2;ARRB1;EPC1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7387587138769431,1.9186972633171135,0.0,0.006634283598862611,0.143,6/16,2.83%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7387587138769431,1.9186972633171135,0.0,0.006634283598862611,0.143,6/16,2.83%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PTPRT
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.829511918584197,1.8896365433620734,0.004524886877828055,0.009446982459868159,0.206,6/10,8.57%,GABRA5;GABRA2;GABRG3;GABRA3;GABRA4;GABRG2
prerank,glycine binding (GO:0016594),0.7860188701922867,1.879897729087119,0.0,0.010517401004750558,0.233,6/11,10.09%,GRIN1;GLRA1;GRIN2B;GLRA3;GLRA2;GRIN3A
prerank,protease binding (GO:0002020),-0.4894929872174433,-1.8682127970445634,0.0,0.06782113866109828,0.194,39/99,19.92%,COL1A2;COL3A1;TIMP3;STIM1;COL1A1;ITGAV;CFLAR;CCBE1;PRKN;GSK3B;ITGB1;LCOR;DPP4;ANXA2;TRIP4;BCL2;F3;ADAMTSL4;LDLR;SELENOS;CHMP3;LONP2;RHBDD2;FAP;RIOK3;FN1;SRI;BRCA2;BDKRB2;ECM1;SERPINE1;BFAR;DERL1;SYVN1;VCP;PARK7;ITGB3;TIMP2;CARD16
prerank,Toll-like receptor binding (GO:0035325),0.7853091694685485,1.8654435252640604,0.0022222222222222222,0.01246703271685438,0.278,7/11,13.89%,TIRAP;S100A8;S100A9;TOLLIP;TLR2;DAB2IP;CD36
prerank,R-SMAD binding (GO:0070412),-0.6760981202602775,-1.820421199965979,0.001937984496124031,0.10851382185775725,0.341,10/18,14.60%,SMAD3;LDLRAD4;SMAD6;DDX5;SMAD2;PMEPA1;JUN;SMAD4;PPM1A;SMURF1
prerank,amino acid binding (GO:0016597),0.5871414764895895,1.815829229518207,0.0021008403361344537,0.02231834639441603,0.449,9/31,10.09%,GRIN1;GRM7;AARS2;GLRA1;GRIN2B;GLRA3;NOS3;GLRA2;GRIN3A
prerank,sodium channel activity (GO:0005272),0.5763676014658955,1.814836033791588,0.0,0.021675205817752907,0.45,12/37,8.42%,HCN1;SCN1A;ASIC2;ASIC4;GRIK1;GRIK2;GRIK5;SCN4B;ASIC1;HCN2;SCN3A;KCNK1
prerank,glutamate receptor binding (GO:0035254),0.6792650930966347,1.7969910511176994,0.002036659877800407,0.0259813693559977,0.52,9/17,10.22%,CAMK2A;IGSF11;SHISA6;SHANK3;HIP1;SHISA7;HOMER1;SHANK2;HOMER2
prerank,semaphorin receptor binding (GO:0030215),0.6163383897811341,1.787449551251511,0.009689922480620155,0.0281038748159728,0.563,8/23,4.44%,RIT2;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,calcium-activated potassium channel activity (GO:0015269),0.7576234649268458,1.775685758256394,0.002,0.031285235669868794,0.614,6/11,7.73%,KCNN2;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNN3
prerank,SUMO transferase activity (GO:0019789),-0.683274643922644,-1.7751123613083475,0.005607476635514018,0.16265816658138924,0.513,8/16,15.42%,PIAS1;HDAC4;RANBP2;NSMCE2;PIAS3;UBE2I;PIAS4;TOPORS
prerank,chemorepellent activity (GO:0045499),0.5943838046350868,1.7743134482356175,0.003913894324853229,0.030927193528313628,0.621,9/25,4.44%,NRG3;SEMA3C;SEMA6A;NRG1;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,ankyrin binding (GO:0030506),0.6336589220865625,1.7631325339571207,0.0044742729306487695,0.03440491088737329,0.668,8/19,11.30%,SLC4A1;SPTBN4;SPTB;SLC8A1;KCNJ11;NRCAM;KCNQ2;SPTBN1
prerank,inward rectifier potassium channel activity (GO:0005242),0.60636390832221,1.7596809279317218,0.0042643923240938165,0.03458470340038515,0.678,8/24,8.42%,KCNJ3;KCNJ6;KCNN2;KCNJ11;KCNN1;KCNJ10;KCNN3;KCNK1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.642956150930214,-1.7550929340532997,0.00749063670411985,0.1809099727178081,0.613,7/18,7.85%,PDLIM5;BAIAP2L1;RAB10;ANXA2;TMOD3;ANXA1;CNN3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6347276983244877,1.7519689545728665,0.005928853754940711,0.03709415904719986,0.714,5/19,5.39%,NRG3;GRM5;NRG1;GAS6;CD24
prerank,histone demethylase activity (GO:0032452),-0.5826685893123201,-1.7508235696490602,0.0019305019305019305,0.16589444498223002,0.629,11/27,15.84%,KDM7A;KDM4B;PHF8;KDM5B;KDM6A;PHF2;FBXL19;KDM3B;KDM3A;JARID2;KDM2A
prerank,ion channel activity (GO:0005216),0.467668931697,1.7402961342256271,0.0,0.041092577696156554,0.764,18/80,7.39%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;ASIC4;GRIA1;GRIK1;GRIN2B;GRIN2D;UNC80;GRIK2;GRIK5;TMEM63B;TRPM2;GRIA3
prerank,androgen receptor binding (GO:0050681),-0.5887772409520011,-1.7251934525989587,0.0038535645472061657,0.19599027069053204,0.719,16/25,25.26%,FOXP1;DDX5;EP300;TGFB1I1;NSD1;PRPF6;PRMT2;WIPI1;KDM3A;RNF14;PARK7;ARID5A;RNF6;TRIM68;KDM1A;ZBTB7A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.5565170204787182,-1.723279191066034,0.0,0.18145672285757747,0.727,17/33,25.47%,PCF11;SCAF8;DHX9;AR;CTR9;TBP;RPRD2;WDR43;GTF2B;HNRNPU;CDC73;DRAP1;WAC;CCAR2;AGO1;RTRAF;RECQL5
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6746855658235911,-1.6955641467778393,0.007858546168958742,0.22277875347447898,0.832,6/15,21.06%,ALDH1A1;ALDH1A2;ALDH2;ALDH1L1;ALDH7A1;ALDH4A1
prerank,I-SMAD binding (GO:0070411),-0.6782028724201115,-1.6912104004474766,0.011516314779270634,0.21265632274510346,0.844,10/13,21.37%,SMAD3;TGFBR1;SMAD6;TGFB1I1;SMAD2;AXIN1;SMAD4;SMURF1;SMAD9;SMAD1
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5852749008676472,-1.6892425489523983,0.012145748987854251,0.2004544347276636,0.848,8/23,6.46%,RBMS1;RBMS3;ATXN1;HNRNPH1;DIS3L2;KHDRBS1;RBMS2;U2AF2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.68564162095329,-1.6873842290467935,0.003838771593090211,0.1890308203820297,0.855,4/13,2.70%,BMP6;BMP5;BMP7;BMP4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6931665387973385,-1.6871233182813188,0.007518796992481203,0.17702911878454314,0.855,6/13,21.06%,ALDH1A1;ALDH1A2;ALDH2;ALDH1L1;ALDH7A1;ALDH4A1
prerank,cAMP binding (GO:0030552),0.7112916066908663,1.6870166738795016,0.015151515151515152,0.06812778143086096,0.915,6/11,13.00%,HCN1;PDE4B;PDE10A;PDE2A;PDE4D;PDE4A
prerank,transforming growth factor beta binding (GO:0050431),-0.5900324638715612,-1.682770465771348,0.003795066413662239,0.1737037254712154,0.864,12/23,16.39%,TGFBR3;TGFBR1;LTBP1;ITGAV;TGFBR2;THBS1;TWSG1;CD109;ACVR1;TGFB3;LRRC32;VASN
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6983745439038171,1.6811306320602157,0.017130620985010708,0.07005550971240233,0.928,2/11,6.29%,HCN1;HCN2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.3969563611360866,-1.6714624946542596,0.0,0.185138299923291,0.901,58/188,17.19%,ZBTB20;PBX1;BNC2;TCF7L2;SMAD3;SOX5;CREB3L2;NFKB1;PRDM5;SMAD6;FOXC1;PER3;FOXO3;HDAC4;BCOR;NCOR1;TFEB;TBL1X;BRD7;TBL1XR1;YAP1;KMT2D;HMGB1;GABPB2;STAT3;FOXC2;RUNX1;DHX9;REST;AR;DHX36;FOXK1;TBP;NFYC;CHD3;GABPA;NR1H3;JUN;CALCOCO1;SMAD4;GLIS2;ZBED4;TBX18;MEF2C;ARID5B;IRF1;SOX13;GLI1;ATF6;SOX6;HINFP;RXRA;KLF15;FOXK2;VSX1;SFPQ;SIX1;NFYB
prerank,poly(U) RNA binding (GO:0008266),-0.6014064375467063,-1.6705315871541444,0.014028056112224449,0.17629118477237074,0.902,7/20,5.06%,RBMS1;RBMS3;ATXN1;HNRNPH1;DIS3L2;KHDRBS1;RBMS2
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.3893020099674836,-1.669320135601905,0.0,0.16902704398350155,0.905,75/232,21.13%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;RNF43;UBR2;TRIM44;PIAS1;KCMF1;PRKN;ARIH1;WWP2;TRIP12;RNF115;RNF217;HUWE1;UBR5;UHRF2;RBBP6;DTX4;RC3H1;MEX3C;SH3RF1;UFL1;NSMCE2;RNF19A;WWP1;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;HLTF;RNFT1;XIAP;PIAS3;RNF216;HERC2;UBR1;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;PIAS4;TRIM25;DTX3L;NHLRC3;SH3RF2;SMURF1;UBR4;TRIM39;SH3RF3;TOPORS;MSL2;RNF181;HECTD1;BFAR;MYLIP;SYVN1;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;ANAPC11;TRIM63;ARIH2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.34816216344146694,-1.6577270822168215,0.0,0.1799370790867479,0.931,183/732,18.30%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;NR3C2;TFEB;MXI1;HOXB3;MEOX2;FOXN3;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;JDP2;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;CEBPG;HOXB5;ZBTB37;GTF2IRD1;AR;DHX36;ZNF496;FOXK1;MAFG;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;ZNF18;CARF;SNAPC3;HOXB9;ZNF697;RXRA;HOXC5;KLF15;RUNX2;MNT;FOXK2;SALL1;PRDM15;ATOH8;IKZF2;KLF6;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;NFYB;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1
prerank,DNA-binding transcription factor binding (GO:0140297),-0.39545668779539406,-1.656957961653687,0.0,0.17276232357614682,0.933,54/189,14.63%,FHL2;TCF7L2;SMAD3;PRRX1;PRDM5;RBPJ;PIAS1;EP300;HDAC4;RERE;NCOR1;RBBP8;WWP2;GSK3B;YAP1;MEF2A;HMGB1;SMAD2;CBX5;SKI;CREBBP;NBN;STAT3;BCL2;DHX9;CRTC3;AR;RUNX1T1;TBP;PIAS3;DACT1;ATF2;TEAD3;CHD4;MIER1;EIF4E;GABPA;JUN;HCFC1;CRTC1;ID2;TLE4;TLE1;MEF2C;HES1;SIK1;TCF3;PIAS4;RB1;BHLHE41;CGGBP1;TCERG1;STAT1;HDAC1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5458680100020575,1.6529211885187305,0.016359918200409,0.08841867175074028,0.967,8/32,11.73%,KCNQ3;KCNC2;KCNC3;KCNH1;KCNQ5;KCNC1;KCNQ2;KCNA2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.3465630135505286,-1.6504862565912464,0.0,0.17580794601247357,0.945,184/731,18.30%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;CREB3L2;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;NR3C2;TFEB;MXI1;HOXB3;MEOX2;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;JDP2;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;CEBPG;HOXB5;ZBTB37;GTF2IRD1;AR;DHX36;ZNF496;FOXK1;MAFG;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;ZNF18;CARF;SNAPC3;HOXB9;ZNF697;RXRA;HOXC5;KLF15;RUNX2;MNT;FOXK2;SALL1;PRDM15;ATOH8;PRMT5;IKZF2;KLF6;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;NFYB;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1
prerank,glucose transmembrane transporter activity (GO:0005355),0.6153491676852956,1.6469968618261215,0.014925373134328358,0.09062637546101658,0.968,4/17,4.30%,SLC2A1;SLC2A3;SLC2A5;SLC5A11
prerank,BMP receptor binding (GO:0070700),-0.6856432956266685,-1.6414135234941962,0.011342155009451797,0.18421704197753846,0.954,4/12,2.70%,BMP6;BMP5;BMP7;BMP4
prerank,ubiquitin protein ligase activity (GO:0061630),-0.3803159676819429,-1.6372920122563248,0.0,0.18423335592032783,0.957,72/228,21.13%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;RNF43;UBR2;TRIM44;KCMF1;PRKN;ARIH1;WWP2;TRIP12;RNF115;RNF217;HUWE1;UBR5;UHRF2;RBBP6;DTX4;RC3H1;MEX3C;SH3RF1;RNF19A;UBE4B;WWP1;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;UBE2K;HLTF;RNFT1;XIAP;RNF216;HERC2;UBR1;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;TRIM25;DTX3L;NHLRC3;SH3RF2;SMURF1;UBR4;TRIM39;SH3RF3;TOPORS;MSL2;RNF181;HECTD1;BFAR;MYLIP;SYVN1;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;ANAPC11;TRIM63;ARIH2
prerank,G protein-coupled receptor activity (GO:0004930),0.38057050145007704,1.6278313927499974,0.0,0.10353395151417782,0.979,57/239,19.10%,ADGRL4;PAX8;GRM5;ADGRL3;ADGRB3;MTNR1B;HCAR2;GRM1;ADGRB1;GRM8;ADRB1;S1PR5;HCRTR1;GPR101;GPR149;LGR5;MTNR1A;GPR35;P2RY1;ADGRA1;APLNR;ELOVL4;GPR26;GPR17;ADRA1D;ADRA1A;ADGRL2;GPR75;TRHR;GPR176;HCRTR2;OPRM1;MRGPRE;CELSR2;F2RL2;F2R;CNR1;GRPR;GPR85;RORB;GRM3;OPRK1;ADGRG1;OPRL1;NPFFR2;NPR1;CALCRL;ADCYAP1R1;ADGRE1;GPR45;CYSLTR1;C3AR1;NTSR2;GPR22;ADGRE5;S1PR1;ADORA2A
prerank,thyroid hormone receptor binding (GO:0046966),-0.5473539771731475,-1.624579407620931,0.011009174311926606,0.19829662716247423,0.97,18/28,27.07%,NCOR1;TRIP12;MED17;NSD1;MED12;NCOA6;MED1;PRMT2;GTF2B;TRIP6;MED16;ARID5A;HMGN3;MED13;GTF2H1;TAF7;GAS2L1;JMJD1C
prerank,calcium ion binding (GO:0005509),0.36306670205732255,1.6174408526783732,0.0,0.10952547182152414,0.984,61/323,11.21%,SPOCK2;ADGRL3;SPOCK1;GRIN1;NRXN1;CDH12;CDH8;SYT1;PCLO;SYT6;S100A16;RASGRP3;KCNIP4;MMP12;SYT7;CDH7;CDH19;CDH20;S100A8;S100A9;S100G;DNER;SYT12;SYT11;CDH18;RYR2;MCTP1;CDH2;RYR3;MEX3B;SNCA;KCNIP1;SLC8A1;ENPP2;RCN2;CDH10;PITPNM1;SLC25A23;HSPA5;SLIT3;SLIT1;TRPM2;CPNE1;MELK;CIB2;TUBB4A;THBS3;SYT10;DYSF;S100A2;PCDHB6;TPT1;ARSA;DCHS1;PVALB;ASTN2;GALNT3;AIF1;CALM1;PCDHA4;SYT2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6139816827872548,-1.6136726685678957,0.007984031936127744,0.2095896152303714,0.978,6/18,5.30%,TGFBR3;SMAD3;TGFBR1;SMAD6;TGFBR2;SMAD2
prerank,SH2 domain binding (GO:0042169),-0.5234500585906725,-1.612124620444935,0.01006036217303823,0.20420343455482368,0.978,8/31,7.61%,AFAP1;DAG1;SH3PXD2B;ABL1;PAG1;IRS1;KHDRBS1;INPPL1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.7116543574399481,-1.6045973413458403,0.012987012987012988,0.2114234547828784,0.982,7/10,22.25%,SETD5;NSD3;NSD1;SETD3;SETD2;ASH1L;PRDM9
prerank,calcium activated cation channel activity (GO:0005227),0.5954235082710938,1.6035086128380693,0.019569471624266144,0.11938833965552723,0.991,6/17,6.13%,KCNN2;KCNMB2;KCNMB3;KCNN1;TMEM63B;KCNMB4
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.3336415873374322,-1.603493404120884,0.0,0.2058020759371258,0.982,203/831,18.69%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;AEBP1;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;CUX1;OSR1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;TFDP2;JDP2;HOXC8;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;VEZF1;CEBPG;HOXB5;ZBTB37;GTF2IRD1;ZBTB8A;AR;DHX36;ZNF496;FOXK1;CDC5L;MAFG;TBP;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;CREBRF;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;RB1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;TRPS1;ZFP3;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;PRDM2;ZNF18;CARF;SNAPC3;HOXB9;ZNF697;RXRA;HOXC5;KLF15;RUNX2;BBX;MNT;FOXK2;SALL1;PRDM15;ATOH8;IKZF2;KLF6;GTF2B;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;ZFP37;NFYB;TWIST2;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1;ZKSCAN7;ZNF436;NFATC3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.522556370036864,1.600564211880406,0.01511879049676026,0.11965306992550608,0.993,8/30,11.74%,SLC39A10;SLC40A1;SLC39A2;SLC30A1;SLC30A3;SLC25A37;SLC39A8;SLC30A5
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5960874589667813,-1.600269269215219,0.0210727969348659,0.2045327949331379,0.984,5/18,3.24%,TGFBR3;TGFBR1;BMPR1A;LTBP1;TGFBR2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.513706115481687,-1.591947901343419,0.013671875,0.21442046515528593,0.99,15/34,15.54%,GAB2;FCHSD2;MYO1B;ADAP2;GBF1;ARAP1;MAPKAP1;CYTH3;ZFYVE1;DAPP1;IQGAP2;KIF16B;OGT;PARD3;ZFYVE16
prerank,calcium-dependent phospholipid binding (GO:0005544),0.46961070340578226,1.5872898113793934,0.010526315789473684,0.1294847238453716,0.994,12/49,7.68%,SYT1;PCLO;SYT6;SYT7;SYT12;SYT11;MCTP1;CPNE9;CPNE8;CPNE1;SYT10;DYSF
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.5029100851392184,-1.5844693682704707,0.016981132075471698,0.22277555557092085,0.997,19/33,34.27%,PCF11;SCAF8;DHX9;CTR9;RPRD2;SPTY2D1;WDR43;GTF2B;HNRNPU;CDC73;WAC;CCAR2;AGO1;RTRAF;RECQL5;RRN3;ZNF326;ELOF1;URI1
prerank,carboxylic acid binding (GO:0031406),0.488801583551701,1.580896381385078,0.008264462809917356,0.13351027219857978,0.994,10/38,10.09%,GRIN1;GRM7;MAG;GLRA1;GRIN2B;GLRA3;NOS3;RTN4R;GLRA2;GRIN3A
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.6513453368304597,-1.5787876977686999,0.018832391713747645,0.2278953991675079,0.999,7/12,20.79%,GAB2;IRS1;SHC1;FRS2;SH2B1;BLNK;PIK3R1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.5796995829738656,-1.5736074963132611,0.024778761061946902,0.23066139763332766,0.999,9/19,18.94%,PRKN;LCOR;SELENOS;CHMP3;RHBDD2;DERL1;SYVN1;VCP;PARK7
prerank,nuclear receptor binding (GO:0016922),-0.40521167260343904,-1.5727609796681161,0.006024096385542169,0.22564699886011408,0.999,63/111,30.15%,FOXP1;TCF7L2;SMAD3;DDX5;EP300;NCOR1;TRIP12;TGFB1I1;BAZ2A;PPARGC1B;LCOR;BCAS3;MED17;DCAF1;TRIP4;NSD1;MED12;PRPF6;PPARGC1A;NCOA6;NCOA1;MED1;JUP;PRMT2;TADA3;HIF1A;WIPI1;MMS19;STAT1;KDM3A;LATS1;RXRA;GTF2B;NR4A1;CNOT1;NR4A2;STAT5B;RNF14;PARK7;TRIP6;MED16;TACC2;PPID;ARID5A;HMGN3;MED13;SMARCD3;MED14;GTF2H1;RNF6;TRIM68;KDM1A;PHB2;ZBTB7A;TAF7;GAS2L1;JMJD1C;ESR1;NCOA7;NR1H4;CALR;SNW1;THRAP3
prerank,vinculin binding (GO:0017166),-0.6604921023888985,-1.572403012384992,0.02490421455938697,0.21997312608613484,0.999,5/11,16.24%,DAG1;CTNNA1;TLN1;SYNM;SORBS3
prerank,metalloendopeptidase activity (GO:0004222),-0.4344590936668491,-1.571573920919983,0.0055762081784386614,0.21579245778767303,0.999,21/76,12.76%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS5;ECE1;ADAMTSL4;ADAMTS9;NRDC;MMP14;ADAM9;MBTPS2;ADAM19;ADAMTS15;MMP2;ADAM33;NLN
prerank,frizzled binding (GO:0005109),-0.49771403658934765,-1.565874295843345,0.011385199240986717,0.2200669312571737,0.999,15/34,25.50%,LRP6;WNT4;RNF43;WNT5B;WNT6;RYK;WNT9A;FZD7;WNT5A;FZD1;MYOC;DVL3;WNT16;DVL2;ZNRF3
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.4498701914687024,-1.5498265958179582,0.0137524557956778,0.24455729668070464,1.0,18/60,15.20%,LRRK1;CTDSPL;PPM1D;LRRK2;PPM1E;CDC14A;PPP4C;CAMK2G;SSU72;PPP2CB;PPM1H;PPM1M;MTMR3;PPM1A;CTDSPL2;DUSP1;CDC14B;PPP1CB
prerank,peptidoglycan binding (GO:0042834),0.6563639368677618,1.5481953800539856,0.05010893246187364,0.16746402367173455,1.0,3/10,10.02%,PGLYRP1;TLR2;NOD1
prerank,cyclic nucleotide binding (GO:0030551),0.5581147098044394,1.545905266275036,0.034552845528455285,0.16697451697603474,1.0,8/21,13.00%,HCN1;PDE4B;PDE10A;PDE2A;PDE11A;KCNH1;PDE4D;PDE4A
prerank,AMP binding (GO:0016208),-0.6572668242354821,-1.5440247349799994,0.028089887640449437,0.24998140030146726,1.0,6/11,21.93%,PRKAG2;MPPED2;PFKP;PRKAG3;PFKM;PFKL
prerank,RNA polymerase II complex binding (GO:0000993),-0.4934867957836147,-1.5429011122539131,0.030418250950570342,0.2463552584580649,1.0,14/32,25.47%,PCF11;SCAF8;DHX9;CTR9;RPRD2;WDR43;GTF2B;HNRNPU;CDC73;WAC;CCAR2;AGO1;RTRAF;RECQL5
prerank,ligand-gated calcium channel activity (GO:0099604),0.5599721706672336,1.541913270547322,0.0395010395010395,0.16873936606986048,1.0,7/19,6.47%,GRIN1;GRIN2A;RYR2;RYR3;GRIN2B;GRIN2D;TRPM2
prerank,neuropeptide binding (GO:0042923),0.5628064481365178,1.5405434789075394,0.03023758099352052,0.16724391761652527,1.0,5/18,15.07%,GPR149;OPRM1;SORL1;OPRK1;OPRL1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.32738198576649297,-1.5382978099684415,0.0,0.24995057860241163,1.0,111/597,13.72%,ZBTB20;PBX1;BNC2;FOXP1;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;MAF;SOX5;TEAD1;CREB3L2;NFKB1;PRDM5;HOXB6;THRB;SMAD6;GLI2;NR1D2;RARB;FOXC1;PER3;FOXO3;HDAC4;CREB5;ABL1;BCOR;NCOR1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;NR6A1;NFIX;YAP1;GMEB1;RARG;KMT2D;HMGB1;NR3C1;KLF3;PRRX2;HOXA5;GABPB2;TBX15;ZIC5;STAT3;TEF;HOXA7;JDP2;HOXC8;ELF4;FOXC2;RUNX1;HOXC4;DHX9;REST;KDM5B;CEBPG;HOXB5;ZBTB37;AR;DHX36;FOXK1;MBD2;MAFG;TBP;SP2;NFYC;ATF2;HOXB4;UBP1;CHD3;RFX2;GABPA;NR1H3;JUN;CALCOCO1;SMAD4;GLIS2;MCM9;NFATC4;ZBED4;TBX18;MEF2C;ARID5B;TFCP2;HES1;TEAD2;IRF9;TCF7L1;BHLHE41;IRF1;YBX1;SOX13;GLI1;ATF6;SOX6
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.6168653089789238,-1.53824921314295,0.040780141843971635,0.24421630901066715,1.0,6/14,19.73%,CYB5R4;NOX4;AIFM1;CYBA;MICAL1;NCF2
prerank,voltage-gated sodium channel activity (GO:0005248),0.5447286105951774,1.5379595169779825,0.03171247357293869,0.16715939976852823,1.0,9/22,15.79%,HCN1;SCN1A;SCN4B;HCN2;SCN3A;SCN2A;CACNA1I;SCN8A;SCN2B
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5210635081563971,-1.5369097685671846,0.04174573055028463,0.24137776056863908,1.0,8/25,10.49%,GAB2;PLEKHA2;FCHSD2;ADAP2;MAPKAP1;ZFYVE1;DAPP1;KIF16B
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5383814151700662,1.5349199148892396,0.0440251572327044,0.16732681012129158,1.0,5/22,6.46%,SYT1;AP2M1;APBB1;APBB3;CLU
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.34073634783054313,-1.5265451297655919,0.0,0.25670097738688447,1.0,105/346,21.19%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;UBE2N;RNF43;UBE2E2;UBR2;TRIM44;KCMF1;BCOR;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;UBR5;UHRF2;RBBP6;RNF213;DTX4;RC3H1;MEX3C;SH3RF1;RNF214;RNF19A;WWP1;UBE2H;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;FBXO10;UBE2K;HLTF;MAEA;RNFT1;XIAP;DDB2;FBXO3;ANAPC4;TNFAIP1;RNF216;HERC2;RNF103-CHMP3;TRAF2;UBR1;UBE2R2;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;TRIM25;DTX3L;NHLRC3;SH3RF2;UBE2B;SMURF1;UBR4;TRIM39;SH3RF3;CUL2;TOPORS;ERCC8;UBE2E1;MSL2;TRAF3;RNF181;HECTD1;RNF20;BFAR;FBXO22;UBE2S;MYLIP;UBA7;SYVN1;FBXW11;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;PML;ANAPC11;CUL1;TRIM63;TTC3;ARIH2;SHARPIN
prerank,histone methyltransferase activity (GO:0042054),-0.48838293321647813,-1.52588510809074,0.03501945525291829,0.25241747980848955,1.0,17/32,24.47%,SETD7;KMT5B;KMT2C;NSD3;SMYD3;SETD2;PRMT2;N6AMT1;SETDB1;EHMT1;PRMT5;PRMT8;KMT5A;NTMT1;EZH2;PRDM9;KMT2E
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6374962456074079,-1.523017507235843,0.03189493433395872,0.2533937130871086,1.0,5/12,3.24%,TGFBR3;TGFBR1;BMPR1A;LTBP1;TGFBR2
prerank,potassium:proton antiporter activity (GO:0015386),-0.6576987975118395,-1.5131835821670214,0.036297640653357534,0.26865800985530497,1.0,3/10,6.17%,SLC9A1;SLC9A8;SLC9A2
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6197386976275951,-1.5124615845399727,0.04570383912248629,0.264691391194233,1.0,6/12,16.31%,SULF1;GNS;SULF2;ARSK;ARSI;GALNS
prerank,tau-protein kinase activity (GO:0050321),-0.539461416896128,-1.510496638090679,0.045368620037807186,0.2635850262055232,1.0,10/20,19.80%,ROCK2;ROCK1;GSK3B;MARK3;MARK4;BRSK1;MARK1;SIK3;PRKAA1;TAOK1
prerank,hexose transmembrane transporter activity (GO:0015149),0.6289126410002533,1.5101077315979172,0.0457516339869281,0.195090794387532,1.0,3/12,2.66%,SLC2A1;SLC2A3;SLC2A5
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5829186718366023,1.510004292942817,0.05732484076433121,0.19162168224046894,1.0,7/15,7.08%,HS6ST3;HS3ST6;HS3ST5;HS3ST2;HS6ST2;NDST4;HS3ST4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.4793332525552713,-1.5026840198258253,0.030476190476190476,0.2742642483126864,1.0,16/32,29.50%,FTO;KDM7A;KDM4B;PHF8;TMLHE;EGLN3;BBOX1;ALKBH1;KDM2A;TYW5;JMJD4;TET2;EGLN2;PHYHD1;HSPBAP1;TET3
prerank,potassium channel regulator activity (GO:0015459),0.4420666595337752,1.498284803999718,0.026156941649899398,0.20382754495644748,1.0,12/49,8.46%,DPP10;KCNIP4;KCNIP1;WNK2;KCNMB2;KCNMB3;DPP6;KCNMB4;KCNAB1;AKT1;LRRC55;SGK3
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6186413896080901,-1.497110383271704,0.0450281425891182,0.27964043064923955,1.0,6/12,24.27%,SLC9A1;SLC9A8;SLC9A2;LETM1;SLC9B2;SLC9A9
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.6221070425076036,-1.493423116380947,0.04716981132075472,0.2814367520232407,1.0,7/12,26.22%,CYFIP2;LARP1;GEMIN5;EIF4E;EIF4E3;NCBP3;NCBP2
prerank,single-stranded DNA binding (GO:0003697),-0.3878549310176408,-1.4907403268223614,0.011627906976744186,0.28189496176856677,1.0,48/93,32.86%,RBMS1;RAD23B;RBBP8;TOP1;HMGB1;SMC6;WDR48;RAD51B;TDP2;MLH1;DHX9;FUBP1;DHX36;PCBP2;SSBP2;MCM9;RTF1;RAD51D;NABP2;APTX;MCM6;BRCA2;CTC1;MSH3;DMC1;SPRTN;WBP11;HNRNPU;POLR2H;PARK7;STN1;SSBP1;ERCC1;CRY2;LONP1;MCM4;POLR2D;MCMDC2;IGHMBP2;SAMHD1;TWNK;NEIL3;RNF138;RPA2;PCBP1;RAD51;CDC45;POLA1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4593940883909312,1.489195542500745,0.02012072434607646,0.21273414005364166,1.0,14/42,12.11%,DSCAM;BSG;LRRC4C;PLXNB3;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ESAM;NTNG1;ROBO3;CNTN4;CNTN2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6418992232037396,1.481246397927904,0.056133056133056136,0.22064763195039672,1.0,5/10,9.16%,IGSF11;SHISA6;SHANK3;SHISA7;SHANK2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.47627373327065925,-1.4781279555392013,0.026871401151631478,0.3032533569344378,1.0,17/34,25.85%,STK3;FAM20A;CCNT2;CAB39L;CCNT1;IGF2;MAP2K1;CCNK;RICTOR;DDX3X;MTCP1;TAOK1;CAB39;ALS2;DBF4;IRGM;INCENP
prerank,glycerophospholipid flippase activity (GO:0140333),0.6250496182318951,1.4775439398442867,0.0782608695652174,0.22170372157555018,1.0,7/11,11.06%,ATP8A1;ATP11A;ATP10A;ATP10B;ATP11C;ATP8A2;ABCB4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.442514723142272,-1.476691958037898,0.025793650793650792,0.3011548012509112,1.0,21/44,24.47%,SETD7;KMT5B;SETD5;KMT2C;KMT2D;NSD3;NSD1;SMYD3;SETD3;SETD2;N6AMT1;SETDB1;EHMT1;KMT5C;ASH1L;KMT5A;KMT2A;EZH2;PRDM9;CXXC1;KMT2E
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.35323539813003724,-1.4715853379995838,0.005940594059405941,0.3062788205561544,1.0,46/173,18.69%,ZBTB20;FOXP2;FOXP1;AEBP1;NFKB1;PRDM5;ZNF148;FOXP4;ZFHX3;ZEB1;FOXO3;MXI1;KCNIP3;ZKSCAN3;NR3C1;SKI;ZBTB16;JDP2;SKIL;ZEB2;REST;ZBTB37;GTF2IRD1;FOXK1;SP2;ZBTB1;JUN;NFATC4;TBX18;HES1;ZNF692;TCF3;BHLHE41;ZBTB34;PATZ1;SOX13;TRPS1;PRDM2;MNT;FOXK2;HEYL;TBX2;ZFP37;CC2D1A;ZNF436;NFATC3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5549151377026407,1.4661092317438504,0.0613107822410148,0.2303914277475071,1.0,4/16,8.67%,ANO3;TTYH2;ANO5;ANO4
prerank,intracellular chloride channel activity (GO:0061778),0.5549151377026407,1.4661092317438504,0.0613107822410148,0.2303914277475071,1.0,4/16,8.67%,ANO3;TTYH2;ANO5;ANO4
prerank,FAD binding (GO:0071949),-0.5106290607868866,-1.465752720441296,0.05385996409335727,0.31411793653738035,1.0,11/24,18.28%,MICAL3;DDO;MICAL2;MTHFR;AIFM1;SQOR;PRODH;KDM1B;NQO2;MICAL1;SQLE
prerank,carboxy-lyase activity (GO:0016831),0.5143506232982286,1.4654030461010656,0.059063136456211814,0.22753313111594192,1.0,6/23,10.45%,FAHD1;DDC;PISD;MVD;UXS1;GAD1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6040228642222918,-1.4623090858956995,0.06043956043956044,0.31631103674304756,1.0,6/12,14.77%,KDM7A;KDM4B;PHF8;PHF2;KDM3B;KDM3A
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5922815744345615,-1.462196249434294,0.049523809523809526,0.31132060164378006,1.0,8/13,19.37%,PDGFRA;PDGFRB;PDGFC;VEGFA;ERN1;VEGFD;ITGA5;ITGB3
prerank,hexosaminidase activity (GO:0015929),-0.6052966710583852,-1.462181537267191,0.06432748538011696,0.3062354386996602,1.0,6/12,19.93%,CEMIP;OGA;HEXD;CEMIP2;HEXA;NAGA
prerank,rRNA binding (GO:0019843),0.44338731603126025,1.4621681984275972,0.03549060542797495,0.22859078862784132,1.0,18/42,18.59%,RPL23;RPF2;RPLP0;MRPS18A;RPL12;MRPS7;RPL5;ERI1;FASTKD5;RPS14;RPS3;UTP23;RPS5;MDM2;PPAN;RPS9;CIRBP;MRPL18
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.42782630490261214,-1.4613835126973602,0.029013539651837523,0.30289387131123074,1.0,27/53,27.41%,MICAL3;AOX1;DDO;MICAL2;POR;NOX4;MTHFR;AIFM1;SQOR;PRODH;KDM1B;PPOX;DPYD;ACOX1;NQO2;MICAL1;SQLE;SDHA;NOS1;ACOX3;ILVBL;CRY2;KDM1A;GSR;MTO1;ACADVL;GFER
prerank,acetyltransferase activity (GO:0016407),-0.4858245968272165,-1.4595245962562522,0.04093567251461988,0.3020526507451403,1.0,11/31,16.29%,KAT2B;EP300;KAT6B;CREBBP;PAFAH2;PAFAH1B2;SAT1;KAT8;NAA15;ESCO1;GTF2B
prerank,neuropeptide receptor activity (GO:0008188),0.4851634376316586,1.4580936559120141,0.03319502074688797,0.23114746002113767,1.0,7/29,11.38%,SORCS3;TACR1;SORCS1;TACR3;HCRTR2;OPRM1;GRPR
prerank,methylation-dependent protein binding (GO:0140034),-0.42043748135621234,-1.4569269817214356,0.028282828282828285,0.3030493306874283,1.0,30/57,30.87%,KDM7A;CBX5;PYGO1;PHF8;CHD8;PHF2;ZCWPW2;MPHOSPH8;TDRD3;KAT8;ING5;PHF1;L3MBTL2;MORC3;MSL3;RRP8;BPTF;MSH6;ZMYND8;MORC4;ING1;NCAPD3;SPIN1;CXXC1;KMT2E;ATRX;ZMYND11;GLYR1;WDR5;CDYL
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.47018553444532585,1.4539566132402841,0.049079754601226995,0.23361076540136902,1.0,7/32,9.58%,SLC7A5;SLC6A6;SLC1A1;MFSD12;SLC7A8;SLC43A2;SLC36A1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.46507281457086597,1.4528599713618717,0.043209876543209874,0.22800764026195447,1.0,17/34,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFB9;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.46507281457086597,1.4528599713618717,0.043209876543209874,0.22800764026195447,1.0,17/34,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFB9;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,retinoic acid binding (GO:0001972),-0.5980286731308184,-1.451250334934189,0.06077348066298342,0.3099900113715057,1.0,2/12,3.51%,NR2F2;CYP26B1
prerank,regulatory RNA binding (GO:0061980),-0.4504914253231338,-1.4463331513797655,0.04150943396226415,0.3156458728029538,1.0,8/38,8.05%,DICER1;PUM2;ZC3H7A;RC3H1;DHX9;PUM1;TUT4;RBM10
prerank,RNA polymerase binding (GO:0070063),-0.5376342980473308,-1.444796103937003,0.06818181818181818,0.3145805413489575,1.0,9/18,15.53%,CCNT2;PABPN1;CCNT1;SCAF8;DHX9;PHRF1;STOM;TCERG1;ANP32B
prerank,GTPase binding (GO:0051020),-0.3384520946704224,-1.4390382768570313,0.005917159763313609,0.3218565777368157,1.0,71/194,23.03%,AKAP13;RNF152;AFDN;PLCE1;ABCA1;ERC1;LRRK2;FLNA;DOCK7;MAPKAP1;SGSM2;RADIL;DNM1L;PDE6D;RANBP2;STRN3;PAK2;TMEM127;RAB3GAP1;BRAF;BRK1;USP6NL;UNC13B;IQGAP2;TNFAIP1;LZTR1;CDC42EP5;RUSC2;USP33;TBC1D20;GGA3;EXOC2;NCKAP1;ARFIP2;YBX3;FGD1;BECN1;YBX1;ARHGDIB;FGD4;ANKRD27;RANBP9;WASF1;RCC1;WHAMM;STOML2;RASA1;GNB1;PICALM;CCDC186;CDC42EP4;AMBRA1;ANKFY1;RABGGTB;RHOH;CHM;TRIOBP;RTKN;RABGAP1;TBC1D7;TRIP11;CHML;DVL3;BNIP3;GGA2;ALS2;ATG14;RAPGEF4;TNPO3;XPO5;RGP1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.3302443551200841,-1.438320589103405,0.004008016032064128,0.31854604690519095,1.0,65/254,18.69%,NFIA;HLF;NFAT5;TCF4;SMAD3;PRRX1;NFKB1;RBPJ;MDM4;FOXC1;FOXO3;HOXB3;MEOX2;ELF1;NFIB;RREB1;GMEB1;MEF2A;NR3C1;SMAD2;HOXA5;PLSCR1;ZBTB16;STAT3;HOXA7;TFDP2;ELF4;FOXC2;RUNX1;HOXC4;VEZF1;CEBPG;AR;CDC5L;NFYC;ATF2;UBP1;GABPA;JUN;HIF1A;SMAD4;GLIS2;CREBRF;MEF2C;NRF1;TFCP2;TCF3;IRF1;ATF6;HINFP;PRDM2;KLF15;FOXK2;PRDM15;KLF6;ZNF112;MYBL1;SIX1;NR4A1;SMARCD2;NFYB;NR4A2;NFIC;TFCP2L1;NFATC3
prerank,sialyltransferase activity (GO:0008373),0.5252992340163911,1.436952677547299,0.05531914893617021,0.2483696985499144,1.0,7/20,12.69%,ST6GALNAC3;ST8SIA4;ST3GAL6;ST8SIA1;ST8SIA6;ST8SIA3;ST6GAL2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.43284239131357255,-1.436339099612031,0.046153846153846156,0.3180477724811385,1.0,14/48,18.38%,TRPM3;PIEZO2;NALCN;ATP6V1B2;SLC41A1;TRPM6;SLC12A7;CALHM2;SLC12A2;PKD2;TRPM4;CALHM5;TRPV2;TRPM7
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5194814868495409,1.4351611308858767,0.0668103448275862,0.24739219287210992,1.0,6/20,11.74%,SLC39A10;SLC39A2;SLC30A1;SLC30A3;SLC39A8;SLC30A5
prerank,sodium:proton antiporter activity (GO:0015385),-0.5994175260601459,-1.4318762503638496,0.08073394495412844,0.32317598982358187,1.0,5/11,24.27%,SLC9A1;SLC9A8;SLC9A2;SLC9B2;SLC9A9
prerank,chemokine binding (GO:0019956),-0.4773511060259278,-1.4301863722215014,0.06593406593406594,0.3223927386654006,1.0,9/30,21.57%,ITGAV;PDPN;CCR9;HMGB1;ITGB1;ITGA4;CX3CR1;ITGB3;FGF2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.6178419579377626,1.4268202724478483,0.08444444444444445,0.25653812643210167,1.0,3/11,12.78%,KCNJ3;KCND3;KCNJ8
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.3378824067554069,-1.426791727354842,0.001984126984126984,0.32527007307843053,1.0,49/181,14.63%,TCF7L2;SMAD3;PRRX1;RBPJ;MDFIC;PIAS1;EP300;HDAC4;RERE;NCOR1;ARNT;RBBP8;WWP2;GSK3B;ANXA4;MEF2A;BAZ2A;BCAS3;CREBBP;STAT3;TRIP4;DHX9;AR;TAF4;PPARGC1A;TBP;PIAS3;NCOA1;DACT1;MED1;JUP;ATF2;TEAD3;CHD4;MIER1;JUN;TADA3;HIF1A;PARP9;ID2;HES1;TCF3;PIAS4;RB1;BHLHE41;DTX3L;TCERG1;STAT1;HDAC1
prerank,alanine transmembrane transporter activity (GO:0022858),0.5957969773680506,1.4266433927933133,0.10021786492374728,0.25311960521152016,1.0,4/12,16.03%,SLC6A6;SLC7A8;SLC36A1;SLC3A2
prerank,metal ion binding (GO:0046872),0.31040155687105153,1.423189340580052,0.0,0.2551762866726365,1.0,88/477,12.30%,SPOCK2;ADGRL3;SPOCK1;GRIN1;NRXN1;CDH12;CDH8;SYT1;MT2A;PCLO;SYT6;S100A16;RASGRP3;KCNIP4;MMP12;SYT7;CDH7;CDH19;CDH20;S100A8;S100A9;S100G;DNER;SYT12;SYT11;CDH18;RYR2;MCTP1;CDH2;PDE2A;PGP;RYR3;MEX3B;SNCA;KCNIP1;NUDT3;SLC8A1;ENPP2;RCN2;MT1G;MT1B;MT1F;MT1E;MT1X;MT1A;MT1M;MT1H;CDH10;PITPNM1;SLC25A23;HSPA5;CSGALNACT1;SLIT3;SLIT1;NUDT12;TRPM2;CPNE1;MELK;CIB2;TUBB4A;HPRT1;THBS3;SYT10;DYSF;S100A2;IDH3G;PCDHB6;TPT1;ARSA;TPPP;ACVR1C;DCHS1;PIF1;PVALB;ASTN2;GALNT3;IMPA1;AIF1;APEX1;CALM1;PCDHA4;BRSK2;SYT2;SNN;HACL1;RET;SPARCL1;SNCB
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.607476537002202,-1.4195698418357052,0.0625,0.33753128759697426,1.0,4/11,20.59%,UBR5;UBE4B;UBE2K;ANAPC11
prerank,transcription cis-regulatory region binding (GO:0000976),-0.3109071179128329,-1.4167877708323755,0.0,0.3392295161312627,1.0,93/406,17.31%,ZBTB20;PBX1;BNC2;FOXP1;AEBP1;TCF7L2;GLI3;SMAD3;SOX5;TEAD1;CREB3L2;NFKB1;PRDM5;SMAD6;FOXC1;PER3;FOXO3;HDAC4;BCOR;NCOR1;ARNT;CUX1;OSR1;TFEB;MXI1;TBL1X;BRD7;FOXN3;TBL1XR1;RREB1;YAP1;MEF2A;KMT2D;HMGB1;NR3C1;SMAD2;GABPB2;STAT3;TFDP2;HOXC8;FOXC2;RUNX1;REST;VEZF1;ZBTB8A;AR;DHX36;TAF4;FOXK1;CDC5L;TBP;NFYC;ATF2;CHD3;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;CREBRF;ZBED4;XRN2;TBX18;RORA;MEF2C;ARID5B;TFCP2;TCF3;RB1;IRF1;SOX13;GLI1;ATF6;SOX6;TRPS1;ZFP3;HINFP;HDAC1;PRDM2;SNAPC3;RXRA;KLF15;BBX;MNT;FOXK2;VSX1;SFPQ;SIX1;ZFP37;NFYB;TWIST2
prerank,small GTPase binding (GO:0031267),-0.34035004424697335,-1.4155874806764361,0.009746588693957114,0.3375208796263611,1.0,65/169,24.36%,AKAP13;RNF152;AFDN;PLCE1;ABCA1;ERC1;LRRK2;FLNA;DOCK7;MAPKAP1;SGSM2;DNM1L;PDE6D;RANBP2;STRN3;PAK2;TMEM127;RAB3GAP1;BRAF;BRK1;USP6NL;UNC13B;IQGAP2;TNFAIP1;LZTR1;CDC42EP5;RUSC2;USP33;TBC1D20;GGA3;EXOC2;NCKAP1;ARFIP2;YBX3;FGD1;ARHGDIB;FGD4;ANKRD27;RANBP9;WASF1;RCC1;WHAMM;PICALM;CCDC186;CDC42EP4;ANKFY1;RABGGTB;RHOH;CHM;TRIOBP;RTKN;RABGAP1;TBC1D7;TRIP11;CHML;DVL3;GGA2;ALS2;RAPGEF4;TNPO3;XPO5;RGP1;GCC1;RAB8A;KIF3A
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.6232726856668431,-1.4143510981185956,0.08014571948998178,0.33622209798277725,1.0,4/10,15.84%,KDM7A;KDM4B;PHF8;KDM2A
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5765211730594386,-1.4134419251286652,0.08159392789373814,0.3337010722971753,1.0,6/13,24.27%,SLC9A1;SLC9A8;SLC9A2;LETM1;SLC9B2;SLC9A9
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6180571457276873,-1.4129123544560263,0.08823529411764706,0.3305741723698682,1.0,3/10,11.00%,SLC6A13;SLC6A12;SLC6A1
prerank,sequence-specific DNA binding (GO:0043565),-0.2999262901481362,-1.4116791773114363,0.0,0.3291435841411641,1.0,96/590,12.24%,ZBTB20;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;MAF;TEAD1;FOXD1;PRDM5;HOXB6;ZNF148;SMG6;RBPJ;THRB;GLI2;ZNF423;NR1D2;RARB;FOXC1;FOXO3;SMG1;HDAC4;CREB5;ABL1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;ELF1;NFIB;NR6A1;NFIX;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;PRRX2;HOXA5;TBX15;ZIC5;TEF;HOXA7;JDP2;HOXC8;BCL2;ELF4;FOXC2;HOXC4;ZEB2;KDM5B;CEBPG;HOXB5;ZBTB37;HNRNPD;SAFB2;FOXK1;MBD2;PPARGC1A;MAFG;SP2;SMG7;ATF2;HOXB4;UBP1;UPF1;RFX2;GABPA;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;NFATC4;TBX18;RORA;MEF2C;FBXL19;TFCP2;TELO2;HES1;TEAD2;IRF9
prerank,DNA binding (GO:0003677),-0.2958045287324156,-1.4049670351388883,0.0,0.33968589565969476,1.0,269/694,30.95%,PBX1;RBMS1;FOXP2;DENND4A;NR2F2;EGFR;HLF;ZIC4;TCF4;TCF7L2;SMAD3;TEAD1;FOXD1;PRDM5;ZNF148;HIVEP2;INO80;RBPJ;THRB;GLI2;ZNF423;RARB;FOXC1;ZIC2;FOXO3;EP300;HDAC4;ABL1;ARNT;CUX1;RAD23B;MEOX2;RBBP8;NFIB;NUPR1;NR6A1;TOP1;CCNT1;BCLAF3;KHDRBS1;EZH1;RARG;MEF2A;KMT2D;HUWE1;HMGB1;ZKSCAN3;SMC6;SMAD2;RBM6;HOXA5;CREBBP;ZBTB16;NBN;STAT3;WDR48;HOXA7;RAD51B;TDP2;MLH1;DNMT3A;BCL2;FOXC2;CHD8;DHX9;ZEB2;KDM5B;HDGFL2;CEBPG;FUBP1;DHX36;ZNF496;SAFB2;PCBP2;AIFM1;WRN;TAF4;PPARGC1A;CDC5L;NFYC;DDB2;CHD2;CHD4;CHD3;RFX2;NR1H3;SSBP2;JUN;DDX60;HIF1A;CALCOCO1;SMAD4;MCM9;BCLAF1;XRN1;RTF1;XRCC4;ZMYM4;RORA;RAD51D;ARID5B;PDS5B;ERCC3;SPTY2D1;TFCP2;HES1;WDR76;NABP2;TCF3;TCF7L1;CCDC25;PATZ1;APTX;CGGBP1;IRF1;TSHZ3;YBX1;SOX13;ZMYM3;GLI1;ATF6;PARP4;SOX6;PHF1;STAT1;PRKDC;RBM5;HINFP;CRLF3;MCM6;BRCA2;CTC1;ILF2;DDX3X;PRDM2;MSH3;CARF;SNAPC3;TOPORS;RXRA;FOXK2;DMC1;SFPQ;MRE11;FOXL1;SPRTN;CAMTA2;SIX1;TBX2;NR4A1;NFYB;ZDHHC1;POGK;NR4A2;WBP11;HNRNPU;TAF6L;MSL3;SDE2;DCLRE1A;POLR2H;PARK7;BPTF;GTF3C4;ELK4;MSH6;RNF11;H1-0;TERT;PCNA;SMC1A;TAF12;NFYA;ZBTB49;ZIC3;STN1;SURF6;USF1;XRCC6;CXXC5;ARID5A;SSBP1;DRAP1;MYRF;PRDM9;SPHK1;IRF2;CLSPN;MAFK;MAFB;DEDD;DNASE2;RAD51C;HDAC2;ERCC1;HSF1;NR2F1;TFAP4;MBD3;ZNF35;ARID3B;GTF3C1;SIRT3;TSHZ2;FOXE1;SNAPC1;CRY2;ZBTB7A;CREBZF;QRICH1;SPO11;KIN;ATAD5;PPARA;OGG1;ZNF219;HOXB2;NR2C1;ENDOV;ORC1;GTF3C6;TIPIN;MBD6;MAFF;SOX12;LONP1;GTF2H4;ZNF292;DNASE1L1;SAP30L;MCM4;APP;SOX10;SAFB;POLR2D;MPG;SLTM;CDK9;MCMDC2;TIMELESS;CGAS;ZBTB4;IGHMBP2;E2F1;SUPV3L1;ZMYND11;EGR1;ZFPL1;FOXO4;POLRMT;NR1H4;GLYR1;NFE2L2;SAMHD1;HIC1;CALR;THRAP3;ZNF76;BATF;PSIP1;MLX;MLXIPL;GTF2A1;CR2;FANCG;TWNK;FOXD2;NR5A2;SOX8
prerank,monocarboxylic acid binding (GO:0033293),-0.5136410052186613,-1.399564415143453,0.08499095840867993,0.3476511155940318,1.0,4/18,15.55%,NR2F2;CYP26B1;NAPEPLD;RXRA
prerank,poly-purine tract binding (GO:0070717),-0.4651258086641828,-1.3945952041029417,0.07676767676767676,0.353810501502921,1.0,6/27,5.06%,RBMS1;RBMS3;RBPMS;ATXN1;KHDRBS1;RBMS2
prerank,methylated histone binding (GO:0035064),-0.39513681112577326,-1.394588207163541,0.04276985743380855,0.3495984717231243,1.0,31/62,30.87%,KDM7A;CBX5;PYGO1;PHF8;CHD8;PHF2;ZCWPW2;MPHOSPH8;TDRD3;KAT8;ING5;PHF1;L3MBTL2;MORC3;MSL3;RRP8;BPTF;MSH6;ZMYND8;MORC4;ING1;NCAPD3;SPIN1;CXXC1;KMT2E;TAF7;ATRX;ZMYND11;GLYR1;WDR5;CDYL
prerank,cytochrome-c oxidase activity (GO:0004129),0.5415666945183598,1.3915654510859443,0.09401709401709402,0.30334512119234447,1.0,8/15,21.29%,COX7A1;NDUFA4;COX4I1;COX6A1;COX6B1;COX10;COX8A;COX5B
prerank,phospholipase activator activity (GO:0016004),-0.606261843708702,-1.3873079401210018,0.12384473197781885,0.36150967892031455,1.0,3/10,11.22%,ARHGAP6;PDPK1;STX4
prerank,histone acetyltransferase binding (GO:0035035),-0.5023552299439438,-1.3872456909732733,0.09072978303747535,0.3574893253135031,1.0,14/21,28.90%,GLI3;KANSL1L;MEF2A;BCAS3;TRIP4;HIF1A;STAT1;CITED2;PCNA;EID1;TRIM68;ZBTB7A;TAF7;EGR1
prerank,lipoprotein particle binding (GO:0071813),0.5013255328238044,1.385169738985825,0.0967032967032967,0.3100306855801891,1.0,7/20,14.42%,PLTP;SCARF1;HSPD1;SORL1;SCARB1;CD36;STAB2
prerank,metallopeptidase activity (GO:0008237),-0.35586288109507813,-1.379638395998518,0.020872865275142316,0.37030399932858926,1.0,26/113,12.76%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;PAPPA;ADAMTS5;BRCC3;MYSM1;ECE1;ANPEP;ADAMTSL4;ADAMTS9;NRDC;MMP14;ADAM9;LAP3;MBTPS2;ADAM19;ADAMTS15;MMP2;ADAM33;NLN
prerank,muscle alpha-actinin binding (GO:0051371),-0.5420038295285048,-1.376903439326611,0.09963768115942029,0.3722231825536211,1.0,6/15,12.34%,PDLIM5;PDLIM7;PALLD;SYNPO2;PDLIM2;PKD2
prerank,double-stranded DNA binding (GO:0003690),-0.2948612506885503,-1.3746278926738178,0.002127659574468085,0.3733024211072433,1.0,101/531,17.06%,ZBTB20;PBX1;RBMS1;FOXP1;EGFR;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;GLI3;MAF;TEAD1;HOXB6;THRB;GLI2;NR1D2;RARB;FOXO3;CREB5;ABL1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;ELF1;RBBP8;NFIB;NR6A1;TOP1;NFIX;GMEB1;RARG;HMGB1;NR3C1;KLF3;SMAD2;PRRX2;HOXA5;TBX15;ZIC5;WDR48;TEF;HOXA7;RAD51B;JDP2;HOXC8;ELF4;FOXC2;HOXC4;DHX9;KDM5B;HDGFL2;CEBPG;HOXB5;ZBTB37;FOXK1;MAFG;SP2;ATF2;HOXB4;UBP1;RFX2;GABPA;JUN;DDX60;GLIS2;NFATC4;TBX18;MEF2C;TFCP2;HES1;TEAD2;IRF9;TCF7L1;BHLHE41;APTX;CGGBP1;YBX1;ATF6;STAT1;PRKDC;MSH3;HOXB9;RXRA;KLF15;RUNX2;BBX;DMC1;VSX1;KLF6;MRE11;SPRTN;CAMTA2;SIX1;TBX2;NR4A1
prerank,pentosyltransferase activity (GO:0016763),-0.4357673246639262,-1.3713745893278784,0.08243727598566308,0.376609000686829,1.0,12/36,13.63%,LARGE1;TNKS2;UPP2;ZC3HAV1;PARP10;PARP14;PARP9;PPAT;PARP1;QTRT2;SIRT5;PARP4
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3943384277946488,1.3637298114713137,0.060542797494780795,0.3451706627932591,1.0,25/57,21.30%,NDUFC1;COX7A1;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;UQCRH;NDUFB9;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;COX5B;NDUFB7
prerank,transcription coregulator binding (GO:0001221),-0.39901540439475713,-1.3637233369427333,0.058333333333333334,0.38992438700928184,1.0,20/50,21.59%,SMAD3;THRB;PER3;CCNT2;VGLL4;LCOR;ZBTB16;AR;UBE2I;SMAD4;RORA;TEAD2;EHMT1;USP11;PHF1;CNOT2;NEK6;TERT;ZBTB49;EZH2
prerank,manganese ion binding (GO:0030145),-0.40314009223367275,-1.36272926904487,0.06395348837209303,0.3881943471586984,1.0,20/48,23.92%,LARGE1;MPPED2;B4GALT1;ABL1;XPNPEP1;TDP2;WRN;ME1;ABL2;FAM20C;PPM1M;PCK2;XYLT2;SOD2;NEK4;GALNT1;B4GALT7;MPPE1;XXYLT1;PRIMPOL
prerank,protein serine/threonine kinase activity (GO:0004674),-0.30330506118777806,-1.3614403803523967,0.0,0.3871188110110929,1.0,110/334,22.14%,ROCK2;GRK5;EGFR;TGFBR1;BMPR1A;CDK8;TLK1;CLK1;MAPK4;MYLK;ARAF;STK3;FAM20A;ROCK1;SMG1;CAMK1D;LRRK2;PRKAA2;TGFBR2;CSNK1A1;TOP1;GSK3B;STK17B;TBK1;IRAK3;NRK;MARK3;CDK16;BCR;CDK7;SLK;PAK2;ALPK1;MAP4K4;TAOK3;EIF2AK3;CAMK2D;IRAK2;MTOR;BRAF;MAP3K5;PDPK1;CAMK2G;MARK4;MAP2K1;CDK13;GRK3;WNK4;CCNK;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;FAM20C;PRKAB2;CLK3;CDK11B;ULK2;RIOK3;MKNK2;SIK1;EIF2AK4;RPS6KC1;STK33;CPNE3;MAPK6;EIF2AK2;PRKDC;BMP2K;ACVR1;ERN1;LATS1;PRKCZ;MAP3K14;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;TRIO;IKBKE;DAPK2;PRKACA;PRKD1;PRKAA1;NEK4;CSNK1D;STK16;MAP3K1;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;NRBP2;BCKDK;CDK6;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;SIK2
prerank,active ion transmembrane transporter activity (GO:0022853),0.4345537986080843,1.360618859283184,0.09033613445378151,0.3469018167468545,1.0,9/37,9.69%,SLCO1C1;SLC4A1;SLCO4C1;COX7A1;NDUFA4;COX4I1;COX6A1;SLCO5A1;SLCO2B1
prerank,transcription corepressor binding (GO:0001222),-0.4489333022032825,-1.3581391289104345,0.08893280632411067,0.3905568316929566,1.0,13/27,28.18%,PER3;LCOR;ZBTB16;RORA;EHMT1;USP11;PHF1;CNOT2;NEK6;EZH2;ZBTB7A;HDAC3;ESR1
prerank,four-way junction DNA binding (GO:0000400),-0.5168007218326497,-1.3578053559616492,0.09523809523809523,0.38720404789995544,1.0,8/17,23.22%,ABL1;HMGB1;RAD51B;WRN;RAD51D;FANCM;MSH6;RAD51C
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.38704408562851705,1.3507049040640235,0.06875,0.3604637285687697,1.0,15/60,8.39%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK;ACVRL1;EPHA10
prerank,GTPase activator activity (GO:0005096),-0.30170999400866627,-1.343920672010411,0.00408997955010225,0.41365735298862816,1.0,84/313,16.78%,AKAP13;RANBP3L;ALDH1A1;ARHGAP29;DENND4A;DOCK5;ARHGAP10;ARHGAP42;DOCK11;ERRFI1;PLCE1;ASAP3;SIPA1L1;DENND2A;FARP1;ARHGAP28;ASAP1;STXBP5;ARHGAP20;LRRK2;ARHGEF10L;ARHGEF17;ARAP1;TBC1D16;SMAP1;SBF2;IQSEC2;ARHGAP24;BCR;SGSM2;DNM1L;RANBP2;SEC23A;NRP1;ARFGEF1;RAB3GAP1;CYTH3;GMIP;RAPGEF3;VAV2;ARHGAP17;USP6NL;RAB3IL1;IQGAP2;ARFGAP1;ARFGAP3;TBC1D2B;HERC2;TBC1D20;TBC1D8B;RAB3IP;RCC1L;JUN;RP2;ARHGEF18;FNIP1;DENND4C;ARHGAP32;MON1A;SERGEF;SEC23B;FGD1;DNMBP;TBCK;DENND5A;GRTP1;TBC1D22B;FGD4;ANKRD27;RCC1;TBC1D9;ACAP2;RAPGEF2;FARP2;RASA1;SH3BP5L;NGEF;ARRB1;ARHGAP18;DOCK1;ARHGEF11;ARHGEF6;RIC8B;TBCD
prerank,lipoprotein particle receptor binding (GO:0070325),0.447182002750827,1.3438849233635768,0.09552845528455285,0.36901590069893375,1.0,6/27,9.08%,SYT1;AP2M1;APBB1;APBB3;CLU;RELN
prerank,low-density lipoprotein particle binding (GO:0030169),0.5187169913262318,1.343236342872661,0.11555555555555555,0.3656222600232799,1.0,6/16,14.42%,PLTP;SCARF1;SORL1;SCARB1;CD36;STAB2
prerank,peptidase inhibitor activity (GO:0030414),-0.4360791499293485,-1.343099763220931,0.10318949343339587,0.4112263968164741,1.0,9/33,11.79%,CAST;PROS1;GPC3;TFPI;ITIH2;RECK;RENBP;SERPIND1;PSMF1
prerank,voltage-gated ion channel activity (GO:0005244),0.5372635676899727,1.3419231510681937,0.13276231263383298,0.36352581414324064,1.0,5/14,14.61%,KCND2;HCN1;CACNA1E;VDAC2;VDAC3
prerank,transcription coactivator binding (GO:0001223),-0.48666204491787507,-1.3419020350160438,0.12601626016260162,0.41000517308966095,1.0,8/20,12.15%,SMAD3;THRB;CCNT2;VGLL4;AR;SMAD4;RORA;TEAD2
prerank,anion transmembrane transporter activity (GO:0008509),0.5534677800778847,1.3354064198142725,0.16274089935760172,0.3713310668265363,1.0,4/12,10.66%,SLC4A1;ABCG2;SLCO2B1;SLC39A8
prerank,secondary active transmembrane transporter activity (GO:0015291),0.40262483982098696,1.3345210783499768,0.07261410788381743,0.3686092556147853,1.0,11/51,9.69%,SLCO1C1;SLC7A5;SLC4A1;SLCO4C1;MFSD2A;SLC35A1;SLCO5A1;SLC7A8;SLC25A14;SLC35C1;SLCO2B1
prerank,ATPase binding (GO:0051117),-0.370686557218339,-1.333780591578616,0.06962025316455696,0.424999961586744,1.0,27/71,22.46%,EGFR;ANK2;ABCA1;TMTC4;SNTA1;PTPN3;ATP6V0A4;CHMP4A;AR;NCSTN;SELENOS;RALA;PKD2;SNX10;METTL21A;NOP58;SNU13;CLPP;DERL1;TCIRG1;SYVN1;ATP5IF1;ATP1B3;PEX26;S100A1;PIH1D1;WFS1
prerank,phospholipase binding (GO:0043274),-0.5320519382210844,-1.3332587747193705,0.14107142857142857,0.42197693360806493,1.0,3/13,7.95%,ARHGAP6;PRKN;PDPK1
prerank,tropomyosin binding (GO:0005523),-0.5030695129708745,-1.3330462654733104,0.13559322033898305,0.41825589608868924,1.0,3/16,10.46%,CALD1;TMOD3;S100A6
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.492646002377973,1.3265403198564807,0.1460446247464503,0.37945277335511984,1.0,6/18,21.43%,SRD5A2;HSD17B7;HSD11B1;HSD17B2;HSD17B10;HSD3B7
prerank,water transmembrane transporter activity (GO:0005372),0.5520314453172767,1.3258011874496893,0.15286624203821655,0.37623130218751677,1.0,3/11,12.22%,AQP9;AQP11;AQP4
prerank,poly(A) binding (GO:0008143),-0.4738565890772648,-1.324294405714187,0.1349206349206349,0.4351677064005251,1.0,5/21,5.06%,RBMS1;RBMS3;RBPMS;KHDRBS1;RBMS2
prerank,SH3 domain binding (GO:0017124),-0.37261910641559115,-1.3227113925982166,0.0703125,0.43489898753248923,1.0,19/62,17.95%,DPYSL3;AFAP1;CBLB;ABL1;PRKN;WASF2;KHDRBS1;SYNJ2;PLSCR1;VASP;PTPN22;PTPN12;ADAM9;ABI1;WIPF1;CYBA;SOCS7;AFAP1L2;MICAL1
prerank,miRNA binding (GO:0035198),-0.4368357386963761,-1.3207455799535484,0.10721247563352826,0.4353173277706211,1.0,12/30,29.37%,PUM2;ZC3H7A;RC3H1;PUM1;TUT4;RBM10;YBX1;RBM4;ZNF346;AGO1;ZC3H7B;ZC3H10
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5624403010442021,-1.3200480806553971,0.14953271028037382,0.4326937723770935,1.0,7/11,39.76%,SLC22A5;SLC22A4;SLC25A47;SLC25A29;SLC25A20;SLC22A3;SLC25A45
prerank,DNA secondary structure binding (GO:0000217),-0.42379981949525636,-1.3190752375122272,0.11010830324909747,0.4307887435882115,1.0,12/31,23.22%,ABL1;RBBP8;HMGB1;RAD51B;WRN;MEF2C;RAD51D;FANCM;MSH6;KMT2A;CLSPN;RAD51C
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5451727850364241,-1.3180680120338453,0.13980582524271845,0.4291718077604226,1.0,7/12,20.79%,IGF1;IRS1;SHC1;IGF2;GNAS;ARRB1;PIK3R1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.490178988224155,-1.3156938866830241,0.14471243042671614,0.4310347609235777,1.0,5/18,12.67%,ALDH1A1;ALDH1A2;ALDH2;AKR1B1;ALDH6A1
prerank,pre-mRNA binding (GO:0036002),-0.43770016915793136,-1.3119060402818432,0.11954459203036052,0.43616822739373196,1.0,8/28,9.95%,CELF2;DDX5;CELF1;U2AF2;SRSF6;RNPC3;SLU7;SLBP
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.573738069649028,-1.3106454168019024,0.15456238361266295,0.43493535049022997,1.0,6/10,18.15%,EP300;HAT1;ATF2;KAT8;BRCA2;MSL3
prerank,receptor ligand activity (GO:0048018),0.3024158011158163,1.3072921655582275,0.017341040462427744,0.40805217012966644,1.0,37/245,10.54%,NRG3;KITLG;IL17F;SEMA3C;SEMA6A;MIF;AMH;IL7;NRG1;SEMA4A;SEMA4F;GAS6;SEMA6D;FGF10;SEMA4D;TAFA2;SEMA7A;BMP8A;IL12A;SCGB3A1;TGFB2;TAFA1;AMELX;WNT7B;FGF5;ENDOU;TNFSF13B;TIMP1;EPO;GPNMB;NMB;SST;POMC;THPO;BMP3;PDGFB;SCG2
prerank,lipase activator activity (GO:0060229),-0.5682270195732825,-1.304103691081225,0.1646234676007005,0.44659374294156423,1.0,2/10,7.95%,ARHGAP6;PDPK1
prerank,CoA-ligase activity (GO:0016405),-0.5167964601102109,-1.3025835879787906,0.15028901734104047,0.4463451049109921,1.0,2/14,3.04%,ACSL1;ACSS3
prerank,acid-thiol ligase activity (GO:0016878),-0.5263836287475785,-1.3013545179821178,0.16287878787878787,0.44529397705574175,1.0,2/13,3.04%,ACSL1;ACSS3
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.40687381687176966,-1.2996673410428194,0.12162162162162163,0.44504135409395945,1.0,16/34,24.47%,SETD7;KMT5B;NSD3;SMYD3;SETD3;SETD2;N6AMT1;SETDB1;EHMT1;METTL21A;EEF2KMT;KMT5A;EZH2;PRDM9;CAMKMT;KMT2E
prerank,phosphotyrosine residue binding (GO:0001784),-0.40526776948543286,-1.2987976832562733,0.12403100775193798,0.44343254174635743,1.0,16/37,25.52%,ABL1;IRS1;SHB;SHC1;PTPN3;VAV2;ABL2;YES1;NCK2;RASA1;PTPN11;PIK3R1;SHF;CRKL;SYK;SHC3
prerank,alpha-actinin binding (GO:0051393),-0.4533945279785222,-1.2907562772725811,0.14744801512287334,0.4577757039917943,1.0,9/24,12.34%,CACNA1C;DAG1;PDLIM5;PDLIM7;CACNA1D;PALLD;SYNPO2;PDLIM2;PKD2
prerank,mRNA binding (GO:0003729),-0.297081713899916,-1.286229509279575,0.026804123711340205,0.46445585968216757,1.0,59/249,14.85%,RBMS1;SAMD4A;CELF2;SRRM2;RBFOX2;RBMS3;RBPMS;DDX5;CELF1;EIF4G3;LUC7L2;HNRNPR;PUM2;YTHDF3;SYNCRIP;PCF11;KHDRBS1;DDX6;RBMS2;EIF4ENIF1;RC3H1;ZC3H12C;SCAF8;NYNRIN;HNRNPM;DHX9;PTBP3;SF3B1;DENR;SRSF6;LARP1;SRBD1;PUM1;HDLBP;FUBP1;DCP1A;DHX36;PCBP2;CSDC2;GEMIN5;HNRNPK;SLBP;LSM14A;SF3B6;DAZAP1;YTHDC1;DCP1B;KHNYN;TPR;SNRNP70;YBX3;SERBP1;NSRP1;ACO1;RBM5;SRSF1;ZC3H12B;EDC3;DDX3X
prerank,alkali metal ion binding (GO:0031420),-0.5201236331998448,-1.2844084602846566,0.15458015267175573,0.46465040043670797,1.0,2/13,2.77%,ATP1A2;HDAC4
prerank,organic anion transmembrane transporter activity (GO:0008514),0.31989447732989024,1.281288569977021,0.0653061224489796,0.45992584451632434,1.0,25/134,10.66%,SLCO1C1;SLC7A5;SLC6A6;SLC4A1;SLCO4C1;SLC7A1;ABCG2;MFSD2A;SLC35A1;SLC17A6;SLC1A1;SLC52A2;SLC25A42;SLC25A23;MFSD12;SLC1A2;SLCO5A1;SLC6A8;SLC7A8;SLC52A3;SLC66A1;SLC36A1;SLCO2B1;ABCC4;SLC39A8
prerank,RNA cap binding (GO:0000339),-0.4948259632595663,-1.2810930289099185,0.14933837429111532,0.4691078361841328,1.0,8/16,31.15%,CYFIP2;LARP1;GEMIN5;EIF4E;EIF4E3;NCBP3;NCBP2;LSM1
prerank,kinesin binding (GO:0019894),0.4239232222152331,1.2804934202701912,0.1554054054054054,0.45650251787680174,1.0,11/27,20.37%,ACTB;MAPK8IP2;SNCA;SPTBN5;MAPK8IP1;RAB29;ATCAY;TTBK2;CLSTN1;KIF1B;CROCC
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.49875660927524584,1.2769543331754216,0.17194570135746606,0.4589249200433554,1.0,5/14,23.53%,CAPN11;CAPN6;CAPN5;CAPN2;CAPN15
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5053440839763947,1.2731109672539391,0.16288659793814433,0.46211516411707654,1.0,3/14,0.51%,SPOCK2;SPOCK1;SPOCK3
prerank,5'-3' exonuclease activity (GO:0008409),-0.5133520270816571,-1.272161555706505,0.16666666666666666,0.486961403896948,1.0,6/14,23.05%,CPSF3;XRN1;XRN2;MRE11;DCLRE1A;EXOG
prerank,vitamin D receptor binding (GO:0042809),-0.5122997635702746,-1.2716192386590925,0.16831683168316833,0.484332378309948,1.0,10/14,30.15%,MED17;MED12;MED1;RXRA;MED16;MED13;MED14;TAF7;SNW1;THRAP3
prerank,mRNA 3'-UTR binding (GO:0003730),-0.33922601514316836,-1.2701558983815164,0.0861344537815126,0.48402545582240053,1.0,34/79,29.25%,RBMS1;CELF2;RBMS3;DDX5;CELF1;PUM2;RBMS2;RC3H1;LARP1;PUM1;DHX36;CSDC2;GEMIN5;DAZAP1;YBX3;SERBP1;EXOSC9;CCT5;CPEB1;RNF20;HNRNPU;RBM4;ANGEL2;NUDT21;PABPC4;AUH;RSL1D1;FXR1;CPSF1;PCBP4;PARN;ZFP36L2;PABPC4L;CRYZ
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5635011086498026,-1.2683276256540519,0.19165085388994307,0.4848400342728691,1.0,3/10,9.25%,DSE;GLCE;RENBP
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.5097809137412134,-1.2662121122726488,0.18518518518518517,0.4861226041094649,1.0,10/13,42.91%,TRMT11;METTL1;THUMPD3;TRMT1L;FTSJ1;TRMT1;TRMT10C;TRMT5;WDR4;TRMT10B
prerank,phospholipid transfer activity (GO:0120014),0.44917918291329123,1.2649337535152443,0.18144329896907216,0.47508469983422413,1.0,9/21,18.20%,PLTP;CERT1;PITPNM1;PRELID3A;PLEKHA3;PRELID2;CPTP;MTTP;PITPNB
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3638067190779314,1.2643320883524765,0.10151187904967603,0.4711948909159284,1.0,13/60,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5409070248812254,-1.2627533920077016,0.17823639774859287,0.49088771313595064,1.0,4/12,9.28%,CDK8;CDK7;CDK13;CCNK
prerank,NAD binding (GO:0051287),-0.42406666269824,-1.261423392684113,0.15063520871143377,0.490207956197474,1.0,9/26,15.19%,ALDH1A1;CRYL1;ALDH2;GLUD1;ZC3HAV1;ME1;PARP9;SIRT5;BDH2
prerank,kinase binding (GO:0019900),-0.27639889691775077,-1.2610417099271574,0.020703933747412008,0.4873318973913817,1.0,138/434,22.57%,PRKAG2;EGFR;SASH1;TCF7L2;SMAD3;PTN;ERRFI1;ANK2;GSN;PKD1;LIMS1;MAPK4;KIF13B;NBEAL1;NISCH;PDGFRB;KAT2B;IL31RA;FOXO3;PPP1R12A;GHR;TAX1BP1;PRKN;WWC2;TNS2;DLG4;IBTK;GSK3B;RPTOR;CNTLN;FLNA;IRAK3;MAPKAP1;IL15RA;DLG1;NR3C1;RND3;EIF4ENIF1;RBBP6;AXIN1;PAK2;SKI;SLC12A7;UBQLN1;STAT3;UFL1;TRIP4;SHC1;TPCN2;ADCY6;CDC42;VDAC1;SP100;PTPRK;PTPN22;ATF2;CCNK;WNK1;PLCG1;TOM1L2;RB1CC1;PTPN2;SLC12A2;TRAF2;RHOA;PRKCD;HIF1A;DNAJC3;PRKAB2;EXOC2;MAVS;KIZ;WWC1;PARP1;TRIM5;TELO2;RHOBTB2;SUFU;SIK1;RB1;RICTOR;MAML1;BECN1;MAPRE1;MOB1B;CDK5RAP1;ERCC6L2;CCND3;LATS1;CDC25B;PPP1CB;MAP2K7;TNIP2;RAB11FIP2;ADRA2A;TTC28;CACUL1;PRKACA;LRRC14;PTPN1;RHOBTB1;FBXW5;BLNK;TRAF6;RHOH;MAP3K1;MYOM1;PARK7;RHOC;MTCP1;PTPN11;NEK6;IRAK1;CARD16;MAP2K6;MVP;TRIP6;SPRED2;CAB39;PRKAG3;PFKM;DGKD;PIH1D1;USF1;CDK5RAP3;LRBA;GATA6;SMAD1;PRKAB1;MSN;TBL2;NBEAL2;PFKL;MAP3K12;CIR1;PRKRIP1;TICAM1;CHP1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5366512248530878,-1.2607355560413531,0.18330308529945555,0.48424574419537286,1.0,4/11,8.85%,AKAP13;KSR1;SH3RF1;MAP2K1
prerank,Tat protein binding (GO:0030957),0.5467534557390209,1.2581585065979566,0.19238900634249473,0.4802081218976813,1.0,3/10,4.32%,ACTB;GABARAPL1;SMARCB1
prerank,ATP binding (GO:0005524),-0.2869711663447596,-1.256300914673646,0.0367965367965368,0.4914605616818445,1.0,84/266,24.03%,ATP1A2;PRKAG2;TGFBR1;BMPR1A;TLK1;ABCA1;MYO1B;KSR1;STK3;ABL1;ENPP1;TOP1;ABCD3;STK17B;N4BP2;IRAK3;MAP4K4;CHD8;DHX9;SMC4;MAP3K5;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;BRSK1;DMPK;HSPA14;CARS2;CDK11B;AK6;HSPA9;PEX6;ABCD4;MKNK2;PNPLA8;SIK1;MYO1F;PGK1;TBCK;MCM6;ACVR1;ERN1;LATS1;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;PXK;PFKP;HNRNPU;MLKL;EIF4G1;MSH6;NEK6;TAOK1;NME1;BCKDK;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;SIK2;SPHK1;GSS;GALK1;CDC42BPG;TRNT1;RRM1;MVK;CLPX
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.47746943928091046,1.250546313191356,0.18354430379746836,0.49261429812967,1.0,5/15,14.18%,SLA2;PIK3R5;SOCS1;PIK3R3;CCKBR
prerank,nuclear localization sequence binding (GO:0008139),0.46591054844603086,1.2501014663730778,0.17982456140350878,0.4885595099201288,1.0,3/18,2.67%,IPO5;IPO4;CABP1
prerank,ubiquitin binding (GO:0043130),-0.3468423931023197,-1.2500844774063538,0.09583333333333334,0.502850556714454,1.0,18/73,17.03%,SMAD3;UBE2N;PRKN;RAD23B;UBXN2B;WDR48;DDI2;NBR1;RNFT1;MARK4;USP33;GGA3;FBXW7;ILRUN;USP13;FAF2;SPRTN;AUP1
prerank,FMN binding (GO:0010181),0.5249263247251708,1.2461939544007914,0.20910973084886128,0.492734917842896,1.0,3/11,7.94%,NDOR1;NOS3;DUS2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.3720044864121843,-1.2438460427370701,0.15849056603773584,0.5139721374520836,1.0,10/42,15.72%,CCNL2;KAT2B;CCNT2;CCNL1;CCNH;CCNT1;CCNK;CCNYL1;CCND3;CNPPD1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.5165903693951379,-1.2426781110708411,0.2130841121495327,0.5130204804115442,1.0,9/12,41.01%,NQO2;CBR4;NDUFS7;DHRS4;CRYZ;CBR1;NQO1;DCXR;AIFM2
prerank,phosphatase inhibitor activity (GO:0019212),-0.4462887075409196,-1.2366349454245642,0.1981981981981982,0.524338462213504,1.0,8/20,27.32%,PTN;STYX;CABIN1;ANP32E;BOD1L1;PPP1R2;BOD1;SAG
prerank,pyridoxal phosphate binding (GO:0030170),-0.4462525182812763,-1.233356777997614,0.19428571428571428,0.5284647317806443,1.0,14/20,41.56%,ABAT;PYGB;PYGM;PDXK;PLPBP;OAT;PSAT1;CBS;ACCS;CTH;PYGL;SHMT2;GLDC;SHMT1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5355780545809542,1.2326946821079001,0.23010752688172043,0.5198082522468693,1.0,4/10,9.69%,SLCO1C1;SLCO4C1;SLCO5A1;SLCO2B1
prerank,glucuronosyltransferase activity (GO:0015020),0.44575368124826675,1.2325489834708925,0.18614718614718614,0.5146899236571707,1.0,3/19,5.63%,B3GAT1;B3GAT2;CSGALNACT1
prerank,CXCR chemokine receptor binding (GO:0045236),0.5235445530964605,1.2306965439651414,0.2239819004524887,0.513543165673062,1.0,1/11,2.70%,CXCL12
prerank,calcium channel activity (GO:0005262),0.3322348562673299,1.2289889732926627,0.13034188034188035,0.5123758271350795,1.0,20/84,14.44%,SLC24A4;SLC24A2;GRIN1;TRPC5;CACNA1A;CACNA1B;RYR2;CACNA2D1;CACNG2;CACNA1E;TRPM2;CACNB2;CACNG3;OPRM1;CACNG8;CACNB4;TRPC1;TMCO1;PSEN1;CACNA1I
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4207416828665523,-1.2279823180326948,0.19576719576719576,0.5384833729502045,1.0,11/25,24.51%,TNKS2;ZC3HAV1;PARP10;PARP14;PARP9;PARP1;SIRT5;PARP4;PARP6;SIRT4;SIRT3
prerank,3'-5' DNA helicase activity (GO:0043138),-0.47597052906639736,-1.2263879116645404,0.21235521235521235,0.5386127382514412,1.0,6/16,14.58%,DHX9;WRN;ASCC3;ERCC3;FANCM;MCM6
prerank,phosphatidylinositol binding (GO:0035091),-0.3246916776017316,-1.2263337708013304,0.1062618595825427,0.5348702381708228,1.0,30/91,21.39%,ITPR1;PARD3B;APPL2;ITPR2;SNX24;NUMA1;EEA1;PIGK;BCAS3;SNX9;ZFYVE1;FCHO2;PITPNA;PITPNC1;TULP3;PITPNM2;PLEKHF2;APPL1;SNX10;PARD3;ZFYVE16;SNX8;RUBCN;PICALM;ANKFY1;GPAA1;PLEKHF1;C2CD2L;MPPE1;PLEKHN1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.31598941947820064,-1.2251908137322276,0.1095890410958904,0.5341837426950514,1.0,30/100,17.98%,GAB2;FCHSD2;MYO1B;ADAP2;SNX24;SH3PXD2B;GBF1;ARAP1;OSBPL8;MAPKAP1;OSBPL5;CYTH3;ZFYVE1;DAPP1;PLA2G4A;IQGAP2;KIF16B;WIPI1;SNX21;ARFIP2;GSDMD;OGT;ATG2A;PARD3;PLEKHA8;ZFYVE16;WDR45B;RUBCN;ATG2B;ANKFY1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5166204545269567,-1.2246159951182867,0.21320754716981133,0.5315797322729816,1.0,8/11,36.82%,CFLAR;CASP12;CASP2;CASP6;PYCARD;CASP1;CASP4;CASP7
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5382274793083106,-1.2210195653298426,0.23268206039076378,0.5373669425177453,1.0,3/10,19.73%,NOX4;CYBA;NCF2
prerank,cadherin binding (GO:0045296),-0.27577036875760963,-1.218980773277979,0.060669456066945605,0.5385454662076299,1.0,94/315,18.04%,PHLDB2;CALD1;PARVA;EGFR;AHNAK;AFDN;VCL;PI4KA;PDLIM5;CAST;MPP7;ASAP1;MPRIP;MYO1B;CTNNA1;ERC1;LIMA1;BAIAP2L1;CDH11;TLN1;NIBAN2;PACSIN2;FLNA;WASF2;DDX6;DLG1;ITGB1;SLK;SNX9;RAB10;ANXA2;PAK2;CDH1;ARVCF;TMOD3;ANXA1;TES;ZC3HAV1;LARP1;HDLBP;CHMP4B;CNN3;ZC3H15;ATXN2L;VASP;GCN1;KTN1;JUP;HNRNPK;CHMP5;GOLGA3;PLCB3;BAG3;PDXDC1;HCFC1;NOTCH3;GIPC1;PLIN3;ABI1;TXNDC9;ARGLU1;CAPZA1;ARFIP2;CEMIP2;CCT8;ATIC;GLOD4;TRIM25;STX5;MAPRE1;SERBP1;PCMT1;CAPZB;LASP1;CTTN;STAT1;NUDC;NUMB;ACVR1;NCK1;DDX3X;YWHAE;P2RX4;EMD;PAICS;ARHGAP18;VASN;MRE11;FXYD5;PICALM;PFKP;CC2D1A;S100A11;PTPN1
prerank,estrogen receptor binding (GO:0030331),-0.3942975522541029,-1.2185935333483722,0.17343173431734318,0.5357517193935675,1.0,15/32,21.79%,PPARGC1B;LCOR;DCAF1;TRIP4;NSD1;NCOA6;NCOA1;MED1;PRMT2;WIPI1;MMS19;LATS1;CNOT1;PPID;ARID5A
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.382191568039344,-1.2137127285184999,0.2056451612903226,0.5447417157676724,1.0,16/38,23.53%,GAB2;SORBS1;LRRK2;IRS1;AXIN1;SHC1;FRS2;MMS19;NCK1;NCK2;SH2B1;BLNK;PTPN11;PIK3R1;DLG5;SPAG9
prerank,death domain binding (GO:0070513),-0.515114213875253,-1.212574743633413,0.2388888888888889,0.5437885765122915,1.0,6/11,28.19%,BCL2;DAP;DAPL1;IRGM;CRADD;TRADD
prerank,magnesium ion binding (GO:0000287),-0.29898152928719884,-1.211558969872567,0.10547667342799188,0.5424060823708429,1.0,41/135,23.77%,EYA2;OPA1;CLYBL;DIS3L2;STK3;ABL1;LRRK2;IRAK3;PLSCR1;NUDT5;TDP2;MAP3K5;DHX36;WRN;MAP3K20;BRSK1;ABL2;RP2;PPA1;SIK1;ERN1;LATS1;MARK1;PDXK;MAP2K7;FOXK2;EPHX2;SIK3;XYLT2;PSPH;MSH6;NEK6;NME1;PGM1;MAST2;SIK2;SPHK1;GSS;CDC42BPG;XXYLT1;MVK
prerank,GABA receptor binding (GO:0050811),0.5008666834282831,1.2100963469583794,0.2542016806722689,0.5538920707982891,1.0,4/11,9.22%,GABARAPL1;GABARAP;SHISA7;LHFPL4
prerank,solute:sodium symporter activity (GO:0015370),-0.4086774493176759,-1.209929533548973,0.18902439024390244,0.5428620898229898,1.0,4/27,10.92%,SLC5A3;SLC20A2;SLC4A10;SLC5A6
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4046215739050424,-1.2095265679645366,0.1884328358208955,0.5402412095340259,1.0,7/27,11.44%,ITPR1;ITPR2;SLC41A1;CNNM2;SLC12A2;ZDHHC13;ATP2B1
prerank,tubulin binding (GO:0015631),0.27519422233612517,1.209425967715876,0.04339250493096647,0.5501376599329155,1.0,66/295,15.28%,DNM3;NAV3;EML5;SYBU;GIT1;PACRG;S100A8;S100A9;TTLL7;UNC5C;AGBL4;MAP1B;MAP2;STMN1;FGF13;REEP1;GABARAPL1;KIF1A;SNCA;HOOK1;KIF21B;MTUS1;DST;MAP6D1;PAK1;GABARAP;SPAG5;CEP44;TRIM36;NEFM;SNPH;MTCL1;MAPRE3;TERF1;KIFC2;CLIP2;STMN4;RMDN1;CAMSAP1;STMN2;NUSAP1;TPPP;TUBGCP3;ARHGEF2;KIF26B;REEP2;MID2;APC;DIP2B;CCDC88A;KIF19;EML6;DCTN1;SGIP1;RPS3;DIXDC1;EFHC2;MACO1;NDRG1;STMN3;GOLGA2;DCX;ARHGEF7;CAPN6;REEP3;TPPP3
prerank,GTPase regulator activity (GO:0030695),-0.28071030753265563,-1.2086922021797657,0.08237547892720307,0.5388954959689128,1.0,64/212,19.75%,RANBP3L;ALDH1A1;ARHGAP29;ARHGAP10;ARHGAP42;ERRFI1;ASAP3;SIPA1L1;ARHGAP28;ASAP1;STXBP5;ARHGAP20;LRRK2;ARHGEF10L;ARAP1;TBC1D16;SMAP1;ARHGAP24;BCR;SGSM2;DNM1L;PDE6D;RANBP2;SEC23A;NRP1;ARFGEF1;RAB3GAP1;GMIP;ARHGAP17;USP6NL;IQGAP2;ARFGAP1;ARFGAP3;TBC1D2B;TBC1D20;TBC1D8B;WASL;JUN;RP2;ARHGAP32;SEC23B;TBCK;GRTP1;TBC1D22B;TBC1D9;ACAP2;RAPGEF2;RASA1;ARRB1;ARHGAP18;DOCK1;ARHGEF6;RIC8B;TBCD;NPRL3;ARHGAP15;RHOH;TBC1D17;RANBP3;SIPA1L3;RALGAPB;RTKN;RABGAP1;TBC1D7
prerank,Wnt-activated receptor activity (GO:0042813),-0.4696206837930671,-1.2074896093971372,0.23728813559322035,0.5382326662141843,1.0,4/15,6.01%,ROR1;PKD1;RYK;FZD2
prerank,protein heterodimerization activity (GO:0046982),-0.29208172426644496,-1.2073966911962979,0.09090909090909091,0.5348620764362333,1.0,51/178,21.38%,ATP1A2;BMP6;TCF4;TPM1;ZHX2;ARNT;ADRA1B;IRAK3;EXT1;SAE1;MEF2A;ITGB1;BCL2;MIGA2;IRAK2;ZBTB1;HIF1A;PAFAH1B2;MEF2C;PSMF1;AGTR1;QTRT2;TCF3;BHLHE41;SRI;ATF6;KATNA1;HEXA;GCA;MICU1;RCC1;YWHAE;CYBA;BDKRB2;PRMT5;ADRA2A;BUD23;NR4A1;TOP2B;TLR4;NR4A2;RALGAPB;IRAK1;TPM2;P4HB;SMC1A;PPP2CA;DGKD;USF1;RALGAPA2;NAE1
prerank,mannose binding (GO:0005537),0.5054334866006309,1.2063361272236413,0.24750499001996007,0.5531408635877779,1.0,1/12,0.95%,MBL2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.3927057093648715,-1.2061524798428696,0.20833333333333334,0.5341527353998159,1.0,11/34,19.22%,UBE2N;UBE2E2;BIRC6;UBE2H;UBE2K;UBE2I;UBE2R2;UBE2B;UBE2E1;UBE2S;UBE2D3
prerank,calcium-release channel activity (GO:0015278),-0.4513851408431945,-1.2059102054468902,0.21756487025948104,0.5312532433929402,1.0,6/17,12.34%,ITPR1;ITPR2;TPCN1;TPCN2;RASA3;PKD2
prerank,myosin binding (GO:0017022),-0.35178656557608023,-1.2056551112217784,0.160075329566855,0.5284210823156306,1.0,12/55,12.22%,CALD1;KIRREL1;TRAK1;GSN;STXBP5;RAB10;ARFGEF1;SPATA6;RHOA;GIPC1;RAB11A;RALA
prerank,phospholipase inhibitor activity (GO:0004859),-0.5201578411020823,-1.2050241049848134,0.22532588454376165,0.5264516753557451,1.0,4/10,7.02%,ANXA4;ANXA5;ANXA2;ANXA1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.36591820130938024,-1.2030412987984132,0.18497109826589594,0.5280371753082367,1.0,18/42,25.52%,ABL1;IRS1;SHB;SHC1;PTPN3;VAV2;ABL2;YES1;FBXW7;YWHAE;NCK2;RASA1;PTPN11;PIK3R1;SHF;CRKL;SYK;SHC3
prerank,RNA binding (GO:0003723),-0.24322804098170855,-1.2025773467828158,0.002188183807439825,0.5257346889785041,1.0,522/1321,31.48%,BICC1;RBMS1;SAMD4A;ROCK2;FNDC3B;CELF2;SRRM2;AHNAK;RRBP1;LRP1;RBFOX2;RBMS3;SON;NSA2;ERI3;HOXB6;SMG6;TNS1;DCN;RBPMS;ANKRD17;DDX5;CELF1;FARS2;ANKHD1;CAST;EIF4G3;HNRNPH1;UBE2N;DIAPH1;RBM39;VIM;NUFIP2;CTNNA1;DICER1;SMG1;SNTB2;LUC7L2;TNRC6B;MBNL2;PABPN1;NUDT4;HNRNPR;TOP1;ZCCHC24;KMT2C;PRRC2C;PUM2;YTHDF3;FLNA;ZC3H7A;RSRC2;SYNCRIP;PCF11;TNRC6A;WDR33;MAP4;DDX17;KHDRBS1;ACIN1;CASC3;EIF4A2;DDX6;HUWE1;TRMT9B;BAZ2A;HMGB1;RBMS2;PPARGC1B;SCAF4;SRSF10;MOV10;EIF4ENIF1;RBM6;RBBP6;DDX46;FUS;GOLGB1;SEC23IP;CCT6A;ANXA2;NUDT5;RC3H1;ZC3H12C;STAT3;SCAF8;MEX3C;CS;NYNRIN;HNRNPM;TBCA;U2AF2;YLPM1;GFM1;STXBP1;IFIT2;PDCD11;PUS10;ANXA7;ADK;DHX9;TES;PTBP3;AKAP8L;SF3B1;DENR;CPSF3;SRSF6;ZC3HAV1;LARP1;SRBD1;PUM1;HDLBP;HNRNPUL1;HNRNPD;NUP42;ZC3H15;SIDT1;TUT4;RBM10;FUBP1;DCP1A;DHX36;PRPF6;SAFB2;PCBP2;KNOP1;DDX42;ATXN2L;PPARGC1A;SPATS2L;CAVIN1;CDC5L;HLTF;GCN1;CSDC2;KTN1;SMG7;NSUN6;CDK13;ABCF1;CHD2;UBE2I;LAS1L;GEMIN5;HNRNPK;MAP3K20;UBAP2L;SPATS2;CSNK1E;ARCN1;PNISR;ALG13;EIF4E;CHD3;PRPF3;FAM120A;UPF1;SLBP;DHX40;CSDE1;RCC1L;JUN;LSM14A;DDX60;SF3A1;RPGR;SF3B6;RPL11;RBM45;DAZAP1;PRRC2B;CLK3;CDK11B;AKAP1;YTHDC1;ASCC3;BCLAF1;SCAF11;FCF1;XRN1;DUSP11;RTF1;ZC3H4;ZBED4;XRN2;LGALS1;PARP1;DCP1B;ACAA2;DYNC1LI1;KHNYN;SF3A3;ALKBH1;ARF1;HSPA9;WDR43;TPR;ZYX;DIMT1;ZCRB1;ALDH6A1;SNRNP70;TRIM25;YBX3;EIF2AK4;CCAR1;APTX;STRAP;SRFBP1;DDX23;TDRD3;HTATSF1;GTPBP10;YBX1;KIF1C;MAPRE1;CWC22;CPNE3;SERBP1;DDX19B;TCERG1;APOBEC1;NSRP1;URB1;RBM42;EIF2AK2;TXN;ACO1;SEC63;RARS2;BMS1;PRKDC;NAA15;RBM5;SRSF1;ZC3H12B;EDC3;OTUD4;EXOSC9;ILF2;DDX3X;YWHAE;RRP36;NOP58;FAM32A;SREK1;MAK16;BRIX1;EFTUD2;RPP14;HELZ;NOM1;DNTTIP2;SNU13;R3HDM2;DDX27;MTREX;EXOSC10;PRR3;DYNC1H1;TYW5;NOP53;SFPQ;BUD23;HELB;MRPL39;NXF1;GANAB;NSUN2;OAS2;TENT5A;CNOT1;PRPF40B;DDX50;HSPE1;SLC25A11;EWSR1;SHFL;CDC42EP4;DDX31;ARHGEF1;WBP11;CSTF3;KRR1;RPN1;HNRNPU;PTPN1;EIF1AX;CHCHD1;VCP;MRPL3;RRP8;TRMT1L;GPATCH4;SNRPF;ALDH18A1;COL14A1;EIF3A;UTP3;ZRANB2;PARK7;MSI2;HNRNPA3;UTP6;ESF1;EIF4G1;MRPL1;SIDT2;RBM4;ELP5;SRSF7;KARS1;SRSF11;NFX1;PKM;TRIP6;H1-0;IFIT3;TERT;EIF3L;NUP98;RRP7A;P4HB;SMC1A;RBPMS2;SRRM1;UPF3B;NME1;CCDC9B;ASS1;RBM33;PSMC1;SRSF2;SURF6;XRCC6;ERAL1;MSN;TBL2;DHX57;EBNA1BP2;ZNF346;MRPL32;FBRSL1;CRKL;SSBP1;PYM1;LRRC47;LUC7L3;PRKRIP1;DALRD3;NAP1L4;CSTF1;MRPL10;ZC3H13;GTF2F1;XPO5;CCAR2;UTP18;LBR;CPSF4;NUDT21;RPUSD4;DDX41;AGO1;HDAC2;IMP3;MRPL43;TRNT1;WDR6;APEH;AATF;USO1;RTRAF;BOP1;BCCIP;EXOSC3;EIF3H;GAR1;CNOT4;DHX15;NONO;PPHLN1;ALDOA;PABPC4;NOA1;PARP12;PPP1R10;GNL3L;IREB2;TRMT1;FAM50A;NAP1L1;ARL6IP4;PRPF38A;UNK;NCBP3;DUS3L;CLUH;KDM1A;NKRF;PSTK;KIN;RBM28;RPL7L1;RSL1D1;FXR1;MTO1;TDRD7;EDF1;TRMT2A;HARS2;NCBP2;TWF2;PRRC2A;ENDOV;ELAC2;PCBP3;TSR1;PRPF8;CRNKL1;FYTTD1;NAT10;DHX58;LSM6;LUC7L;NOL12;PES1;NIP7;DHX37;RBM22;SRP72;CCT3;GNL3;PNLDC1;RBM19;MRPL22;PCBP4;EIF3C;ZC3H7B;CACTIN;LONP1;GTF2E2;POLR1G;RRS1;SUGP1;RPL22;SAFB;POLR2D;HNRNPL;GRN;ISY1;SLTM;PARN;NELFE;PIN4;CCDC124;RBM34;FASTKD1;ZFP36L2;MRPL12;POP4;IGHMBP2;ZNF106;PABPC4L;SUPV3L1;RBM18;NUDT1;KPNA2;CCDC47;TBL3;PNO1;SNRNP200;UTP4;RBM47;THOC2;POLRMT;ZC3H10;ZC3H18;RBM27;HNRNPUL2;SAMHD1;PEF1;ENO1;MPHOSPH10;MRPS24;MTPAP;CALR;SNW1;THRAP3;GDI2;NUDT7;SF3A2;TBRG4;PSIP1;USP36;CCDC86;FLYWCH2;DDX25;YWHAZ;ADARB1;UBE2L3;PINX1;UBA1;RPP38;MRPS26;TLR3;TRMT10C;IFIH1;SNRPA1;C1QBP;DHX33;SUGP2;LSM1;ZNF326;GTPBP1;GIGYF2;SRP19;SF3B4;MRM1;ERH;RDX
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5107044836624698,1.1972726163361411,0.24,0.5706983168151532,1.0,1/10,0.14%,ADARB2
prerank,sterol binding (GO:0032934),-0.3463780908648601,-1.1959005943099728,0.16334661354581673,0.538819292387895,1.0,16/56,12.63%,ABCA1;ANXA6;OSBPL8;SOAT1;GRAMD1C;INSIG2;OSBPL5;OSBPL11;SIDT1;VDAC1;NR1H3;NPC2;RORA;ERLIN1;OSBPL9;APOD
prerank,tRNA methyltransferase activity (GO:0008175),-0.46375292931634293,-1.191919880491666,0.2518518518518518,0.545361891089842,1.0,10/16,33.29%,TRMT9B;METTL2A;METTL2B;THUMPD3;FTSJ1;LCMT2;TRMT44;TYW3;ALKBH8;TRMT12
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.37682271351797764,-1.1908976426371327,0.2147117296222664,0.544416894167363,1.0,8/35,12.43%,CLK1;ABL1;FRK;LYN;FER;ABL2;YES1;TEC
prerank,cation transmembrane transporter activity (GO:0008324),0.35433106358993594,1.1882184880035804,0.1991701244813278,0.588098982650643,1.0,8/48,9.58%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;MFSD12;SLC7A8;SLC66A1;SLC36A1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4902544618688127,1.1872043950968847,0.2537634408602151,0.5850552986406796,1.0,2/13,2.91%,PRKAR2B;RYR2
prerank,microtubule binding (GO:0008017),0.2771670443839624,1.1860780956785362,0.09732824427480916,0.5821188513956435,1.0,57/222,17.80%,DNM3;NAV3;EML5;SYBU;S100A8;S100A9;MAP1B;MAP2;FGF13;REEP1;KIF1A;HOOK1;KNSTRN;KIF21B;MTUS1;DST;MAP6D1;SPAG5;CEP44;NEFM;SNPH;MTCL1;MAPRE3;TERF1;KIFC2;CLIP2;RMDN1;CAMSAP1;NUSAP1;TPPP;TUBGCP3;ARHGEF2;KIF26B;REEP2;MID2;APC;CCDC88A;KIF19;EML6;DCTN1;SGIP1;RPS3;MACO1;NDRG1;GOLGA2;DCX;CAPN6;REEP3;MACF1;CAMSAP3;STARD9;CLASP2;KIF21A;FHDC1;CCDC61;CRIPT;DNM1
prerank,protein tyrosine kinase activity (GO:0004713),0.3073373892650136,1.1859340398914062,0.16568047337278108,0.5769362124002473,1.0,16/108,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;WEE2;FLT3;AATK;SRMS;ALK
prerank,telomeric DNA binding (GO:0042162),-0.3780462502756237,-1.1857453568765959,0.2198852772466539,0.5534809958098821,1.0,13/32,21.30%,SMG6;SMG1;HNRNPD;WRN;SMG7;UPF1;TELO2;CTC1;UPF3A;TERF2;TERT;STN1;XRCC6
prerank,nuclear import signal receptor activity (GO:0061608),0.4467710618722697,1.1845676849864581,0.25327510917030566,0.5749039881223998,1.0,2/15,1.49%,IPO5;IPO4
prerank,general transcription initiation factor binding (GO:0140296),-0.403398953137841,-1.183779265215471,0.22549019607843138,0.5549723669352168,1.0,13/25,30.58%,AR;TBP;TAF13;GTF2B;TAF12;PSMC1;DRAP1;YEATS2;THRA;ESR1;BRF2;RUVBL2;GTF2A1
prerank,endopeptidase regulator activity (GO:0061135),-0.3661981410701866,-1.1833304566375455,0.21072088724584104,0.5525819427307864,1.0,8/40,11.79%,CAST;PROS1;TFPI;ITIH2;RECK;RENBP;SERPIND1;PSMF1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.3785021734261314,-1.1832465359156743,0.19767441860465115,0.5494404819403448,1.0,18/34,28.16%,ERI3;DIS3L2;PAN3;CNOT8;XRN2;ERI2;EXOSC9;CNOT2;PAN2;EXOSC10;CNOT1;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,NADPH binding (GO:0070402),0.46377568046864975,1.1821002473274431,0.25675675675675674,0.5756153773941806,1.0,3/13,7.97%,NDOR1;DUS2;KCNAB1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5035481558572785,-1.180046183425739,0.25794392523364484,0.5541826470495977,1.0,4/11,11.00%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,actin binding (GO:0003779),-0.28610052184281953,-1.1798853126470037,0.132,0.5512810513554501,1.0,32/170,11.65%,CALD1;SYNE2;PARVA;PAWR;MICAL3;PHACTR1;SORBS1;DAG1;VCL;GSN;TPM1;PDLIM5;LIMA1;PHACTR2;ABL1;PRKN;LRRK2;SHROOM2;MICAL2;NCALD;ITGB1;PDLIM7;PLEKHH2;CORO7;SMTN;MAEA;IQGAP2;SYNPO2;ABL2;GIPC1;PDLIM2;CAPZA1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2897167052051502,-1.1793215310256142,0.12830957230142567,0.549295957216778,1.0,39/147,16.73%,AKAP13;DENND4A;DOCK5;DOCK11;PLCE1;DENND2A;FARP1;ARHGEF17;SBF2;IQSEC2;BCR;ARFGEF1;RAB3GAP1;CYTH3;RAPGEF3;VAV2;RAB3IL1;HERC2;RAB3IP;RCC1L;ARHGEF18;FNIP1;DENND4C;MON1A;SERGEF;FGD1;DNMBP;DENND5A;FGD4;ANKRD27;RCC1;RAPGEF2;FARP2;SH3BP5L;NGEF;DOCK1;ARHGEF11;ARHGEF6;RIC8B
prerank,voltage-gated calcium channel activity (GO:0005245),0.36596257082013683,1.1789655539747883,0.22245322245322247,0.5783621471457318,1.0,10/37,10.79%,CACNA1A;CACNA1B;CACNA2D1;CACNG2;CACNA1E;CACNB2;CACNG3;OPRM1;CACNG8;CACNB4
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5092410120848024,-1.1785746124749743,0.26542056074766357,0.5478536544931792,1.0,7/10,36.82%,CFLAR;CASP12;CASP2;CASP6;CASP1;CASP4;CASP7
prerank,insulin-like growth factor I binding (GO:0031994),-0.4737187634372143,-1.1781964680562977,0.2585895117540687,0.5455239721765105,1.0,6/13,8.22%,IGFBP2;IGFBP5;ITGAV;IGFBP3;IGFBP6;IGFBP4
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.39543977132539937,-1.1780686033006196,0.2164750957854406,0.5426756808440494,1.0,8/26,27.32%,PTN;PPP1R1A;CABIN1;BOD1L1;PPP1R2;PPP1R14A;BOD1;SAG
prerank,damaged DNA binding (GO:0003684),-0.3501899245011829,-1.1749667208986145,0.2035225048923679,0.5467340588829118,1.0,21/44,33.12%,EP300;RBBP8;HMGB1;SMC6;CREBBP;NBN;DDB2;ERCC3;APTX;SDE2;DCLRE1A;PCNA;ERCC1;CRY2;OGG1;MPG;FANCG;NEIL3;RPA2;PNKP;DDB1
prerank,calcium:sodium antiporter activity (GO:0005432),0.5113725440562927,1.1711622115872105,0.26824034334763946,0.5929400336940519,1.0,3/10,4.70%,SLC24A4;SLC24A2;SLC8A1
prerank,acetylation-dependent protein binding (GO:0140033),-0.4262395889782081,-1.1710193082749676,0.24308300395256918,0.549584863476251,1.0,7/20,21.38%,MLLT3;BRD7;BAZ2A;BRD3;PHIP;ZMYND8;KMT2A
prerank,lysine-acetylated histone binding (GO:0070577),-0.4262395889782081,-1.1710193082749676,0.24308300395256918,0.549584863476251,1.0,7/20,21.38%,MLLT3;BRD7;BAZ2A;BRD3;PHIP;ZMYND8;KMT2A
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.46068946181194076,-1.1697408299608254,0.2803030303030303,0.5494662293790425,1.0,7/15,29.77%,KMT2C;KMT2D;SETD3;KMT2A;PRDM9;CXXC1;WDR5
prerank,fibroblast growth factor binding (GO:0017134),-0.419814826912683,-1.1686493663196147,0.2504816955684008,0.5486114561681172,1.0,13/21,28.70%,ITGAV;THBS1;GLG1;FGFR2;KL;FIBP;CEP57;ITGB3;FGFR4;GPC1;FGFRL1;S100A13;FGFBP3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3974642723841494,1.1642164051228496,0.22105263157894736,0.6052980963722081,1.0,6/24,15.44%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3459385415688956,-1.16387290498007,0.21631878557874762,0.5569389894328425,1.0,10/47,12.32%,SLC7A11;SLC7A2;SLC6A13;SLC47A1;PDPN;SLC1A5;SLC38A11;SLC6A1;SLC38A6;SLC22A4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.3848996632107261,-1.163183936995128,0.23977695167286245,0.5553607235213585,1.0,10/31,19.22%,UBE2N;UBE2E2;BIRC6;UBE2H;UBE2K;UBE2R2;UBE2B;UBE2E1;UBE2S;UBE2D3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.25256685377659494,-1.161429280700979,0.08351648351648351,0.5564649939477636,1.0,147/431,28.23%,ATP1A2;PRKAG2;RHOQ;TGFBR1;BMPR1A;TLK1;ABCA1;MYO1B;KSR1;STK3;ANXA6;ABL1;ENPP1;LRRK2;RHOJ;ATL3;TOP1;ABCD3;STK17B;N4BP2;IRAK3;ARL3;RND3;RAP1B;RAB10;MAP4K4;MRAS;RAB22A;CHD8;GLUD1;DHX9;SMC4;MAP3K5;CDC42;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;ATL2;BRSK1;RHOA;DMPK;RHOT1;HSPA14;CARS2;CDK11B;ARFIP2;DYNC1LI1;AK6;ARF1;RALA;HSPA9;PEX6;ABCD4;RHOBTB2;MKNK2;PNPLA8;SIK1;MYO1F;GTPBP10;PGK1;TBCK;RASL12;RAB21;GBP3;BMS1;MCM6;ACVR1;ERN1;LATS1;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;GBP7;GBP2;PXK;PFKP;HNRNPU;RHOBTB1;TUBB2A;RHOH;RHOC;MLKL;GBP6;EIF4G1;MSH6;NEK6;MTG2;TAOK1;NME1;BCKDK;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;RIT1;SIK2;SPHK1;RABL3;TUBB6;GSS;GALK1;ARL5A;CDC42BPG;TRNT1;RRM1;MVK;RHOT2;CLPX;RAB8A;RAB9A;NOA1;RAB7A;RPS6KA4;TAP1;RAB5A;TWF1;ABCF3;RRAGA;TWF2;TSR1;PRKCI;GNL3;DIRAS2;ABCB8;PIM1;LONP1;PRPS1;PRPS1L1;ARL4C;TUBA1C;MINK1;RAB39A
prerank,cAMP response element binding (GO:0035497),-0.5141976036783475,-1.1607447282628516,0.27715355805243447,0.5550525749717559,1.0,4/10,10.31%,CREB3L2;CREB5;ATF2;JUN
prerank,growth factor activity (GO:0008083),0.3184306890871308,1.1604830051890536,0.19348659003831417,0.6097383182028104,1.0,10/74,10.22%,NRG3;IL7;NRG1;FGF10;IL12A;AMELX;FGF5;ENDOU;THPO;PDGFB
prerank,fibroblast growth factor receptor binding (GO:0005104),0.41499403404163326,1.1592157650969508,0.26403326403326405,0.6075542316954302,1.0,4/21,6.90%,FGF10;FRS3;NPTN;FGF5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.3228020203769192,-1.1537013399522218,0.20967741935483872,0.5689058281476083,1.0,20/69,22.26%,KAT2B;CERS5;EP300;KAT6B;SOAT1;CREBBP;PLA2G4A;ZDHHC13;MOGAT3;MBOAT7;KAT8;NAA15;ESCO1;ASPG;GTF2B;ZDHHC1;ZDHHC16;HHAT;LPCAT3;SPHK1
prerank,diacylglycerol kinase activity (GO:0004143),0.49024364451521796,1.1529948896386466,0.28832951945080093,0.618097705295004,1.0,3/11,7.02%,DGKI;DGKH;DGKB
prerank,actinin binding (GO:0042805),-0.41842680714814345,-1.1505345342634512,0.2593320235756385,0.5734810399851263,1.0,8/21,14.52%,CACNA1C;DAG1;NFKB1;PDLIM5;CACNA1D;SYNPO2;PKD2;CSRP2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.403556894549736,-1.1504835050584359,0.2572463768115942,0.5704059233597223,1.0,5/25,4.47%,MICAL3;CYP26B1;CYP27A1;MICAL2;POR
prerank,adenyl ribonucleotide binding (GO:0032559),-0.2597429404037577,-1.1496177489371646,0.11316872427983539,0.5695973684606435,1.0,91/291,24.03%,ATP1A2;PRKAG2;TGFBR1;BMPR1A;MPPED2;TLK1;ABCA1;MYO1B;KSR1;STK3;ABL1;ENPP1;TOP1;ABCD3;STK17B;N4BP2;IRAK3;MAP4K4;CHD8;GLUD1;DHX9;SMC4;MAP3K5;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;BRSK1;ME1;DMPK;HSPA14;CARS2;CDK11B;AK6;HSPA9;PEX6;ABCD4;MKNK2;PNPLA8;SIK1;MYO1F;PGK1;TBCK;MCM6;ACVR1;ERN1;LATS1;RAPGEF2;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;PXK;HMGCR;PFKP;HNRNPU;MLKL;EIF4G1;MSH6;NEK6;TAOK1;NME1;BCKDK;PRKAG3;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;SIK2;SPHK1;RAPGEF4;GSS;GALK1;CDC42BPG;TRNT1;RRM1;MVK;CLPX
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.4712452130653343,-1.1481624276541946,0.2730560578661845,0.5701816609473737,1.0,7/12,28.16%,PAN3;CNOT8;CNOT2;PAN2;CNOT1;PNLDC1;PARN
prerank,ion gated channel activity (GO:0022839),0.39456799129550674,1.1480574470777094,0.2598752598752599,0.6264712772394898,1.0,5/24,8.67%,ANO3;TMEM63B;TTYH2;ANO5;ANO4
prerank,nuclear export signal receptor activity (GO:0005049),-0.48171523283681206,-1.1478271547002998,0.30206378986866794,0.5677863863554511,1.0,4/11,10.44%,XPO4;EIF4ENIF1;NUP42;NUP214
prerank,phosphatase binding (GO:0019902),-0.2992670556406914,-1.1462619479160483,0.17857142857142858,0.5686357916280613,1.0,38/105,24.91%,EGFR;SMAD3;JAK1;DLG4;SHOC2;TBK1;CTSC;DLG1;SMAD2;STAT3;EIF2AK3;AP3B1;ANAPC5;MAP3K5;ANAPC7;JUP;ANAPC4;WNK1;TRAF2;MTMR3;TRPC4AP;SH3RF2;MAP2K7;CDC27;TRAF3;IKBKE;VCP;MVP;PIK3R1;STX17;KIFAP3;MAST2;PPP1R3C;PPP1R3F;GTF2F1;SIRPA;KIF3A;CRY2
prerank,death receptor activity (GO:0005035),0.4855076136119175,1.1461775168949222,0.2879120879120879,0.6256114570243828,1.0,5/11,23.27%,TNFRSF19;TNFRSF25;TNFRSF1A;TNFRSF10B;EDA2R
prerank,signal sequence binding (GO:0005048),0.3641550435966869,1.1461621286186388,0.21604938271604937,0.6202938234446727,1.0,8/35,13.27%,IPO5;IPO4;CABP1;AP2M1;PEX5L;AP2B1;TIMM22;NFKBIA
prerank,actin monomer binding (GO:0003785),0.4091875405100396,1.144928769146913,0.2806652806652807,0.6182589451431096,1.0,4/22,4.58%,MRTFA;TMSB4X;TMSB10;NOS3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4191779464058048,1.1447242006115512,0.2611464968152866,0.6135343769757056,1.0,3/18,7.87%,GAS6;SNCA;RPS6KA1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.36726770382606294,1.1419741822382785,0.24384787472035793,0.6157852080076496,1.0,7/31,11.73%,HCN1;SLC12A6;KCNK10;KCNK9;KCNK1;SLC12A3;KCNA2
prerank,adenylyltransferase activity (GO:0070566),-0.4063100778966745,-1.1381537149119703,0.2870544090056285,0.5854895139989553,1.0,9/21,20.00%,TENT2;NMNAT2;ABL1;NMNAT3;PAPOLG;NMNAT1;OAS2;FLAD1;KARS1
prerank,syntaxin binding (GO:0019905),0.32248443309082214,1.1373172510993104,0.24324324324324326,0.622708225590847,1.0,11/61,7.63%,CACNA1A;SYT1;SYT6;SYT12;SNAP25;UNC13A;STXBP5L;SNPH;NAPG;SYNPR;SYT10
prerank,insulin-like growth factor binding (GO:0005520),-0.4396554142440491,-1.1365438747509768,0.2956204379562044,0.5866023601646763,1.0,6/15,8.22%,IGFBP2;IGFBP5;ITGAV;IGFBP3;IGFBP6;IGFBP4
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.3359314518523423,-1.1359413570923629,0.2637571157495256,0.5849431004872141,1.0,12/49,16.04%,ATP1A2;MPPED2;DUSP16;PRUNE1;PTPN22;DUSP11;PXYLP1;PPP1CB;SACM1L;EPHX2;ACP2;DUSP10
prerank,solute:anion antiporter activity (GO:0140323),-0.44597823643835105,-1.1356148466063296,0.31135531135531136,0.5825986048159102,1.0,4/14,12.47%,SLC7A11;SLC26A7;SLC26A2;SLC4A3
prerank,protein kinase binding (GO:0019901),-0.24605337880683764,-1.135614369425168,0.09456740442655935,0.5795322963695106,1.0,152/479,24.20%,PRKAG2;GRK5;SASH1;TCF7L2;SMAD3;PTN;ERRFI1;ANK2;PKD1;LIMS1;MAPK4;PDLIM5;KIF13B;NBEAL1;ITGAV;NISCH;PDGFRB;PARD6G;KAT2B;IL31RA;FOXO3;PPP1R12A;GHR;ABL1;PRKN;PPM1D;IBTK;GSK3B;RPTOR;CNTLN;IRAK3;IRS1;KHDRBS1;MAPKAP1;IL15RA;DLG1;NR3C1;ITGB1;RND3;RBBP6;AXIN1;PAK2;SKI;SLC12A7;STAT3;UFL1;TRIP4;DUSP16;SHC1;NOX4;TPCN2;ADCY6;CDC42;EPHA4;NBR1;VDAC1;PTPRK;DACT1;ATF2;CCNK;WNK1;PLCG1;TOM1L2;RB1CC1;PTPN2;SLC12A2;TRAF2;RHOA;PRKCD;HIF1A;ADAM9;DNAJC3;PRKAB2;EXOC2;MAVS;KIZ;PARP1;ROR2;TRIM5;TELO2;RHOBTB2;TPR;SUFU;SIK1;TCF3;APPL1;RICTOR;MAML1;BECN1;MAPRE1;TRIB2;CDK5RAP1;ERCC6L2;DUSP1;ACVR1;CCND3;LATS1;CDC25B;PPP1CB;MAP2K7;DUSP10;TNIP2;RAB11FIP2;ADRA2A;CAVIN3;TOP2B;CACUL1;PRKACA;PTPN1;RHOBTB1;FBXW5;BLNK;TRAF6;RHOH;DACT3;MAP3K1;RHOC;MTCP1;PTPN11;NEK6;IRAK1;MAP2K6;MVP;SPRED2;PRKAG3;PIH1D1;USF1;CDK5RAP3;LRBA;GATA6;SMAD1;PRKAB1;MSN;TBL2;NBEAL2;MAP3K12;CIR1;DUSP7;PRKRIP1;TICAM1;NSF;PKIA;HSF1;MAPK7;SPAG9;CSPG4;BORA;AP2A1;SIRPA;BAG5;DACT2;PTPN23
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2594418006556114,-1.1349239762741135,0.13934426229508196,0.5782484708889505,1.0,71/268,18.52%,FHIT;EGFR;SMAD3;VCL;SMAD6;UBE2N;PRKN;JAK1;ARIH1;GSK3B;SNCAIP;CASC3;HM13;USP7;SMC6;SMAD2;DNM1L;SNX9;AXIN1;SKI;TRIP4;BCL2;MID1;RNF8;PCBP2;UBE2K;JKAMP;PPARGC1A;UQCRC1;HLTF;PTPN22;TXNIP;HERC2;TRAF2;JUN;SPOPL;HIF1A;RPL11;PARP9;CCDC50;RALA;HSPA9;CUL3;PIAS4;RB1;FBXW7;PATZ1;BECN1;SLF1;LTBR;DTX3L;TRIB2;STAT1;USP2;UBE2B;USP13;YWHAE;CUL2;FAF2;NDUFS2;ARRB1;TRAF3;IKBKE;AUP1;RNF20;DERL1;PRKACA;AMBRA1;TRAF6;VCP;TANK
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.45497258964093934,1.134669162866276,0.29411764705882354,0.6244795174649493,1.0,3/14,12.78%,KCNJ3;KCND3;KCNJ8
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3337553540272413,-1.1336439633784476,0.24907063197026022,0.5783733705096825,1.0,23/49,31.47%,ZFAND6;RNF169;RAD23B;UBQLN1;BRCC3;PARP10;ZBTB1;ABRAXAS2;TNIP2;SPRTN;ZRANB3;IKBKE;VCP;WDR81;SHARPIN;BAG6;UBQLN4;PRPF8;ABRAXAS1;TNFAIP3;ZFAND2B;FAAP20;UFD1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.45934130896441505,1.133437537945274,0.3050847457627119,0.6225283717466009,1.0,4/12,13.00%,PDE4B;PDE2A;PDE4D;PDE4A
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.47851034894898203,-1.1319869281481425,0.33515482695810567,0.579447664510262,1.0,2/11,1.07%,ITPR1;ITPR2
prerank,leak channel activity (GO:0022840),-0.4191288411738995,-1.127865470274674,0.2948960302457467,0.5863596840824132,1.0,3/18,6.27%,KCNK2;NALCN;KCNK5
prerank,ubiquitin protein ligase binding (GO:0031625),-0.2588937119013189,-1.1265122785830977,0.1721311475409836,0.5868220595154894,1.0,67/253,18.52%,FHIT;EGFR;SMAD3;VCL;SMAD6;UBE2N;PRKN;JAK1;ARIH1;GSK3B;SNCAIP;CASC3;HM13;USP7;SMC6;SMAD2;DNM1L;SNX9;AXIN1;SKI;BCL2;MID1;RNF8;PCBP2;UBE2K;JKAMP;PPARGC1A;UQCRC1;HLTF;PTPN22;TXNIP;HERC2;TRAF2;JUN;SPOPL;HIF1A;RPL11;CCDC50;RALA;HSPA9;CUL3;PIAS4;RB1;FBXW7;PATZ1;BECN1;SLF1;LTBR;TRIB2;USP2;UBE2B;USP13;YWHAE;CUL2;FAF2;NDUFS2;ARRB1;TRAF3;IKBKE;AUP1;RNF20;DERL1;PRKACA;AMBRA1;TRAF6;VCP;TANK
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4697160201166163,-1.1242905886410965,0.32421875,0.5893989479408817,1.0,3/11,9.37%,EGFR;MAP3K5;MAP3K20
prerank,adrenergic receptor binding (GO:0031690),0.42624342997632836,1.1230517105381077,0.31777777777777777,0.644837373078149,1.0,5/16,12.59%,ADRB1;MAGI2;GRK2;UCHL1;PDE4D
prerank,nucleosomal DNA binding (GO:0031492),0.39298797896547605,1.1217335854695074,0.29338842975206614,0.6430028624766646,1.0,5/21,8.78%,ACTB;HMGA2;SMARCB1;HNRNPC;H3-3A
prerank,PDZ domain binding (GO:0030165),-0.3215225811035659,-1.1189043124246125,0.26907630522088355,0.5992921914960633,1.0,12/61,7.19%,TGFBR3;ARHGAP29;CRIM1;PLEKHA2;SDC2;ERC1;PRKN;DLG4;SYNJ2;CXADR;FZD2;SLC22A5
prerank,metalloexopeptidase activity (GO:0008235),-0.32461024308270764,-1.1188958604776602,0.25868725868725867,0.5962938890655898,1.0,12/51,17.11%,CPQ;AEBP1;XPNPEP1;ANPEP;MMP14;LAP3;AGBL3;NPEPPS;CPM;CPXM2;LNPEP;CPXM1
prerank,cation channel activity (GO:0005261),0.2931522669432001,1.11787811928901,0.24358974358974358,0.6482925431974561,1.0,14/94,8.42%,HCN1;SLC24A4;SLC24A2;GRIN1;TRPC5;RYR2;UNC80;TMEM63B;KCNK10;CACNA1E;TRPM2;KCNK9;CACNB2;KCNK1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.30592993177277267,-1.1176188486739942,0.22265625,0.596629170773314,1.0,22/72,19.90%,GSN;SVIL;MYO1B;ADAP2;GSDME;SLC9A1;MAPKAP1;ANXA2;KCNJ2;FCHO2;ACTN2;PLCD1;TULP3;SNX21;GSDMD;FZD7;PARD3;MARK1;PICALM;FRMPD4;AVIL;VILL
prerank,channel activity (GO:0015267),0.3394386564803245,1.1169110252702563,0.2698072805139186,0.6459302487472885,1.0,3/41,2.98%,AQP9;AQP11;ASIC4
prerank,LRR domain binding (GO:0030275),-0.4442082785979227,-1.115654777657433,0.33210332103321033,0.5984976283655774,1.0,5/14,11.46%,PAWR;ROBO1;ERC1;ZXDC;LRRFIP2
prerank,cGMP binding (GO:0030553),0.4637056543609098,1.1132478097908163,0.32991803278688525,0.6511952281937257,1.0,3/11,6.21%,PDE10A;PDE2A;PDE11A
prerank,phosphate ion binding (GO:0042301),0.48331901724648846,1.1065850658121772,0.34368530020703936,0.6638833718477125,1.0,1/10,3.36%,PDE2A
prerank,high voltage-gated calcium channel activity (GO:0008331),0.47097602142313744,1.1042391115911807,0.34725274725274724,0.6648642022296917,1.0,4/10,10.79%,CACNA1A;CACNA1B;CACNB2;CACNB4
prerank,hormone receptor binding (GO:0051427),-0.43222659128982593,-1.104097456944375,0.32342007434944237,0.6242328110254255,1.0,4/14,22.07%,JAK1;NCOA6;TYK2;PTHLH
prerank,Hsp70 protein binding (GO:0030544),0.36279281023327714,1.103861354819544,0.32093933463796476,0.6606312426885866,1.0,9/31,13.23%,PACRG;SNCA;SACS;FICD;CYP2E1;MVD;IQCG;RNF207;RPS3
prerank,sodium channel regulator activity (GO:0017080),0.3518378551510367,1.1027939818673675,0.305668016194332,0.6584021035096361,1.0,9/37,17.63%,FGF12;FGF14;FGF13;SCN4B;SGK3;ATP2B4;SCN2B;GPLD1;PKP2
prerank,endopeptidase activity (GO:0004175),-0.2544682985635591,-1.0985445153207183,0.21575984990619138,0.6359210434616401,1.0,46/257,15.13%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;USP24;ADAMTSL5;PCSK5;HTRA3;PLAT;USP7;CTSC;CTSH;ADAMTS5;DPP4;F3;DDI2;ECE1;ADAMTSL4;ADAMTS9;NRDC;USP33;MMP14;ADAM9;SENP1;USP47;MBTPS2;ADAM19;FAP;ADAMTS15;MMP2;ADAM33;NLN;CASP2;USP12;USP11;USP46;RHBDF1;USP35;PSMB2;USP2;ADAMTS17;USP13;MBTPS1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.4393432591784753,-1.0963163804376186,0.3574144486692015,0.6383834669467481,1.0,2/14,0.95%,SLC7A11;SLC1A3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.4217772789310782,1.0942818169916204,0.33186813186813185,0.6710858414531076,1.0,5/17,8.39%,EPHA6;EPHB1;EPHA5;EFNB3;EPHA10
prerank,ephrin receptor activity (GO:0005003),0.4217772789310782,1.0942818169916204,0.33186813186813185,0.6710858414531076,1.0,5/17,8.39%,EPHA6;EPHB1;EPHA5;EFNB3;EPHA10
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.38990827458665056,1.0938317189085422,0.3163265306122449,0.6575420713123187,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,serotonin receptor activity (GO:0099589),0.38990827458665056,1.0938317189085422,0.3163265306122449,0.6575420713123187,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.38990827458665056,1.0938317189085422,0.3163265306122449,0.6575420713123187,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,retinoic acid receptor binding (GO:0042974),-0.41089177544441347,-1.0923526965678663,0.3320825515947467,0.6456113306993589,1.0,8/17,21.79%,RARG;NSD1;NCOA6;MED1;PRMT2;CNOT1;NR4A2;ARID5A
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.28826328742964213,-1.091417447512799,0.2991967871485944,0.6450263202008342,1.0,28/91,20.57%,GSN;SVIL;MYO1B;ADAP2;SH3PXD2B;GBF1;GSDME;SLC9A1;MAPKAP1;ANXA2;KCNJ2;FCHO2;ACTN2;PLCD1;TULP3;KIF16B;WIPI1;SNX21;GSDMD;FZD7;PARD3;MARK1;WDR45B;PICALM;FRMPD4;AVIL;VILL;WIPI2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4821289083377567,-1.0857578770344407,0.3823008849557522,0.6565779105638259,1.0,1/10,0.40%,DPYSL3
prerank,MAP kinase kinase activity (GO:0004708),-0.42586353088782447,-1.0844662519634678,0.3512476007677543,0.6568972203566741,1.0,9/15,36.51%,LRRK2;MAP2K4;MAP2K1;MAP2K7;MAP2K6;MAPK14;MAP2K3;MAPKAPK3;MAP2K2
prerank,mannosyltransferase activity (GO:0000030),0.38253098955958564,1.0835135414698907,0.3456521739130435,0.6803451583662234,1.0,6/21,12.41%,TMTC2;ALG3;PIGM;ALG1;DPY19L1;ALG8
prerank,histone deacetylase binding (GO:0042826),-0.28618180573546365,-1.0819458354140543,0.3002028397565923,0.6600546741781721,1.0,25/88,18.35%,GLI3;KAT2B;HDAC4;BCOR;NCOR1;PRKN;MEF2A;LCOR;AKAP8L;DHX36;SP2;DACT1;CHD4;MIER1;NIPBL;MEF2C;HES1;BHLHE41;HDAC1;YWHAE;SFPQ;CAMTA2;TOP2B;ZMYND15;TRAF6
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3656572628639836,-1.08133429861521,0.34099616858237547,0.6584745990929781,1.0,8/26,14.17%,SLC6A13;SLC16A12;SLC6A12;SLC16A6;SLC16A9;SLC5A6;SLC6A1;SLC27A1
prerank,phosphatidate phosphatase activity (GO:0008195),0.434738191188252,1.079940618709894,0.388412017167382,0.6852559969417882,1.0,4/13,8.87%,PLPPR1;PLPPR5;PLPPR4;PLPP4
prerank,ribonuclease P RNA binding (GO:0033204),0.45686078278213116,1.078220466896129,0.35152838427947597,0.6848749265517369,1.0,3/10,12.32%,RPP40;RPP30;POP5
prerank,C2H2 zinc finger domain binding (GO:0070742),0.4478121693857595,1.077696316453014,0.36774193548387096,0.6813749782428911,1.0,2/11,3.68%,LEF1;HMGA2
prerank,lipid phosphatase activity (GO:0042577),0.4231169879986918,1.0756951584632106,0.376,0.6818219072047597,1.0,7/14,19.58%,PLPPR1;PLPPR5;SGPP2;PLPPR4;PLPP6;SGPP1;PLPP7
prerank,translation elongation factor activity (GO:0003746),0.4116731541833565,1.0730329883451528,0.37303370786516854,0.684041006423267,1.0,6/14,17.75%,EEF1B2;TUFM;EIF5A2;EEF1A2;EEF1A1;EEF2
prerank,bHLH transcription factor binding (GO:0043425),-0.3921858629719069,-1.0720561000792201,0.36900369003690037,0.6786991735003849,1.0,5/19,12.85%,FHL2;SMAD3;CREBBP;TCF3;BHLHE41
prerank,nuclease activity (GO:0004518),-0.30772715180642024,-1.0696808425831057,0.3003875968992248,0.6816177146702234,1.0,19/52,29.59%,DIS3L2;ENPP1;N4BP2;PLSCR1;WRN;RNASE12;REXO5;XRN2;REXO1;MRE11;RNASE4;NME1;EXOG;OGG1;PDE12;DNASE1L1;DIS3;PARN;SAMHD1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3633035557237937,1.0679706468895789,0.3620689655172414,0.6933055416428464,1.0,3/24,4.11%,CAMK2A;CAMKV;CAMK4
prerank,CoA hydrolase activity (GO:0016289),-0.4086825911882531,-1.0672630352656594,0.374031007751938,0.6846627045060141,1.0,6/16,23.25%,HIBCH;ACAA2;ACOT11;ACOT9;ACOT8;ACOT6
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.34319004182414836,-1.067195411688791,0.32894736842105265,0.6815804455708292,1.0,16/33,28.16%,ERI3;DIS3L2;CNOT8;XRN1;XRN2;ERI2;EXOSC9;PAN2;EXOSC10;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,protein homodimerization activity (GO:0042803),-0.22597202875564285,-1.0663086154819412,0.1970649895178197,0.6808466982384859,1.0,196/589,27.74%,CPQ;FOXP2;NR2F2;SMAD3;APPL2;BMPR1A;PDGFRA;TPM1;LRP6;AOX1;NADK2;RBPMS;MAPK4;ZHX2;GHR;CRYL1;ARNT;ENPP1;LRRK2;NPR3;TPST1;XPNPEP1;NR6A1;EEA1;FBLN5;KIT;ABCD3;FLNA;IRAK3;EXT1;HM13;SLK;DNM1L;SNX9;EIF2AK1;AXIN1;SNX6;DPP4;NUDT5;ZBTB16;VPS4B;STAT3;GLCE;FGFR2;MKLN1;MMUT;BCL2;MIGA2;CAMK2D;IRAK2;CDADC1;TRIM8;CRPPA;MID1;RNF8;MAP3K5;ECE1;CHMP4B;CHMP4A;S100A10;UBA5;CAMK2G;WRN;ABCD2;ZBTB1;JUP;PRMT2;PDGFC;TARS2;S100A6;SMAD4;PAFAH1B2;TBX18;TRIM5;PSMF1;NRF1;FAP;ACSL6;PAXX;HES1;ATIC;QTRT2;PKD2;TPR;TCF3;IL6R;BHLHE41;APPL1;EFEMP2;UPB1;SOX6;TXN;GBP3;APOE;TPD52L1;STAT1;VEGFA;ZNF318;GCA;ACVR1;ERN1;DPYD;MSH3;IL17D;PGRMC1;GLIPR2;PDXK;EPHX2;RAB11FIP2;NECTIN3;PTPA;TYW5;SFPQ;ADRA2A;CUBN;SMCHD1;CCDC66;GBP2;ACOX1;NQO2;S100A11;ANO1;ATP5IF1;PRMT8;CEP57;MYOM1;PARK7;PSPH;MGLL;MSH6;TERF2;IRAK1;GNPTG;PEX7;NAGA;KARS1;TPM2;CARNMT1;SNF8;SPPL3;TERT;PML;SLC39A13;RBPMS2;S100A1;DGKD;USF1;KMT2A;BNIP3;MAP3K12;ALS2;SSBP1;GALM;ST6GAL1;PRDM9;RABL3;F11R;GSS;PTH1R;GSTM2;NUDT21;HIP1R;SLC8B1;CYP2R1;TFAP4;PON3;MAP3K13;MZF1;SLIT2;TRIM68;TAP1;PHB2;GGCT;CBS;FBXO4;LDB1;BCL2L2;TRPC6;PHETA1;ST3GAL2;FXR1;RPE;LPL;RRAGA;NFS1;WARS1;SPPL2A;ZBTB7B;S100A13;SMIM1;ADRB2;RABEP1;PRPS1;PRPS1L1;CIP2A;PEX11B
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3423326672496898,-1.065942152732619,0.3688073394495413,0.6785700277765361,1.0,19/33,33.49%,PRKN;ARIH1;RNF217;RNF19A;TCERG1;AUP1;TRAF6;RNF14;DCUN1D3;PARK7;ARIH2;RNF144A;SIAH2;PPARA;DCUN1D5;UBA2;RNF180;ANKIB1;DCUN1D4
prerank,endoribonuclease activity (GO:0004521),-0.3532863885811509,-1.065641114312066,0.36926147704590817,0.6761424614497369,1.0,8/32,14.72%,SMG6;DICER1;ZC3H12C;NYNRIN;CPSF3;KHNYN;ZC3H12B;ERN1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.305235490505285,-1.0634109872839714,0.3620689655172414,0.6791528965765249,1.0,11/55,12.32%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC38A11;SLC16A9;SLC38A6;SLC22A4
prerank,sulfotransferase activity (GO:0008146),-0.3426151002984201,-1.0629442288606064,0.3567362428842505,0.6772871044669851,1.0,9/33,19.07%,UST;TPST1;HS3ST3A1;HS2ST1;CHST15;SULT1A1;CHST11;HS6ST1;CHST12
prerank,calcium channel inhibitor activity (GO:0019855),-0.4523047127325967,-1.06137819532051,0.3747645951035782,0.6783732969062006,1.0,1/11,0.25%,ITPR1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.38086875513281554,-1.0609026377000188,0.353515625,0.6765331268236693,1.0,9/21,17.47%,WASF2;ARFGEF1;AKAP8L;PRRC1;ACBD3;AKAP1;WASF1;AKAP9;PRKACA
prerank,nuclear receptor coactivator activity (GO:0030374),-0.3118695559742619,-1.0597557593445053,0.33394160583941607,0.6766655113488854,1.0,13/52,12.88%,ZMIZ1;PPARGC1B;SS18;MED17;MED12;ENY2;PPARGC1A;NCOA6;NCOA1;MED1;CALCOCO1;DCAF6;CCAR1
prerank,endopeptidase inhibitor activity (GO:0004866),-0.28520200522165784,-1.0593335978729448,0.3346228239845261,0.6748546826527273,1.0,15/82,11.79%,TIMP3;COL4A3;CAST;ROCK1;BIRC6;SERPING1;PROS1;TFPI;ANXA2;ITIH2;RECK;RENBP;NGF;SERPIND1;PSMF1
prerank,thioesterase binding (GO:0031996),-0.4507594451222475,-1.0589856936443653,0.3970037453183521,0.6728026561660603,1.0,7/11,22.24%,CDC42;TRAF2;ADRA2A;TRAF3;TRAF6;HAUS7;TRAF5
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.34269909132226506,1.0571835079273781,0.36909871244635195,0.7180073302095594,1.0,4/30,7.87%,SPOCK1;GAS6;SNCA;RPS6KA1
prerank,single-stranded RNA binding (GO:0003727),0.3204341080739519,1.0558461699280344,0.3741935483870968,0.7166558934131934,1.0,6/43,9.63%,ADARB2;ZFR2;SNRPC;RBM11;STRBP;DDX11
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.28302201763043805,-1.0555552545531917,0.34990439770554493,0.6787993440223157,1.0,23/78,24.05%,USP24;CFLAR;USP7;CTSC;CTSH;PIGK;CASP12;USP33;USP47;CASP2;USP12;USP11;USP46;USP35;USP2;USP13;USP34;CTSF;GPAA1;CTSL;USP18;USP9X;USP28
prerank,chemokine receptor activity (GO:0004950),0.3630529537727365,1.0524832660645775,0.38963963963963966,0.7212166697692783,1.0,4/24,9.26%,GPR35;ACKR4;GPR17;GPR75
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4320863670600051,1.0518299353417868,0.39872068230277186,0.7180153243534487,1.0,11/11,56.82%,DDAH1;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;ARG2;PADI2;DDAH2
prerank,potassium ion antiporter activity (GO:0022821),-0.40885789923532023,-1.051089337500298,0.4107806691449814,0.6874793375096226,1.0,4/15,6.17%,SLC24A3;SLC9A1;SLC9A8;SLC9A2
prerank,N-methyltransferase activity (GO:0008170),-0.3864698363018022,-1.0476647308139697,0.3757115749525617,0.6935024596245745,1.0,11/20,32.06%,ZCCHC4;SETD3;TRMT11;N6AMT1;DIMT1;METTL15;TRMT1L;TRMT1;HNMT;NNMT;FDXACB1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.32536014253133844,-1.0473122026744288,0.3769230769230769,0.6912953483970291,1.0,15/38,24.68%,SH3PXD2B;ZFYVE1;PLA2G4A;KIF16B;WIPI1;SNX21;ATG2A;PARD3;WDR45B;ATG2B;PLEKHF1;WIPI2;PLEKHA4;JPH2;SNX12
prerank,myosin V binding (GO:0031489),0.40693400997597323,1.044539742878975,0.40444444444444444,0.7335913236848569,1.0,3/15,7.16%,RAB3C;RAB6B;RAB39B
prerank,protein tyrosine kinase binding (GO:1990782),0.28861494980275687,1.0427131921468906,0.351129363449692,0.7335915936881834,1.0,7/71,5.48%,NRG3;GRM5;GRB14;NRG1;DOCK4;GAS6;PITPNM1
prerank,calcium channel regulator activity (GO:0005246),0.32803718297013973,1.0421134971686823,0.3925619834710744,0.7302577149699511,1.0,8/37,13.77%,NRXN1;PRKG1;NRXN2;SLC30A1;SGK3;CACNG8;CALM1;CALM2
prerank,ribonuclease P activity (GO:0004526),0.4283312865027403,1.0414774670839788,0.38913043478260867,0.7270924781104491,1.0,3/11,12.32%,RPP40;RPP30;POP5
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3793229361344016,-1.0413433625248982,0.3916349809885932,0.7041608591888916,1.0,11/20,23.94%,USP7;SENP3;SENP1;USP47;SENP5;COPS2;USP50;DESI2;SENP2;USP9X;EIF3H
prerank,semaphorin receptor activity (GO:0017154),-0.444302607815814,-1.039378113952752,0.43263757115749524,0.7063848890289345,1.0,5/11,15.99%,PLXNA2;NRP1;PLXNB2;PLXND1;PLXNB1
prerank,Notch binding (GO:0005112),-0.3722579558455759,-1.0392208339358906,0.4052044609665427,0.70379328029899,1.0,4/22,12.57%,SNED1;JAG1;CCN3;CUL3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2764224776229733,1.0390208426720575,0.3872340425531915,0.7292650687039833,1.0,11/85,10.38%,AARS2;ABHD2;ENPP2;LYPLA1;LIPE;CA2;PLAAT1;PTRH2;PLA2G12A;ABHD8;ESD
prerank,N-acetyltransferase activity (GO:0008080),-0.3809932226101647,-1.0388978138560852,0.40229885057471265,0.7016383143912082,1.0,4/19,14.47%,KAT2B;EP300;SAT1;ESCO1
prerank,protein phosphatase binding (GO:0019903),-0.26969413105755785,-1.0388458366532598,0.36590038314176243,0.6987498670768885,1.0,39/117,24.95%,EGFR;JAK1;DLG4;SHOC2;SLC9A1;TBK1;STRN3;STAT3;EIF2AK3;AP3B1;ANAPC5;MAP3K5;ANAPC7;SMG7;JUP;ANAPC4;ANKLE2;TRAF2;MTMR3;PPP1R3B;SH3RF2;MAP2K7;CDC27;BOD1L1;PTPA;TRAF3;IKBKE;VCP;MVP;PIK3R1;STX17;KIFAP3;PPP1R3C;SPHK1;PPP1R3F;GTF2F1;SIRPA;KIF3A;MASTL
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.35123503525692784,-1.0385424036943567,0.38278388278388276,0.6965287585934987,1.0,16/27,33.49%,PRKN;ARIH1;RNF217;RNF19A;AUP1;TRAF6;RNF14;DCUN1D3;ARIH2;RNF144A;SIAH2;PPARA;DCUN1D5;RNF180;ANKIB1;DCUN1D4
prerank,cytokine activity (GO:0005125),0.2614357288123646,1.0376821312261295,0.3706140350877193,0.727927528024664,1.0,16/131,10.54%,KITLG;IL17F;MIF;IL7;NRG1;CXCL12;BMP8A;IL12A;SCGB3A1;TGFB2;WNT7B;TIMP1;EPO;CCL2;BMP3;SCG2
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2846361527106423,-1.0358379932159902,0.3890063424947146,0.7007005750523514,1.0,20/71,14.98%,EYA2;PTPN13;EYA1;EYA4;PTPN14;CDC14A;TNS2;PTPN9;PTPRS;PTPN21;PTPN3;PTPRK;PTPN22;PTPN12;PTPN2;DUSP11;MTMR3;DUSP1;CDC14B;CDC25B
prerank,endonuclease activity (GO:0004519),-0.3079133379870081,-1.0356802136957133,0.3807763401109057,0.6980972845293407,1.0,11/49,16.79%,SMG6;DICER1;N4BP2;ZC3H12C;NYNRIN;CPSF3;KHNYN;ZC3H12B;ERN1;MRE11;ZRANB3
prerank,protein kinase inhibitor activity (GO:0004860),0.31064476264567403,1.0354170336511872,0.3987730061349693,0.7291656829850912,1.0,13/42,16.15%,YWHAB;CAMK2N1;INKA1;SNCA;DUS2;SPRY4;SOCS1;MAPK8IP1;CEP43;CIT;CIB1;CDKN1A;CDKN1B
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.4229846626673689,-1.032711967936797,0.43911439114391143,0.7029568727474043,1.0,7/12,30.58%,TBP;STAT1;HDAC1;GTF2B;TBPL1;RUVBL2;GTF2A1
prerank,TBP-class protein binding (GO:0017025),-0.36684779741328266,-1.0316033880408633,0.41030534351145037,0.7027028481027245,1.0,11/21,30.58%,TAF13;GTF2B;TAF12;PSMC1;DRAP1;YEATS2;THRA;ESR1;BRF2;RUVBL2;GTF2A1
prerank,"DNA binding, bending (GO:0008301)",0.40091884705271313,1.0304040295880428,0.43312101910828027,0.73835669695551,1.0,3/14,7.01%,LEF1;HMGA2;TERF1
prerank,transition metal ion binding (GO:0046914),-0.22642776002001355,-1.0263044900097202,0.37450980392156863,0.7135042027265458,1.0,99/397,20.02%,AGMO;SMAD3;LARGE1;MPPED2;AOX1;LIMS1;SEC24D;GLI2;B4GALT1;MOXD1;CBLB;ZEB1;MDM4;PAPPA;HDAC4;ABL1;PRKN;ENPP1;ARIH1;KDM7A;XPNPEP1;ZCCHC4;EEA1;PLSCR1;SKI;RC3H1;TDP2;SEC23A;NSD1;PHF8;ASAH2;CDADC1;TRIM8;ZFYVE1;TES;KDM5B;ACO2;RNF8;ECE1;ANPEP;UBA5;WRN;ACER3;SLU7;PHF2;CHD4;CHD3;USP33;MNAT1;ENPP3;ME1;ABL2;FAM20C;NAPEPLD;BBOX1;SOD3;PPM1M;MSRB3;FBXL19;NPEPPS;PIAS4;ADAM33;KDM1B;CZIB;PCK2;SIRT5;UPB1;GLO1;ESCO1;KDM3A;PRDM2;P2RX4;RXRA;LNPEP;PDXK;KDM2A;LOXL3;TYW5;GTF2B;TARS1;ZFP37;NQO2;BAZ1B;RASSF1;PTPN1;RABGGTB;XYLT2;SOD2;NEK4;GALNT1;PARK7;APIP;B4GALT7;ZMYND8;NFU1;TIMP2;ETHE1;QPCTL;RNF11
prerank,syntaxin-1 binding (GO:0017075),0.3568708171553639,1.023759362221288,0.4177215189873418,0.7521199150175957,1.0,6/22,10.56%,SYT1;SNAP25;UNC13A;SNPH;SYNPR;CPLX1
prerank,MHC class II protein complex binding (GO:0023026),0.4216243716924116,1.0222467651944713,0.42203742203742206,0.7516700726387506,1.0,4/11,17.05%,HSPA8;HSP90AB1;ATP1B1;HSP90AA1
prerank,E-box binding (GO:0070888),-0.3266371778537106,-1.0168257894061972,0.4260700389105058,0.7354246911395816,1.0,10/34,24.88%,TCF4;ZEB1;HES1;TCF3;BHLHE41;ATOH8;PRMT5;TFAP4;SNAI1;TWIST1
prerank,zinc ion binding (GO:0008270),0.23058415216834743,1.0165464426216428,0.3822937625754527,0.7625793465904508,1.0,46/293,11.74%,MT2A;MMP12;MME;GLRA1;S100A8;S100A9;GRIN2A;SHANK3;PDE2A;TRIM2;GRIN2B;QPCT;PPARG;PHEX;RPS27;SNCA;ENPP2;MT1G;MT1B;MT1F;MT1E;MT1X;MT1A;MT1M;MT1H;SNRPC;CA2;NUDT12;KLF4;MYT1;TIMP1;MMP16;PITRM1;MSRB2;ZDHHC15;TMEM163;RNF112;ARHGEF2;DPF3;TRIM24;SMPDL3A;SMPD1;ZNF22;IKZF5;THAP1;SLC30A5
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3701284249076164,1.0159232851975484,0.4495798319327731,0.7595804938758783,1.0,5/18,14.18%,SLA2;PIK3R5;SOCS1;PIK3R3;CCKBR
prerank,dipeptidyl-peptidase activity (GO:0008239),0.43907213351954133,1.0157783886448926,0.44372294372294374,0.7552106481575315,1.0,2/10,6.05%,DPP10;DPP6
prerank,cholesterol binding (GO:0015485),-0.29995856514576413,-1.013122802499693,0.4171539961013645,0.7422052742936954,1.0,12/47,12.63%,ABCA1;ANXA6;OSBPL8;SOAT1;GRAMD1C;OSBPL5;SIDT1;VDAC1;NR1H3;NPC2;ERLIN1;APOD
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.3185023952152608,-1.0096274705703512,0.4266409266409266,0.7488034755319387,1.0,18/35,30.58%,FOXP1;BAZ2A;NR3C1;TAF4;TBP;STAT1;HDAC1;SNAPC3;GTF2B;PARK7;PIH1D1;DRAP1;AGO1;TBPL1;TAF1C;RRN3;RUVBL2;GTF2A1
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.3645382548605189,-1.0081944356949353,0.44582593250444047,0.7464436467007082,1.0,8/21,20.87%,CDK8;CDK7;CDK13;CCNK;CDK11B;CDK10;CDK2;CDK6
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.3645382548605189,-1.0081944356949353,0.44582593250444047,0.7464436467007082,1.0,8/21,20.87%,CDK8;CDK7;CDK13;CCNK;CDK11B;CDK10;CDK2;CDK6
prerank,cytokine receptor binding (GO:0005126),-0.2706689784519962,-1.0076420859304098,0.42574257425742573,0.7448791830052098,1.0,8/83,5.30%,TGFBR3;SMAD3;IL34;IL6ST;JAK1;PIBF1;IL13RA1;SMAD2
prerank,acetylcholine receptor activity (GO:0015464),0.3473491679973537,1.0066320494008207,0.44488977955911824,0.7765816033324545,1.0,1/22,1.72%,CHRM3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4036837422584721,1.005800352507274,0.43683083511777304,0.7742448797583443,1.0,6/13,25.53%,RANBP1;CCDC88A;GDI1;ARHGDIG;SH3BP4;EIF5
prerank,growth factor receptor binding (GO:0070851),-0.2627774488675376,-1.0037742264274598,0.44490644490644493,0.7515563097723981,1.0,18/95,15.36%,EFEMP1;PDGFRA;FGF1;PDGFRB;IL6ST;PIBF1;PLSCR1;SHC1;FRS2;NCSTN;FER;PDGFC;KL;IL6R;VEGFA;ERN1;VEGFD;ITGA5
prerank,nucleotidyltransferase activity (GO:0016779),-0.3666535072931801,-1.0030442060870295,0.4497991967871486,0.7504184890008981,1.0,5/19,13.97%,TENT2;NUDT5;CRPPA;TUT4;REV1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3272686327909681,-1.0026849677987022,0.4549019607843137,0.7483601847591144,1.0,4/29,7.01%,SLC13A3;SLC1A5;SLC26A7;SLC26A2
prerank,tRNA binding (GO:0000049),-0.30302222586434613,-1.0021985766202246,0.45353159851301117,0.7466180510977591,1.0,21/43,33.71%,FARS2;TRMT9B;NSUN6;ALKBH1;EIF2AK4;TYW5;NSUN2;ELP5;KARS1;TERT;DALRD3;RPUSD4;TRNT1;PSTK;NAT10;IGHMBP2;TRMT10C;MRPS27;PUS1;ALKBH8;CARS1
prerank,hormone activity (GO:0005179),0.2928578033740218,1.001880955473658,0.43912175648702595,0.7805154205259782,1.0,13/54,20.08%,AMH;TRH;ADCYAP1;NMB;SST;POMC;GRP;PNOC;VGF;EDN1;CCL25;METRN;AGT
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.29009847132935107,1.0014731164677673,0.42418032786885246,0.7769187925516184,1.0,13/55,14.16%,SLC24A4;SLC24A2;GRIN1;TRPC5;RYR2;ATP2B3;TRPM2;CACNB2;TRPC1;TMCO1;PSEN1;ATP2B2;ATP2B4
prerank,acylglycerol lipase activity (GO:0047372),0.4252030013368432,1.0008990597450658,0.4521158129175947,0.7738484711227931,1.0,2/11,5.48%,ABHD2;LIPE
prerank,gap junction channel activity (GO:0005243),-0.35916418583212706,-0.9998148988769702,0.46332046332046334,0.7494332452679358,1.0,3/22,8.72%,GJB6;GJA1;GJB2
prerank,sequence-specific mRNA binding (GO:1990825),0.4257382527727088,0.9951005462956437,0.4607218683651805,0.7849902332327467,1.0,2/10,6.86%,LARP6;ETF1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2744437671535592,0.9946788332573341,0.44507575757575757,0.7815543495465179,1.0,16/73,17.97%,HCRTR1;LGR5;SORCS3;SORCS1;APLNR;HCRTR2;F2R;GRPR;OPRK1;CCKBR;NPR1;NPSR1;CALCRL;ADCYAP1R1;CYSLTR1;EDNRB
prerank,wide pore channel activity (GO:0022829),-0.3544234432038683,-0.9935975436004932,0.4682080924855491,0.7627215908619474,1.0,3/23,8.72%,GJB6;GJA1;GJB2
prerank,nucleotide diphosphatase activity (GO:0004551),-0.40152887603109816,-0.9914971813730781,0.46593001841620624,0.7654277721302639,1.0,3/14,3.50%,FHIT;ENPP1;NUDT4
prerank,RNA stem-loop binding (GO:0035613),-0.4160730466960251,-0.9902818826644039,0.4954954954954955,0.7657673464934953,1.0,4/12,14.85%,RC3H1;DHX9;CSDE1;DDX3X
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.40052490014712916,-0.9896567757126737,0.4600760456273764,0.7644046202528982,1.0,2/14,11.71%,DHRS3;AKR1A1
prerank,myosin II binding (GO:0045159),-0.4365461456073642,-0.9888795775266345,0.45540796963946867,0.7634736394747635,1.0,2/10,2.45%,GSN;STXBP5
prerank,store-operated calcium channel activity (GO:0015279),0.43708727275762527,0.9887491310448477,0.4868995633187773,0.7934878642409368,1.0,2/10,11.90%,TRPC5;TRPC1
prerank,SUMO binding (GO:0032183),-0.39534913849540154,-0.9864313264604555,0.48863636363636365,0.7665891008125624,1.0,4/13,20.28%,HERC2;SERBP1;SIMC1;PML
prerank,hyaluronic acid binding (GO:0005540),-0.43481854711055057,-0.9859339647255909,0.5046554934823091,0.7649577185291718,1.0,6/10,34.45%,CEMIP;IMPG2;C1QBP;LYVE1;CHODL;CD44
prerank,endopeptidase activator activity (GO:0061133),0.42575619640658424,0.9858556877022198,0.46578366445916114,0.7968021541337709,1.0,3/10,21.77%,PSENEN;PSME3;APH1B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.28368775317657213,-0.9836655639996809,0.47609942638623326,0.7677190398140037,1.0,12/54,14.81%,NGLY1;HDAC8;HDAC4;ASPA;ASAH2;ACER3;MIER1;NTAN1;SIRT5;UPB1;HDAC1;ASPG
prerank,phosphatidylcholine transporter activity (GO:0008525),0.36573989713591337,0.983502132301172,0.49888641425389757,0.798272853655075,1.0,4/17,5.48%,PLTP;ATP10A;ATP10B;PITPNM1
prerank,lysine N-methyltransferase activity (GO:0016278),-0.350381087039722,-0.9813997790222846,0.48841698841698844,0.7707207373801466,1.0,7/20,19.36%,SETD7;SETD3;SETD2;EHMT1;METTL21A;EEF2KMT;KMT5A
prerank,exoribonuclease activity (GO:0004532),0.3983513632966196,0.9803217166684285,0.4762886597938144,0.8024430128962873,1.0,1/12,0.97%,EXOSC5
prerank,filamin binding (GO:0031005),-0.42055266135616254,-0.9798012903919343,0.48713235294117646,0.7718782040771172,1.0,2/11,10.00%,DPYSL3;SYNPO2
prerank,beta-tubulin binding (GO:0048487),0.3211504630473623,0.9788943019251448,0.4559139784946237,0.8017512554995412,1.0,5/31,5.97%,PACRG;TTLL7;FGF13;GABARAPL1;GABARAP
prerank,chloride transmembrane transporter activity (GO:0015108),0.364152843835837,0.9780370556621736,0.48043478260869565,0.7994225571507051,1.0,2/16,4.33%,SLC4A1;SLC1A1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.37134251920816,0.9757787283260864,0.5088495575221239,0.8013175805329038,1.0,3/16,7.54%,SLC18A3;SLC25A42;SLC7A8
prerank,neuropeptide hormone activity (GO:0005184),0.34598544218586375,0.9738260140014804,0.4782608695652174,0.8017803898410089,1.0,4/22,11.63%,ADCYAP1;NMB;GRP;PNOC
prerank,cardiolipin binding (GO:1901612),-0.42683391597883,-0.9732652332206833,0.516994633273703,0.7859675513180415,1.0,5/10,21.39%,OPA1;GSDME;GSDMD;STOML2;PLEKHN1
prerank,protein kinase C binding (GO:0005080),-0.29409027137167676,-0.9720004030709398,0.4971751412429379,0.7862425970370504,1.0,9/43,10.53%,GRK5;PDLIM5;ITGAV;PARD6G;ABL1;IRS1;ADCY6;DACT1;ADAM9
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.2783204171146909,-0.9705525403381884,0.5074349442379182,0.7870311135761279,1.0,5/53,3.12%,SLC7A11;SLC7A2;SLC1A3;SLC47A1;SLC1A5
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.2993368374476538,0.970238114371532,0.5118279569892473,0.80735688624223,1.0,5/37,6.27%,AARS2;VARS1;VARS2;GARS1;RARS1
prerank,galactosyltransferase activity (GO:0008378),-0.41090570885971067,-0.9701766652546664,0.5095986038394416,0.7849973386186235,1.0,8/11,35.76%,B4GALT1;A4GALT;B4GALT5;B4GALT7;B4GALT3;A3GALT2;B3GALT6;B4GALT2
prerank,iron ion binding (GO:0005506),-0.2910744878864226,-0.969839356520797,0.516,0.7828169439335481,1.0,15/48,20.98%,AGMO;AOX1;FTO;KDM7A;PHF8;ACO2;PHF2;EGLN3;ALKBH1;KDM3A;TYW5;NFU1;ETHE1;FDX1;FXN
prerank,protein kinase regulator activity (GO:0019887),-0.25107201880485547,-0.9697796277219752,0.5129224652087475,0.7800370767645578,1.0,19/95,15.88%,PRKAG2;PARVA;CCNL2;CCNT2;CCNL1;CCNH;RPTOR;CCNT1;TAOK3;CCNK;GPRC5C;WNK1;CCNYL1;DNAJC3;GMFB;CCND3;NCK1;CNPPD1;SH3BP5L
prerank,leucine zipper domain binding (GO:0043522),-0.42588789357389145,-0.9684283340830661,0.5144404332129964,0.7806550970098763,1.0,2/10,2.80%,PAWR;ERC1
prerank,phosphatidylglycerol binding (GO:1901611),0.3827745792677156,0.966416346380248,0.49887640449438203,0.8132630211446461,1.0,2/13,1.59%,PLTP;MME
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.400936658279357,-0.9632535010920824,0.5149253731343284,0.7910495214545631,1.0,8/11,59.79%,CHRNA4;CHRNA7;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,snRNA binding (GO:0017069),-0.2886216740336924,-0.9609831385752513,0.52046783625731,0.7939781682903778,1.0,16/42,32.00%,CCNT2;CCNT1;RNPC3;GEMIN5;SNRNP70;COIL;EFTUD2;SNU13;HNRNPU;NCBP2;PRPF8;LSM11;RBM22;CDK9;SNRPA1;RBM41
prerank,omega peptidase activity (GO:0008242),0.2518329773488348,0.9608583728478923,0.5509803921568628,0.823885553842693,1.0,27/89,19.12%,USP44;OTUD7A;USP29;USP53;USP14;USP49;ASRGL1;UCHL1;GGT7;YOD1;UCHL3;GGH;GGT1;USP32;USP22;OTUB2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,outward rectifier potassium channel activity (GO:0015271),-0.4191566008624294,-0.9597747000390581,0.5103969754253308,0.7942822088425283,1.0,2/11,1.32%,KCNK2;KCNT2
prerank,dynactin binding (GO:0034452),0.3958238281724997,0.9594973277821336,0.511727078891258,0.8230345220689295,1.0,3/12,8.93%,BICD1;BICDL1;SPTBN5
prerank,phosphatase activity (GO:0016791),-0.26094377719457845,-0.9553202802578441,0.5492125984251969,0.8028138375815833,1.0,20/73,19.55%,ATP1A2;PLPP3;DUSP16;NT5M;PRUNE1;PTPN22;DUSP11;APTX;PXYLP1;PPP1CB;ENOPH1;SACM1L;EPHX2;ACP2;DUSP10;LPIN2;LPIN3;INPP5K;PSPH;HDDC2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.40920097896425756,-0.9552692878276214,0.5288808664259927,0.799967729463087,1.0,4/11,18.35%,SASH1;ROR2;TCF3;TRAF6
prerank,tau protein binding (GO:0048156),-0.2935350814315978,-0.9541875184894052,0.5128205128205128,0.7997828882773499,1.0,15/40,21.04%,ROCK2;EP300;ROCK1;GSK3B;MARK3;SMAD2;MARK4;PPP2CB;BRSK1;APOE;MARK1;PICALM;PRKAA1;TAOK1;PPP2CA
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.3644813172626472,0.9522615217631689,0.5468085106382978,0.8380485356353046,1.0,7/16,25.46%,MACROD2;RPS3;CD38;ADPRS;SARM1;ADPRH;TDG
prerank,phosphoric diester hydrolase activity (GO:0008081),0.29830070576680884,0.9521765199863745,0.5217391304347826,0.8336759723649398,1.0,8/35,10.84%,GPCPD1;PLCXD3;ENPP2;PDE11A;PLCB4;SMPDL3A;APEX1;SMPD1
prerank,receptor tyrosine kinase binding (GO:0030971),0.27435913011556684,0.9500478404971403,0.5492957746478874,0.8349146879310918,1.0,6/56,5.48%,NRG3;GRB14;NRG1;DOCK4;GAS6;PITPNM1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.29345069824918957,-0.9489588167603087,0.5203094777562862,0.8099282783143223,1.0,13/40,20.13%,PCMTD2;DNMT3A;COMT;SETD3;N6AMT1;METTL2A;METTL2B;PCMT1;TPMT;THUMPD3;PRMT8;RRP8;CARNMT1
prerank,deubiquitinase activity (GO:0101005),0.25083491389249485,0.946247268842383,0.592814371257485,0.8403894414745668,1.0,26/88,19.12%,USP44;OTUD7A;EIF3F;USP29;USP53;USP14;USP49;UCHL1;YOD1;UCHL3;USP32;USP22;OTUB2;MINDY1;MINDY2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,serine-type peptidase activity (GO:0008236),0.24761752386622182,0.945437876699692,0.5729166666666666,0.8379344323758244,1.0,10/96,11.25%,MASP2;PCSK1;PCSK2;RHBDF2;PCSK6;ENDOU;PREP;PCSK7;TMPRSS4;PROC
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.33089113030964173,-0.9450991000559398,0.5400763358778626,0.8168444740579804,1.0,6/23,10.26%,PLCE1;PLCD3;EDNRA;PLCG1;PLCB3;PLCD1
prerank,steroid hydroxylase activity (GO:0008395),-0.36279945636316846,-0.9442303802028155,0.5337078651685393,0.8160640548725678,1.0,3/16,9.27%,CYP7B1;CYP27A1;CYP1B1
prerank,phospholipase C activity (GO:0004629),-0.3262513425021175,-0.9422092449242367,0.5255905511811023,0.8182788209147954,1.0,8/25,16.71%,PLCE1;PLCD3;EDNRA;PLCG1;PLCB3;PLCD1;BDKRB2;PLCL1
prerank,neurexin family protein binding (GO:0042043),0.4108178850178486,0.9396087099803445,0.5844155844155844,0.8490395824326792,1.0,2/10,6.42%,NLGN1;SYTL2
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.42205395007912616,-0.936858802903345,0.551094890510949,0.829230939047016,1.0,2/10,2.20%,B4GALT1;B3GALT1
prerank,cysteine-type peptidase activity (GO:0008234),-0.2525987769163353,-0.9360692868378955,0.5843137254901961,0.8282078796741623,1.0,22/73,25.32%,USP24;USP7;CTSC;CTSH;USP33;USP47;CASP2;USP12;USP11;USP46;USP35;USP50;USP2;USP13;ATG4D;USP34;CTSF;CTSL;USP18;USP9X;USP28;CASP6
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3995362102796155,-0.9355632178597402,0.576,0.8265909940394027,1.0,3/11,24.07%,PPP1R1A;PPP1R2;PPP1R14A
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.31908328380579215,0.9346805032957002,0.569620253164557,0.8572046013962163,1.0,5/26,11.70%,B4GALNT1;CSGALNACT1;CHSY3;B3GALT5;B3GNT2
prerank,telomerase RNA binding (GO:0070034),-0.32440914861821896,-0.933712830254737,0.5893909626719057,0.828233996653437,1.0,10/22,30.55%,SMG6;DHX36;SMG7;XRN1;EXOSC10;HNRNPU;TERT;GAR1;PARN;PINX1
prerank,microtubule plus-end binding (GO:0051010),0.33471647725298553,0.9329011171474503,0.5308641975308642,0.8573314272114506,1.0,10/20,19.70%,KNSTRN;DST;MAPRE3;CLIP2;APC;DCTN1;CLASP2;KIF18A;TTBK2;CLASP1
prerank,retinoid X receptor binding (GO:0046965),-0.3994891023427851,-0.930197932006213,0.5496323529411765,0.8339753738603628,1.0,5/11,21.79%,RARG;NSD1;NCOA6;NR4A2;ARID5A
prerank,ion channel inhibitor activity (GO:0008200),-0.2918924744406734,-0.9268228770174672,0.5872689938398358,0.839556280797828,1.0,5/35,9.41%,ITPR1;VTI1B;CAMK2D;WNK4;WNK1
prerank,sterol transfer activity (GO:0120015),0.3580588204006067,0.9267083449665503,0.5921052631578947,0.8696309691043099,1.0,2/17,5.56%,PLTP;GRAMD1B
prerank,ferrous iron binding (GO:0008198),0.3331438007581823,0.9252074076192305,0.5728744939271255,0.8689106468570991,1.0,7/21,18.32%,FTH1;SNCA;FTL;ISCU;ALKBH3;FECH;EGLN1
prerank,aminopeptidase activity (GO:0004177),-0.31025661126462406,-0.9248525816185682,0.5791433891992551,0.8413786865588586,1.0,7/26,15.62%,XPNPEP1;CTSH;ANPEP;MMP14;LAP3;NPEPPS;LNPEP
prerank,chemoattractant activity (GO:0042056),0.31335752644094145,0.9236319567346752,0.579476861167002,0.8683964620689222,1.0,5/26,10.54%,MIF;FGF10;GPNMB;PDGFB;SCG2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.313456341775318,0.9203225322030575,0.5907258064516129,0.8727278648797688,1.0,7/27,17.14%,POLR1H;POLR2J;POLR2B;POLR2I;MED20;POLR3A;POLR2G
prerank,serine-type endopeptidase activity (GO:0004252),0.2451502359890795,0.9158088209363127,0.6275720164609053,0.8800205029949613,1.0,8/80,11.25%,MASP2;PCSK1;PCSK2;RHBDF2;PCSK6;PCSK7;TMPRSS4;PROC
prerank,chloride channel inhibitor activity (GO:0019869),-0.39612130225724485,-0.9155367740589856,0.5768500948766604,0.8618766267067091,1.0,6/10,27.28%,VTI1B;WNK4;WNK1;STX8;STX1A;STX7
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.38908854693092415,0.9152096573679604,0.5583333333333333,0.876946299341938,1.0,3/11,6.47%,RYR2;RYR3;TRPM2
prerank,cytokine receptor activity (GO:0004896),-0.2455737243379678,-0.9122477267907944,0.6429942418426103,0.8670876047863079,1.0,14/83,16.18%,LEPR;IL6ST;IL31RA;GHR;CCR9;IL15RA;IL13RA1;F3;IL17RA;CNTFR;IL17RD;IL6R;IFNGR1;CMKLR1
prerank,cholesterol transfer activity (GO:0120020),0.3591811071305554,0.9107821128146508,0.5951859956236324,0.8835191565356849,1.0,2/16,5.56%,PLTP;GRAMD1B
prerank,DNA polymerase binding (GO:0070182),-0.3383045625537483,-0.9102213540459869,0.5871559633027523,0.8689402586405891,1.0,10/18,35.32%,SMG6;HMGB1;NABP2;FANCI;PCNA;NAT10;LONP1;FANCD2;RAD51;SMARCA4
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3923923548881094,0.9047952588109376,0.5574837310195228,0.8942561832054449,1.0,1/10,0.28%,MECOM
prerank,chemokine activity (GO:0008009),0.29222619297326785,0.9040988697933646,0.6090712742980562,0.8916904107239753,1.0,6/31,20.52%,CXCL12;CCL2;CCL25;CKLF;CCL13;CCL19
prerank,phospholipase activity (GO:0004620),-0.25182294463336163,-0.9032099581697343,0.6410748560460653,0.883248572275644,1.0,15/67,19.19%,PLCE1;SEC23IP;DDHD1;PLA2G4A;PLCB3;ABHD3;NAPEPLD;PNPLA8;PNPLA7;ASPG;PLCL1;ABHD12;SMPD4;ABHD6;MGLL
prerank,antiporter activity (GO:0015297),0.32483158027844544,0.9015312506069545,0.6041237113402061,0.8935567522785032,1.0,5/20,12.51%,SLC35A1;ATP1A3;SLC25A14;SLC35C1;SLC35E4
prerank,proton transmembrane transporter activity (GO:0015078),0.27995310707418225,0.9015258519105525,0.6317991631799164,0.8890838456248338,1.0,14/39,21.29%,COX7A1;NDUFA4;COX4I1;COX6A1;ATP6V1F;COX6B1;DMAC2L;UQCRH;NNT;COX10;COX8A;CLCN3;CLCN4;COX5B
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.25032867464511455,-0.8965605401304034,0.6607495069033531,0.8962654152396142,1.0,12/70,18.37%,GXYLT2;LARGE1;B4GALT1;B3GALT1;EXT1;B3GLCT;POGLUT2;OGT;HEXA;CHPF2;CHSY1;GCNT2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3548039567516609,-0.8960115581834928,0.6340996168582376,0.8945936247829206,1.0,6/15,17.35%,EEA1;SNX9;ZFYVE1;SNX10;ZFYVE16;PICALM
prerank,ATP hydrolysis activity (GO:0140603),-0.276534740721803,-0.8947576524201187,0.6634799235181644,0.8946412649607047,1.0,11/41,18.42%,RNF213;ABCA4;VPS4B;VWA8;DHX9;ABCD2;CHD3;ATP2B1;DDX3X;SMCHD1;VCP
prerank,U6 snRNA binding (GO:0017070),0.3510702353168572,0.8937782254195717,0.5762004175365344,0.9036559564102176,1.0,8/14,27.27%,LSM4;LSM2;LSM7;LSM3;PRPF4;DDX39B;EIF5A;LSM8
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3840785909808778,-0.8931069721944551,0.5639097744360902,0.8955395936992693,1.0,7/11,32.30%,NUDT4;NUDT5;NUDT1;NUDT11;NUDT7;NUDT16;NUDT16L1
prerank,snoRNA binding (GO:0030515),-0.2888468459591635,-0.8924948992897159,0.6288032454361054,0.8938758998410449,1.0,16/30,32.30%,NUDT4;NUDT5;BMS1;PRKDC;NOP58;SNU13;UTP6;IMP3;GAR1;TSR1;DHX37;NUDT1;TBL3;NUDT7;NUDT16;NUDT16L1
prerank,cation:chloride symporter activity (GO:0015377),-0.3848485730949062,-0.8918094406631825,0.6098418277680141,0.8923695525552101,1.0,5/10,20.33%,SLC12A7;SLC12A2;SLC6A1;SLC12A8;SLC12A9
prerank,potassium ion leak channel activity (GO:0022841),0.3461309813245056,0.8905398383156042,0.6388888888888888,0.9069532058015507,1.0,4/15,8.42%,KCNK13;KCNK10;KCNK9;KCNK1
prerank,palmitoyltransferase activity (GO:0016409),0.29115574178214404,0.88928714686426,0.6444906444906445,0.9053397904332756,1.0,6/28,15.44%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14
prerank,methyltransferase activity (GO:0008168),-0.2738207915302625,-0.8892815902877759,0.6601941747572816,0.8954603339544992,1.0,15/46,20.49%,COQ3;COMT;NSUN3;TRMT11;N6AMT1;EHMT1;PRMT5;BUD23;NSUN2;PRMT8;RRP8;NTMT1;FTSJ1;CARNMT1;COQ5
prerank,protein kinase C activity (GO:0004697),0.34564907909656684,0.8872440217532965,0.6076233183856502,0.9059632999056976,1.0,3/14,6.51%,PRKCH;PKN1;PRKCQ
prerank,MAP kinase activity (GO:0004707),-0.35780193242492037,-0.8871276007044028,0.6346516007532956,0.897526604565323,1.0,5/14,25.75%,MAPK4;MAPK6;MAPK7;MAPK9;MAPK14
prerank,ribonuclease activity (GO:0004540),-0.2554038359777068,-0.8859567280705756,0.6866537717601547,0.8971944878514236,1.0,12/56,15.99%,SMG6;DIS3L2;DICER1;ZC3H12C;NYNRIN;CPSF3;RNASE12;KHNYN;ZC3H12B;EXOSC9;ERN1;EXOSC10
prerank,heme binding (GO:0020037),-0.25292205329613693,-0.8850459109099819,0.6909448818897638,0.8962695606701526,1.0,9/65,9.27%,PTGIS;CYP26B1;CYP27A1;CYB5B;CYB5R4;EIF2AK1;NOX4;PGRMC2;CYP1B1
prerank,O-acyltransferase activity (GO:0008374),0.29381729498540105,0.8846077970658793,0.650103519668737,0.9078907231841086,1.0,8/30,16.72%,MBOAT1;LPCAT2;DGAT2;PLAAT1;GPAM;MOGAT1;SOAT2;PIGW
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3901080508398701,-0.8840695213375258,0.6387225548902196,0.8954868270736174,1.0,1/10,0.21%,PRKAG2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3165561966067509,-0.8805936202165028,0.6324110671936759,0.900266109051107,1.0,2/21,0.52%,PDE1A;PDE5A
prerank,phosphatidic acid binding (GO:0070300),-0.3224462435367854,-0.8801446184164847,0.6317757009345795,0.8984246539349772,1.0,7/19,15.67%,OPA1;PACSIN2;MAPKAP1;PITPNC1;GSDMD;RAPGEF2;MARK1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3609363284472902,0.8771563593274684,0.6341463414634146,0.9212250834484911,1.0,1/13,1.05%,DNASE1
prerank,protein phosphatase regulator activity (GO:0019888),-0.2603974692660789,-0.8764796822502403,0.6837944664031621,0.9037944358993456,1.0,20/53,27.68%,PTN;SHOC2;PPP1R7;PPP4R2;CABIN1;ANKLE2;DMPK;PPP2R5E;EIF2AK2;PPP2R5D;BOD1L1;PTPA;PPP2R5C;PPP2R1B;PPP4R1;PPP1R2;PPP2R2C;BOD1;SAG;PPP1R15B
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3449141347361685,0.8740405993201278,0.6391304347826087,0.9237711344857722,1.0,3/15,5.81%,SLC17A6;SLC1A1;SLC1A2
prerank,adenylate cyclase binding (GO:0008179),0.37485564728409293,0.8726326006716522,0.6383442265795207,0.9225735557049842,1.0,5/10,14.32%,AKAP6;CAP2;CALM1;CALM2;CALM3
prerank,epidermal growth factor receptor binding (GO:0005154),0.30303459690970147,0.8723823026498083,0.6488095238095238,0.9186644733232072,1.0,5/25,12.16%,ERBB4;HIP1;LINGO1;CCDC88A;ARF4
prerank,metalloaminopeptidase activity (GO:0070006),-0.3377129817080442,-0.8712040594310829,0.6227544910179641,0.9126696462938937,1.0,5/16,15.62%,XPNPEP1;ANPEP;MMP14;NPEPPS;LNPEP
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2410796675344047,-0.8683638920158688,0.7402862985685071,0.9159731309239231,1.0,35/74,33.76%,PI4KA;NADK2;FAM20A;GK5;DGKA;NADK;ADK;PANK2;FAM20C;DCAKD;PIK3C3;RFK;PDXK;PIK3CD;FCSK;SHPK;PKM;DGKD;GALK2;SPHK1;DGKK;GALK1;MVK;ETNK1;DOLK;POMK;SPHK2;PI4KB;PIK3C2A;HK2;TKFC;PAPSS1;HYKK;COASY;TRPT1
prerank,lipase activity (GO:0016298),-0.2644437972044178,-0.8647702494677723,0.7077205882352942,0.9209804035381278,1.0,13/43,26.17%,SEC23IP;DDHD1;ABHD5;ABHD3;PNPLA8;PLA1A;ABHD12;ABHD6;MGLL;SMPD2;DAGLB;PNPLA2;LPL
prerank,neuropeptide receptor binding (GO:0071855),-0.3425110303172716,-0.8622438874680974,0.6939163498098859,0.9233233758617194,1.0,5/14,43.43%,AGRP;NMU;PPY;NPY;APLN
prerank,GTPase activity (GO:0003924),-0.20577446437099647,-0.8621846382069759,0.8417849898580122,0.9204089809650116,1.0,58/192,26.43%,RHOQ;OPA1;LRRK2;RHOJ;ATL3;RND3;DNM1L;RAP1B;ABCA4;MRAS;RAB22A;GFM1;MMUT;TBC1D24;CDC42;ATL2;RHOA;RHOT1;RAB11A;GNA14;RALA;GNAS;RHOBTB2;GTPBP10;RASL12;GNG5;GFM2;ARHGDIB;RAB21;GBP3;BMS1;DNAJC27;DDX3X;EFTUD2;GNB1;GBP7;GBP2;RHOBTB1;RHOH;RHOC;GBP6;MTG2;RAB24;RIT1;RABL3;NKIRAS1;GNAZ;GPN3;RHOT2;RAB8A;RAB9A;SAR1B;RAB7A;IRGM;RAB5A;RRAGA;TSR1;MFN2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.35338237978017667,0.8616923210264785,0.6522633744855967,0.9383659989703991,1.0,3/13,17.32%,MIF;IDI1;EBP
prerank,exonuclease activity (GO:0004527),-0.2559224033595042,-0.8610098028531716,0.708253358925144,0.9200068954672304,1.0,11/46,16.40%,ENPP1;APEX2;CPSF3;WRN;REXO5;ENPP3;XRN2;REXO1;EXOSC9;EXOSC10;MRE11
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3035065330998726,-0.8592865737608862,0.6872509960159362,0.9204370484658954,1.0,2/23,0.52%,PDE1A;PDE5A
prerank,disordered domain specific binding (GO:0097718),-0.2994059476956345,-0.8592536332302875,0.6763636363636364,0.9175275032572576,1.0,6/23,13.17%,NUMA1;SMAD2;TEAD2;RB1;FN1;FKBP8
prerank,clathrin adaptor activity (GO:0035615),0.3310345630431388,0.8568689640313966,0.6566523605150214,0.9450020272804737,1.0,3/15,8.96%,AP2M1;HIP1;AP2B1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.327364675804926,-0.8553032271123057,0.6990825688073394,0.919904783345605,1.0,3/16,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.327364675804926,-0.8553032271123057,0.6990825688073394,0.919904783345605,1.0,3/16,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,NAD+ binding (GO:0070403),0.3484475626280187,0.852504510409602,0.6523605150214592,0.9501206467456813,1.0,4/12,10.21%,HADH;SIRT1;HPGD;UXS1
prerank,ATPase activator activity (GO:0001671),0.31054704326492233,0.8516997632990279,0.6991869918699187,0.9472777147609214,1.0,8/20,22.33%,DNAJC15;ATP1B1;DNAJA2;DNAJB2;AHSA1;DNAJC19;DNAJA1;ATP1B2
prerank,hexosyltransferase activity (GO:0016758),0.21922369468412062,0.8508168711458943,0.8208333333333333,0.944635512316542,1.0,12/101,10.07%,TMTC2;MFNG;B4GALNT1;CSGALNACT1;FUT9;CHSY3;PIGM;B3GALT5;B4GALT6;ALG1;MGAT4C;DPY19L1
prerank,peptidase activator activity (GO:0016504),0.2986135281107539,0.8489466134749373,0.7043478260869566,0.9442860042590621,1.0,2/22,4.98%,MAL;PSENEN
prerank,fatty acid synthase activity (GO:0004312),0.36821810694937307,0.8475062214904734,0.649895178197065,0.9429814329749209,1.0,2/10,7.45%,ELOVL7;ELOVL4
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.30003558379546375,0.847424945499787,0.6901709401709402,0.9388592365492209,1.0,1/20,0.24%,DLG2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.35112420074894213,0.847177858229717,0.6621923937360179,0.9350769600710728,1.0,4/11,17.61%,HMGA2;APEX1;RPS3;APLF
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3734478783349692,-0.8458602085245157,0.6692759295499021,0.9365111408488809,1.0,2/10,9.18%,CXADR;JUP
prerank,protein kinase activator activity (GO:0030295),-0.24114351234257675,-0.8449379880357789,0.7549019607843137,0.9352849073885363,1.0,17/60,20.64%,PRKAG2;STK3;FAM20A;CAB39L;RPTOR;PAK2;IGF2;MAP2K1;GPRC5C;WNK1;ABI1;RICTOR;DDX3X;AFAP1L2;MTCP1;TAOK1;CAB39
prerank,ADP binding (GO:0043531),-0.2926434994886331,-0.8449283273827961,0.6733212341197822,0.9323242175887712,1.0,9/25,27.56%,PRKAG2;GLUD1;ME1;PGK1;ERN1;MSH6;TAP1;GCLC;LONP1
prerank,protein phosphatase 2A binding (GO:0051721),0.2996031481214943,0.8443732863071011,0.6767895878524945,0.9364346490926988,1.0,6/23,14.55%,ADCY8;DAB2IP;GRIN3A;FOXO1;CTTNBP2NL;MFHAS1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.30861942514566115,-0.8421614334001506,0.6833333333333333,0.9348462536868494,1.0,6/20,26.38%,RBBP8;MRE11;ZRANB3;EXOG;ERCC1;ENDOV
prerank,mRNA 5'-UTR binding (GO:0048027),0.2904595311319282,0.8417960560310916,0.6861471861471862,0.9373469298791837,1.0,7/24,15.57%,LARP6;RPL41;RPL5;RPS7;RPS14;UTP23;MYH10
prerank,ephrin receptor binding (GO:0046875),-0.30277696181703595,-0.8415076452496364,0.7064220183486238,0.9332628970367391,1.0,4/21,6.93%,EFNB2;ABL1;SHC1;LYN
prerank,nucleotidase activity (GO:0008252),0.3351101041533579,0.8384190744346156,0.7111597374179431,0.9399163029815512,1.0,3/15,12.72%,NT5DC2;NT5C;BPNT2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.22264706424745365,0.8382224189726571,0.80990099009901,0.9360728745300727,1.0,23/83,19.12%,USP44;OTUD7A;USP29;USP53;USP14;USP49;UCHL1;YOD1;UCHL3;USP32;USP22;OTUB2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.31728348630245407,-0.8378811825803919,0.6959847036328872,0.9375841641102707,1.0,7/16,29.94%,SLC13A3;SLC1A5;SLC25A11;SLC38A7;SLC25A22;SLC13A5;SLC1A6
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.36426194265445144,-0.8334214067914117,0.7013232514177694,0.9434286935889378,1.0,5/10,24.26%,EHHADH;ECHDC2;ECHDC3;ECI1;AUH
prerank,kinase activator activity (GO:0019209),-0.27364044203634397,-0.8315151725747624,0.7194656488549618,0.9441516930470365,1.0,5/30,13.39%,PRKAG2;RPTOR;GPRC5C;WNK1;MOB1B
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.2928991128874923,-0.8305758549400665,0.716,0.94305504369892,1.0,10/23,23.63%,SH3PXD2B;GBF1;MAPKAP1;KIF16B;WIPI1;WDR45B;WIPI2;PLEKHA4;HIP1R;JPH2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.31594274978715503,0.8272881406744711,0.7228144989339019,0.9539675696459281,1.0,1/16,2.35%,BCO1
prerank,3'-5' exonuclease activity (GO:0008408),-0.24991846451282956,-0.8215133737450674,0.7852882703777336,0.9572756336647111,1.0,17/45,28.16%,ERI3;DIS3L2;WRN;CNOT8;XRN2;ERI2;EXOSC9;PAN2;EXOSC10;MRE11;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,GTP binding (GO:0005525),-0.19566150459917708,-0.8185401652477073,0.9275653923541247,0.9598820964040641,1.0,57/172,30.41%,RHOQ;ANXA6;LRRK2;RHOJ;ATL3;ARL3;RND3;RAP1B;RAB10;MRAS;RAB22A;GLUD1;CDC42;ATL2;RHOA;RHOT1;ARFIP2;DYNC1LI1;ARF1;RALA;RHOBTB2;GTPBP10;RASL12;RAB21;GBP3;BMS1;GBP7;GBP2;RHOBTB1;TUBB2A;RHOH;RHOC;GBP6;MTG2;NME1;RIT1;RABL3;TUBB6;ARL5A;RHOT2;RAB8A;RAB9A;NOA1;RAB7A;RAB5A;RRAGA;TSR1;GNL3;DIRAS2;ARL4C;TUBA1C;RAB39A;RANBP17;TUBB2B;GNL1;ADSS1;ARF6
prerank,motor activity (GO:0003774),0.22933044926702847,0.8155624105062798,0.824847250509165,0.9718061518698852,1.0,15/60,20.01%,MYO1E;KIF1A;KIF21B;KIFC2;MYL6;MYO6;KIF26B;KIF19;KIFC3;STARD9;DNAH3;KIF21A;KIF18A;KIF1B;KIF26A
prerank,G protein-coupled receptor binding (GO:0001664),-0.20357641488389053,-0.8153466093408229,0.9224652087475149,0.9627651618893254,1.0,24/132,18.96%,LRP6;WNT4;RNF43;PRKN;WNT5B;WNT6;FLNA;RYK;WNT9A;GRK3;USP33;TULP3;ARHGEF12;GNA14;AGTR1;GNAS;FZD7;USP4;PTCH1;ARRB1;ARHGEF11;WNT5A;FZD1;MYOC
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.35318240865591644,-0.8139495034788049,0.7093235831809872,0.9622534445166614,1.0,1/10,2.52%,KAT2B
prerank,voltage-gated anion channel activity (GO:0008308),-0.3218010448409462,-0.8139401256666059,0.7167300380228137,0.9593169097162016,1.0,6/15,24.00%,CLCN2;VDAC1;ANO1;GPR89B;GPR89A;CLCN6
prerank,kinase inhibitor activity (GO:0019210),-0.2595497889639361,-0.8096489230924655,0.7762376237623763,0.9639085590682429,1.0,10/33,22.54%,PARVA;LRP6;TAOK3;DNAJC3;GMFB;NCK1;SH3BP5L;RHOH;CDKN1C;PRKRIP1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.28465024249375287,0.8085876581614596,0.7422037422037422,0.9806337257078679,1.0,2/22,3.84%,DUSP6;PPM1F
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.28659268605974875,-0.8076407446147097,0.7413127413127413,0.9646097615653256,1.0,6/22,20.60%,ATP6V1B2;ATP6V0D1;ATP6V0A4;ATP2A2;TCIRG1;ATP2A3
prerank,NADP binding (GO:0050661),0.25721040580265864,0.8049481506225409,0.7995951417004049,0.9830915489988752,1.0,8/32,17.56%,NDOR1;NOS3;DUS2;KCNAB1;HSD11B1;DHCR7;TM7SF2;NNT
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.30550644658774184,-0.8045795184596698,0.751984126984127,0.9670363642741429,1.0,5/17,23.25%,ACAA2;ACOT11;ACOT9;ACOT8;ACOT6
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.18526127752060503,-0.8040092793107294,0.9784735812133072,0.9650345254841785,1.0,66/248,24.95%,RHOQ;OPA1;LRRK2;RHOJ;ATL3;RND3;DNM1L;RAP1B;RNF213;ABCA4;VPS4B;MRAS;VWA8;RAB22A;GFM1;MMUT;DHX9;TBC1D24;CDC42;ABCD2;ATL2;CHD3;RHOA;RHOT1;ATP2B1;RAB11A;GNA14;RALA;GNAS;RHOBTB2;GTPBP10;KIF1C;RASL12;GNG5;GFM2;ARHGDIB;RAB21;GBP3;BMS1;DNAJC27;DDX3X;EFTUD2;GNB1;SMCHD1;GBP7;GBP2;RHOBTB1;VCP;RHOH;RHOC;GBP6;MTG2;RAB24;RIT1;TOR1A;RABL3;NKIRAS1;GNAZ;GPN3;RHOT2;CLPX;RAB8A;RAB9A;SAR1B;RAB7A;IRGM
prerank,double-stranded RNA binding (GO:0003725),0.22173244265951325,0.803062963842742,0.8533916849015317,0.9820945515323836,1.0,10/70,13.37%,TFRC;ADARB2;ZFR2;HSP90AB1;DUS2;STRBP;LRRFIP1;HSPD1;DROSHA;RFTN1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2655545911386451,-0.8030192996024732,0.7518939393939394,0.9637577383504118,1.0,7/28,19.96%,LRRK2;PRKAA2;MAP2K4;MAP2K1;MAP2K7;PRKACA;MAP2K6
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.27144837406274636,0.8004726514438194,0.76,0.9822076764857519,1.0,6/28,13.22%,RPP40;APEX1;RPP30;POP5;DROSHA;RNASEH2A
prerank,MAP kinase phosphatase activity (GO:0033549),-0.33328421189933755,-0.8001709172416097,0.724007561436673,0.9659064616003198,1.0,4/12,22.44%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.31681790448983504,0.7984148670481811,0.723404255319149,0.9812875792924568,1.0,2/14,10.02%,MAL;NOD1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.30875020327725305,0.7970601476517375,0.7162162162162162,0.9793289728616342,1.0,3/14,12.32%,RPP40;RPP30;POP5
prerank,protein phosphatase activator activity (GO:0072542),-0.32551253721212864,-0.7962038634144853,0.7660377358490567,0.9695374725569683,1.0,5/13,18.01%,IGFBP3;PPP2R5E;PPP2R5D;PTPA;PPP2R5C
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.27239488649356114,-0.7947153206936876,0.7634615384615384,0.9692322112053003,1.0,6/24,14.23%,OSBPL8;OSBPL5;PLA2G4A;ARFIP2;GSDMD;PLEKHA8
prerank,anion:anion antiporter activity (GO:0015301),0.29372449120785815,0.7934403218405643,0.7447698744769874,0.9813192415736824,1.0,1/17,0.53%,SLC4A1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.26273356056556346,-0.7906555885413774,0.782,0.9728348924928896,1.0,3/29,4.08%,PRKAG2;KAT2B;RPTOR
prerank,Hsp90 protein binding (GO:0051879),0.25837657135453096,0.7904208483062475,0.8055009823182712,0.982023413167645,1.0,10/33,18.99%,PACRG;KDR;NPAS2;CYP2E1;UNC45B;RPS3;PTGES3;CHORDC1;AHSA1;NOD2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2655991405267031,-0.7895859034681051,0.7791164658634538,0.9717050855412757,1.0,4/27,6.17%,SLC41A1;SLC9A1;SLC9A8;SLC9A2
prerank,microtubule minus-end binding (GO:0051011),-0.3270092293582005,-0.7887776581916218,0.758893280632411,0.970210133131565,1.0,7/13,30.47%,NUMA1;TUBGCP6;TUBGCP2;TUBGCP4;HAUS7;CAMSAP2;HAUS4
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.30861681602184016,-0.7885783330327687,0.7650375939849624,0.9676418139557424,1.0,2/14,7.01%,SLC26A7;SLC26A2
prerank,O-methyltransferase activity (GO:0008171),0.3449740538824556,0.783918297451386,0.7540983606557377,0.9885219887969109,1.0,5/10,20.34%,CMTR2;CMTR1;BCDIN3D;MEPCE;ASMT
prerank,hydro-lyase activity (GO:0016836),-0.24219241406243003,-0.7824085590852919,0.8587786259541985,0.9745968728809351,1.0,21/41,32.90%,GMDS;ACO2;EHHADH;ACO1;ECHDC2;HACD4;ECHDC3;ECI1;PARK7;APIP;UROS;AUH;IREB2;CBS;ENO3;TBXAS1;ENO1;CDYL;FAHD2A;CYP2S1;ALAD
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.31184304390112466,0.7821068270714848,0.7591397849462366,0.9872097441379507,1.0,1/13,1.91%,PIP5K1B
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.26076831468133543,-0.7818397552873501,0.7818532818532818,0.9726251419233832,1.0,7/27,17.81%,SLC26A7;SLC39A14;SLC26A2;SLC22A6;SLC5A5;SLC25A11;ANO1
prerank,transaminase activity (GO:0008483),-0.3323610904640082,-0.7805260119923754,0.7620817843866171,0.9719231022653969,1.0,5/11,34.73%,ABAT;OAT;PSAT1;GOT1;GOT2
prerank,kinase activity (GO:0016301),-0.20287897965952972,-0.7787199318101147,0.9247967479674797,0.9718127691313256,1.0,29/109,21.07%,PI4KA;NADK2;ABL1;LRRK2;GK5;GSK3B;DGKA;MAP4K4;NADK;TRRAP;LYN;MTOR;EPHA4;PANK2;PGK1;DCAKD;PIK3C3;RFK;CSNK2A1;PDXK;PIK3CD;PRKD1;FCSK;ITPKC;IRAK1;TAOK1;SHPK;BCKDK;DGKD
prerank,titin binding (GO:0031432),0.313787980615204,0.7780624718828577,0.7860082304526749,0.9894344097813674,1.0,4/13,14.32%,TCAP;CALM1;CALM2;CALM3
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.2779933435827675,0.7761752476569521,0.7886178861788617,0.9882321666786688,1.0,2/21,11.50%,GRIK2;P2RX7
prerank,mechanosensitive ion channel activity (GO:0008381),-0.32070270103037635,-0.7756511019120629,0.7598499061913696,0.973460693898673,1.0,3/12,19.26%,PIEZO2;TMC4;TMC6
prerank,GDP binding (GO:0019003),0.22180605600665454,0.773989633308045,0.8813905930470347,0.9873871366306926,1.0,15/63,17.98%,RIT2;DIRAS1;NME2;RAB4A;RAB35;MIEF1;RASEF;HRAS;RAP1A;GNAI1;RAB29;RAP2B;RAB31;RALB;RERG
prerank,exopeptidase activity (GO:0008238),0.22706451381598816,0.7731919468113062,0.8754940711462451,0.9844977006086179,1.0,4/50,6.05%,DPP10;MME;METAP2;DPP6
prerank,guanyl ribonucleotide binding (GO:0032561),-0.18162180030382416,-0.7730910145296228,0.9791231732776617,0.9745968922999501,1.0,38/196,19.51%,PDE5A;RHOQ;MPPED2;ANXA6;LRRK2;RHOJ;ATL3;ARL3;RND3;RAP1B;RAB10;MRAS;RAB22A;GLUD1;RAB12;CDC42;ATL2;RHOA;RHOT1;ARFIP2;DYNC1LI1;ARF1;RALA;RHOBTB2;GTPBP10;RASL12;RAB21;GBP3;BMS1;RAPGEF2;GBP7;GBP2;RHOBTB1;TUBB2A;RHOH;RHOC;GBP6;MTG2
prerank,N-acyltransferase activity (GO:0016410),-0.2488295487499711,-0.770359390360283,0.8473282442748091,0.9757821135445105,1.0,3/32,3.30%,CERS5;EP300;NMT2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.3156982679973263,0.7696016691797213,0.7610062893081762,0.9858886229070832,1.0,5/12,23.38%,SLC25A42;ENTPD3;ENTPD1;ENTPD5;ENTPD7
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.3206991209117226,-0.7687391031515624,0.7587548638132295,0.9755019974559068,1.0,6/12,36.20%,CTSH;BCL2L13;ATP2A3;APAF1;PYCARD;CASP1
prerank,5'-nucleotidase activity (GO:0008253),0.31279651756398885,0.7676637546718389,0.759656652360515,0.9846023047066828,1.0,2/13,9.52%,NT5DC2;NT5C
prerank,gamma-tubulin binding (GO:0043015),-0.2753200594876758,-0.7675393818164782,0.8292220113851992,0.9744394411289585,1.0,7/21,14.85%,TUBGCP6;TUBGCP2;MARK4;BRSK1;RAD51D;BRCA2;DDX3X
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.29252628273691805,0.7668597443891969,0.7730337078651686,0.9817067099731358,1.0,1/15,0.53%,SLC4A1
prerank,symporter activity (GO:0015293),0.33088463512531485,0.7667638766006398,0.7685589519650655,0.9777548596814853,1.0,1/10,3.76%,MFSD2A
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.31191126313159717,-0.7661004771541048,0.7815442561205274,0.9737528230920249,1.0,5/13,20.39%,AGPAT4;ABHD5;GPAT4;LPCAT1;GPAT3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3303327382314152,-0.7611041107263282,0.7771428571428571,0.9781097530832996,1.0,5/11,25.94%,PRMT2;PRMT5;PRMT8;PRMT9;FBXO11
prerank,chemokine receptor binding (GO:0042379),0.23647055156353478,0.7602133286279928,0.860813704496788,0.9830300237308379,1.0,7/35,22.93%,CXCL12;CCL2;CCL25;CKLF;CCL13;CCL19;ITCH
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.315987696943067,0.7561119976734416,0.7841140529531568,0.9849979210571336,1.0,12/12,68.43%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW;OPN1MW3;RRH;GPR52;GPR88;OPN3
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.30433178711603615,-0.7556632685778031,0.8131212723658051,0.9830255110731811,1.0,6/15,32.01%,PI4KA;PIK3C3;PIK3CD;PI4K2B;PI4KB;PIK3C2A
prerank,alpha-tubulin binding (GO:0043014),0.24166191615787652,0.7539946490934863,0.8794178794178794,0.9838652715640565,1.0,11/31,21.31%,PACRG;TTLL7;SNCA;TRIM36;DIP2B;EFHC2;ARL8A;FYN;TRPV4;CDK5R1;HDAC6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3336361642750417,-0.7518982806459662,0.7959558823529411,0.9825265860114366,1.0,4/10,22.44%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3336361642750417,-0.7518982806459662,0.7959558823529411,0.9825265860114366,1.0,4/10,22.44%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,BMP binding (GO:0036122),-0.3138360447347975,-0.7465048501958049,0.7811320754716982,0.9869433919212313,1.0,2/11,11.09%,NBL1;GREM2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.2529246114332979,0.7423533081631347,0.8492063492063492,0.9949658397819644,1.0,7/27,17.14%,POLR1H;POLR2J;POLR2B;POLR2I;MED20;POLR3A;POLR2G
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.25910784586388164,-0.7404050580878019,0.8480300187617261,0.9921929725627368,1.0,7/22,21.16%,RNF169;PARP10;ZBTB1;SPRTN;ZRANB3;IKBKE;WDR81
prerank,ATPase regulator activity (GO:0060590),0.23413991337766948,0.7397045184063817,0.888671875,0.994306512221405,1.0,14/38,22.56%,HSPBP1;DNAJC15;BRSK2;ATP1B1;PFN1;DNAJA2;DNAJB2;AHSA1;BAG2;DNAJC19;DNAJA1;BAG1;ATP1B2;FNIP2
prerank,histone deacetylase activity (GO:0004407),-0.2747881965858474,-0.7384738869811966,0.8313725490196079,0.991657390841962,1.0,13/19,38.07%,HDAC8;HDAC4;MIER1;HDAC1;HDAC2;SIRT3;HDAC3;MIER2;HDAC10;MIER3;HDAC5;SIRT6;SUDS3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.29699336473425036,-0.737013870777411,0.8142076502732241,0.990769688032639,1.0,1/13,0.48%,SLC7A2
prerank,metallocarboxypeptidase activity (GO:0004181),-0.24950761190743026,-0.7307959433701565,0.8638132295719845,0.9956417614623817,1.0,5/26,17.11%,AEBP1;AGBL3;CPM;CPXM2;CPXM1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2985012428675546,-0.7259844642505815,0.8534136546184738,0.9985379152974924,1.0,4/12,19.37%,VEGFA;VEGFD;ITGA5;ITGB3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.2825800996402564,0.7239149897656726,0.8622222222222222,1.0,1.0,4/14,15.33%,ISCU;ISCA2;ETFDH;RSAD2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.23688853714961386,-0.7189210606662215,0.879472693032015,1.0,1.0,7/29,17.27%,GANC;ACER3;HEXD;GUSB;PGGHG;GANAB;ABHD10
prerank,NF-kappaB binding (GO:0051059),-0.2501120876955852,-0.7176139648871898,0.8645833333333334,1.0,1.0,3/24,4.84%,EP300;GSK3B;ANXA4
prerank,DNA replication origin binding (GO:0003688),-0.25075935272863903,-0.7139702350461283,0.8605504587155963,1.0,1.0,15/23,44.85%,DHX9;MCM9;MCM6;ORC1;MCM4;MCMDC2;CDC45;POLA1;MCM2;MCM7;MCM5;MCM10;GRWD1;ORC3;CDC6
prerank,phosphatase activator activity (GO:0019211),-0.2859475067433048,-0.7136552847651758,0.8503937007874016,1.0,1.0,6/14,22.79%,FRS2;PPP2R5E;PPP2R5D;PPP2R5C;BMP2;GTF2F1
prerank,mRNA methyltransferase activity (GO:0008174),0.29437332977327896,0.712572725717892,0.8373101952277657,1.0,1.0,4/12,21.55%,CMTR2;CMTR1;METTL8;METTL3
prerank,receptor antagonist activity (GO:0048019),0.26776115534194045,0.7113582765792101,0.8893528183716075,1.0,1.0,1/17,2.62%,FST
prerank,GTPase inhibitor activity (GO:0005095),0.2863689303627499,0.709920237081534,0.8456221198156681,1.0,1.0,2/13,8.56%,IPO5;GPS2
prerank,CARD domain binding (GO:0050700),0.28479488686279153,0.7098398951744361,0.8518518518518519,1.0,1.0,3/14,11.60%,CARD19;NOD1;BCL10
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.29769416258588577,0.7083497884291189,0.8280254777070064,1.0,1.0,3/12,8.49%,TENT5C;TENT4A;PAPOLB
prerank,deoxyribonuclease activity (GO:0004536),0.27182687818190315,0.7068265229127105,0.8641975308641975,1.0,1.0,4/14,17.61%,APEX1;RPS3;DFFB;APLF
prerank,mitogen-activated protein kinase binding (GO:0051019),0.23505307316410398,0.7067578994638287,0.9078947368421053,1.0,1.0,8/29,17.11%,DUSP6;SIRT1;DIRAS1;PTPRJ;ATF7;GCH1;MAPKAPK2;TNIP1
prerank,gated channel activity (GO:0022836),-0.27980720000702913,-0.7060286692638195,0.8584558823529411,1.0,1.0,1/14,1.06%,PIEZO2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.29619819412469905,0.7010643475618993,0.8516129032258064,1.0,1.0,2/11,5.53%,SLC25A42;SLC25A23
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.19407542481857587,0.7007198869956249,0.9661354581673307,0.998489696374095,1.0,20/75,21.43%,HADHA;HADH;KCNAB1;HSD17B7;PHGDH;HPGD;PRXL2B;ABCC4;BDH1;KDSR;RDH11;HSD17B10;LDHB;IMPDH1;LDHA;NSDHL;RDH10;UGDH;HSD17B4;HSD3B7
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.28738540960597747,0.6994750779173906,0.8568421052631578,0.9958053993988882,1.0,2/12,5.53%,SLC25A42;SLC25A23
prerank,translation initiation factor activity (GO:0003743),-0.21897475106017197,-0.6960021732536463,0.9223484848484849,1.0,1.0,14/36,31.42%,EIF4G3;EIF4A2;EIF4E;EIF3A;EIF4G1;EIF3L;EIF2B4;EIF2B5;EIF4E3;EIF3H;EIF3C;EIF3M;COPS5;EIF2B1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.28113003456464314,0.6937674219837645,0.8611111111111112,0.9970680597965297,1.0,1/12,1.48%,SPPL2B
prerank,MHC protein binding (GO:0042287),-0.2510448212664288,-0.6919990523559557,0.908256880733945,1.0,1.0,7/20,35.68%,TAP2;DERL1;TAP1;CD81;ATP5F1A;LAG3;TAPBP
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.2919407040503465,-0.6905365595587515,0.8558225508317929,1.0,1.0,1/11,2.66%,SLC5A3
prerank,lysophospholipase activity (GO:0004622),0.248813568604522,0.6893353937305328,0.8898488120950324,0.9974588878712606,1.0,2/20,4.89%,ENPP2;LYPLA1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.28786453932119976,0.6892707406781418,0.8425357873210634,0.9937120314384418,1.0,6/12,21.70%,ISCU;ISCA2;ISCA1;CISD2;CIAPIN1;CISD1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.2807373682981163,0.6886284455318494,0.8872651356993737,0.9905818199009834,1.0,2/12,7.05%,TRAF1;TRIM37
prerank,voltage-gated chloride channel activity (GO:0005247),-0.30529968035585,-0.688606335902737,0.8764478764478765,1.0,1.0,3/10,24.00%,CLCN2;ANO1;CLCN6
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.2629128915741966,0.688461051996318,0.8711111111111111,0.9869292984507247,1.0,2/15,8.28%,ACKR4;GPR17
prerank,carbohydrate kinase activity (GO:0019200),0.2897986473370195,0.6880383656643516,0.875,0.9835274485680374,1.0,1/11,3.26%,KHK
prerank,chloride channel regulator activity (GO:0017081),-0.271051826656928,-0.6867946913454626,0.8752399232245681,1.0,1.0,7/14,31.15%,VTI1B;WNK4;WNK1;STX8;STX1A;STX7;SGK1
prerank,pyrophosphatase activity (GO:0016462),-0.20586401123843867,-0.6858927288744524,0.9580952380952381,1.0,1.0,22/50,32.30%,ENPP1;NUDT4;NUDT5;DHX9;PRUNE1;ENPP3;PPA1;DDX3X;ENTPD6;RNGTT;ALPL;PPA2;DOLPP1;NUDT1;NUDT11;PLPP1;PLPP5;NUDT7;CILP;FITM2;NUDT16;NUDT16L1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2368482701635065,-0.6827688694341024,0.9142857142857143,1.0,1.0,12/22,38.67%,RBMS3;DHX36;EXOSC9;CPEB1;NUDT21;CPSF1;ZFP36L2;EXOSC8;RBM24;ELAVL1;MEX3D;ILF3
prerank,histone methyltransferase binding (GO:1990226),-0.29301705366106795,-0.681572794672177,0.876425855513308,1.0,1.0,3/11,14.13%,LCOR;CBX1;PHF1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.20629393679910646,-0.6812520370765685,0.9342105263157895,1.0,1.0,7/46,14.24%,LARGE1;B3GALT1;EXT1;B3GLCT;MGAT3;OGT;HEXA
prerank,peptide hormone receptor binding (GO:0051428),0.2752150837061865,0.6684661754147805,0.8741721854304636,0.9958027311222934,1.0,1/11,7.53%,ADCYAP1
prerank,death receptor binding (GO:0005123),-0.2619903101519575,-0.666714544397125,0.8961538461538462,1.0,1.0,2/15,9.78%,EDA;NGF
prerank,WW domain binding (GO:0050699),-0.2262739419254105,-0.6585287696521577,0.9502868068833652,1.0,1.0,9/26,34.38%,PMEPA1;RAPGEF2;TCEAL9;WBP11;WBP1;TCEAL8;DAZAP2;TCEAL1;TRAF4
prerank,DNA polymerase activity (GO:0034061),-0.2317026475633071,-0.658252105230874,0.9317269076305221,1.0,1.0,13/22,38.89%,POLM;REV1;POLE4;TERT;POLN;PRIMPOL;POLE2;POLH;POLA1;POLE;POLD4;REV3L;POLE3
prerank,carboxypeptidase activity (GO:0004180),-0.20461231263008325,-0.6566354689219662,0.9487666034155597,1.0,1.0,6/35,17.11%,AEBP1;AGBL3;CPM;CTSA;CPXM2;CPXM1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.2384799970886594,-0.6553678117129811,0.931098696461825,1.0,1.0,6/20,20.39%,AGPAT4;ABHD5;GPAT4;MOGAT3;LPCAT1;GPAT3
prerank,ubiquitin-dependent protein binding (GO:0140036),0.28624481200314567,0.6524863092726655,0.8946236559139785,1.0,1.0,6/10,25.82%,DNAJB2;ANKRD13A;DNAJC2;USP15;ANKRD13D;LAPTM5
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.25079380322446804,-0.6508940900535563,0.9348230912476723,1.0,1.0,3/16,15.39%,MTMR12;MTMR3;SACM1L
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.20221379972828188,0.6493735726833675,0.9732510288065843,1.0,1.0,3/38,10.05%,SPOCK1;SERPINB8;SLPI
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.2723119187835543,0.6466466951302253,0.9134199134199135,1.0,1.0,4/12,18.99%,PIK3R3;ATM;IPMK;PIK3R6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.25181366414382084,-0.6461172413809709,0.9236499068901304,1.0,1.0,5/15,20.39%,AGPAT4;ABHD5;GPAT4;LPCAT1;GPAT3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.2565649418322412,-0.6445192891466459,0.9257142857142857,1.0,1.0,6/14,35.63%,MTHFR;ALDH1L1;ALDH4A1;PYCR2;AASS;PYCR3
prerank,P-type ion transporter activity (GO:0015662),0.266116907308814,0.6436420349888881,0.9118852459016393,0.9984936670178635,1.0,4/12,19.25%,ATP2B3;ATP2B2;ATP2B4;ATP2C1
prerank,glutathione transferase activity (GO:0004364),0.22412170319122204,0.6400171952956981,0.9369565217391305,0.9971180690517611,1.0,2/23,8.06%,GSTA4;GSTM5
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2642004401113638,-0.6379531612205621,0.9092592592592592,1.0,1.0,1/12,2.20%,B3GALT1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.23183602467041053,0.6327080258448379,0.9332023575638507,0.9978695510663881,1.0,4/17,16.65%,PECR;TECR;DHCR7;TM7SF2
prerank,C-C chemokine binding (GO:0019957),-0.22877120928166347,-0.6326845876582172,0.9339449541284404,1.0,1.0,15/22,54.92%,CCR9;CX3CR1;CCR5;ACKR1;CCR2;CXCR4;CCRL2;CXCR6;CCR1;ZFP36;CCR10;CXCR5;ACKR3;CCR6;CXCR2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2069230149994246,-0.6326250961337991,0.9730250481695568,1.0,1.0,17/35,33.76%,FTO;TRMT9B;PUS10;TARS2;ALKBH1;QTRT2;FTSJ1;LCMT2;DTWD1;DUS3L;ELAC2;DTWD2;MRPL58;TYW3;QRSL1;TRMT12;TRPT1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.26320843037225644,0.6304288201518718,0.9203354297693921,0.9954280102850812,1.0,3/11,15.47%,SGMS1;AASDHPPT;SAMD8
prerank,C-C chemokine receptor activity (GO:0016493),0.22400618616403106,0.6276741369456078,0.9351851851851852,0.9933023474237085,1.0,2/21,9.26%,ACKR4;GPR75
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.26655391656203986,0.6225874778141932,0.9317697228144989,0.9924016983011928,1.0,2/10,13.12%,APEX1;POLD1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2638052736472481,-0.6214063876852066,0.9313543599257885,1.0,1.0,6/11,32.88%,NABP2;CTC1;TERF2;STN1;RPA2;HNRNPA2B1
prerank,MHC class I protein binding (GO:0042288),-0.25069390610404096,-0.6200921319537083,0.9425493716337523,1.0,1.0,5/13,35.68%,TAP2;DERL1;TAP1;ATP5F1A;TAPBP
prerank,ribosomal large subunit binding (GO:0043023),-0.2588655224554884,-0.6180456292464409,0.9328214971209213,1.0,1.0,4/11,35.57%,MRRF;LTN1;DHX33;NPM1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.2381619312689697,-0.6094865754321201,0.945631067961165,1.0,1.0,5/15,27.77%,SH3PXD2B;PLA2G4A;PLEKHF1;JPH2;SAP30L
prerank,transferrin receptor binding (GO:1990459),-0.2635767982185774,-0.6073665291277905,0.9319470699432892,1.0,1.0,1/10,8.17%,RGMA
prerank,ribosomal small subunit binding (GO:0043024),-0.2210111415038566,-0.6055421100714072,0.9596928982725528,1.0,1.0,5/17,27.55%,LARP1;DDX3X;NME1;ERAL1;PIM1
prerank,adenyl nucleotide binding (GO:0030554),0.25697312431418556,0.5995508044670478,0.9219712525667351,0.996491613050995,1.0,1/11,1.66%,HSPBP1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.25697312431418556,0.5995508044670478,0.9219712525667351,0.996491613050995,1.0,1/11,1.66%,HSPBP1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.22968677179601427,0.5995340050235538,0.9544513457556936,0.9928842596778015,1.0,2/15,11.50%,P2RY1;P2RX7
prerank,ribosome binding (GO:0043022),-0.18004386333776148,-0.5985855319128196,0.9864077669902913,1.0,1.0,16/46,31.68%,YTHDF3;GEMIN5;SERBP1;NAA15;CPEB1;SHFL;PYM1;BAG6;NAA16;SRP72;EIF3C;IGHMBP2;CCDC47;C1QBP;SRP19;MRPS27
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.20870907322184395,-0.591442876681928,0.9764705882352941,1.0,1.0,12/21,38.89%,POLM;REV1;POLE4;POLN;PRIMPOL;POLE2;POLH;POLA1;POLE;POLD4;REV3L;POLE3
prerank,pseudouridine synthase activity (GO:0009982),-0.2402009138074912,-0.5910352106102205,0.9503676470588235,1.0,1.0,8/13,42.04%,PUS10;PUS3;RPUSD4;PUS1;PUS7L;PUSL1;RPUSD2;RPUSD3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.193313504934542,0.589216442601571,0.9766990291262136,0.9936756066164917,1.0,6/28,18.96%,TRAF1;TRIM37;DAB2IP;MADD;TMBIM1;RIPK1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.25509992581452096,-0.5887380184062342,0.9460966542750929,1.0,1.0,6/11,36.40%,NAA15;NAA16;NAA80;NAA25;NAA40;NAA10
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.24583671087010264,-0.577077134317853,0.965034965034965,1.0,1.0,2/11,11.71%,AKR1B1;AKR1A1
prerank,microtubule motor activity (GO:0003777),0.16942214487023918,0.576210024873486,0.9893842887473461,0.9951496856455674,1.0,12/51,20.01%,KIF1A;KIF21B;KIFC2;KIF26B;KIF19;KIFC3;STARD9;DNAH3;KIF21A;KIF18A;KIF1B;KIF26A
prerank,aspartic-type peptidase activity (GO:0070001),-0.25163735647811863,-0.574248250347307,0.9540441176470589,1.0,1.0,1/10,7.42%,DDI2
prerank,phospholipase A2 activity (GO:0004623),0.19515279978056,0.5710609742145999,0.9788583509513742,0.9933502635907584,1.0,5/26,19.73%,PLAAT1;PLA2G12A;PNPLA3;PLA2G4E;PRDX6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.22822451223335466,0.5708040578805523,0.9587628865979382,0.9898857134184286,1.0,5/14,18.82%,YOD1;MINDY1;MINDY2;ATXN3;OTUD7B
prerank,methyl-CpG binding (GO:0008327),-0.19823679224691715,-0.5694525075066287,0.9705340699815838,1.0,1.0,10/22,33.86%,MBD2;PRMT5;CXXC5;MBD3;CXXC4;ZBTB4;TET3;ZBTB38;ERH;ZBTB21
prerank,protein phosphatase 1 binding (GO:0008157),-0.19773729555507769,-0.5495067840649772,0.9792060491493384,1.0,1.0,5/21,22.77%,SHOC2;PPP1R3B;SH3RF2;PPP1R3C;PPP1R3F
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.21407793870655012,-0.5393674498230977,0.9799635701275046,1.0,1.0,2/14,13.06%,MTMR12;MTMR3
prerank,copper ion binding (GO:0005507),0.16789595437098392,0.5392361268687538,0.9958246346555324,0.9946954256362681,1.0,6/42,16.48%,AOC2;SNCA;ATOX1;SNCB;COX17;COA6
prerank,triglyceride lipase activity (GO:0004806),-0.18799649895575718,-0.5101184640649162,0.9893617021276596,1.0,1.0,4/20,26.17%,ABHD5;DAGLB;PNPLA2;LPL
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.22114526525807543,-0.49641310338265743,0.9888268156424581,1.0,1.0,5/10,36.40%,NAA15;NAA16;NAA80;NAA25;NAA10
prerank,single-stranded DNA helicase activity (GO:0017116),-0.18000835968380557,-0.49365829373955994,0.9926470588235294,1.0,1.0,10/19,43.69%,DHX9;MCM6;HELB;HELQ;RAD51;MCM2;MCM7;MCM5;DSCC1;CHTF18
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.16891043597598412,-0.4923987514125832,0.992467043314501,1.0,1.0,9/24,34.32%,DTYMK;NME6;ITPKC;NME1;IP6K2;CMPK2;AK1;AK7;PPIP5K2
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.19679623482585526,-0.4919490961052984,0.9923664122137404,1.0,1.0,5/14,27.09%,DTYMK;NME6;NME1;CMPK2;AK1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.2156376151364125,-0.4863545924597539,0.9849906191369606,1.0,1.0,4/10,34.04%,PML;ANKRD13B;FAAP20;IDE
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.18324683158687594,-0.4819582655413438,0.9926470588235294,1.0,1.0,5/17,27.09%,DTYMK;NME6;NME1;CMPK2;AK1
prerank,RNA methyltransferase activity (GO:0008173),-0.17458372309691447,-0.47187255867269673,0.9925093632958801,1.0,1.0,7/19,33.29%,TRMT9B;TGS1;FTSJ1;LCMT2;TYW3;MRM2;TRMT12
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.201420296005466,0.45980035273289666,0.9829787234042553,1.0,1.0,2/10,14.19%,PIK3R3;ATM
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.17619084466791687,0.45468390919045665,0.9977973568281938,1.0,1.0,2/15,17.41%,PLA2G12A;PLA2G4E
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.19264048711169032,0.44681576949904417,0.9954545454545455,0.997240730341342,1.0,4/10,24.19%,YOD1;ATXN3;STAMBP;CYLD
prerank,solute:proton symporter activity (GO:0015295),-0.16649890454653674,-0.42371298389703965,0.9981412639405205,1.0,1.0,6/16,33.63%,SLC33A1;SLC25A3;CTNS;SLC2A10;SLC17A5;SLC11A2
prerank,CCR chemokine receptor binding (GO:0048020),-0.12783010083850657,-0.38266726714872695,0.9981412639405205,0.9996238573977017,1.0,2/28,11.86%,NES;CNIH4
